LOCUS_COUNT	DISCOV_COUNT	TRAIT	CHR	BP	ID	A1	A2	A1_FREQ	BETA	SE	P	N	A1_FREQ_SE	A1_FREQ_MIN	A1_FREQ_MAX	DIRECTION	HET_ISQ	HetChiSq	HET_DF	HET_P	REGION	NEAREST_GENE	DISTANCE	GENES	CYTOBAND	NEAREST_GENE_BIOTYPE	NEAREST_GENE_DESCRIPTION	COJO_bJ	COJO_bJ_se	COJO_pJ	COJO_LD_r	LEAD_SNP	LEAD_SNP_KB	LEAD_SNP_RSQ	LEAD_SNP_ALLELES	LEAD_SNP_CHR	LEAD_SNP_BP	LEAD_SNP_GWS	sbayes_numCausal	sbayes_pep	sbayes_cssizes	sbayes_genes	susieR_snpCausal	susieR_minPurity	susieR_cssizes	susieR_genes	finemap_snpCausal	finemap_bestK	finemap_cssize	finemap_genes	nonsyn_customPthresh	SMR_eqtl	SMR_sqtl	GTEx_singleTissue	GTEx_multiTissue	PoPS	GWAS_CATALOG	prioritized	LITERATURE_LONG	LITERATURE_SHORT
1	1	gap_wm	1	39471759	1:39471759_CT_C	CT	C	0.8878	0.19904522	0.03377476	3.785e-09	53057	2e-04	0.8877	0.8881	++?	0	0.516	1	0.4728	downstream	AKIRIN1	0	AKIRIN1(dist=21)	1p34.3	protein_coding	akirin 1	0.19748	0.0337868	5.06934e-09	0.00885029	1:39471759_CT_C	0	1	CT/C	1	39471759	1	1	0.89	3	AKIRIN1 (0.892) | NDUFS5 (0.072)	1	0.87	22	AKIRIN1 (0.433) | MACF1 (0.311) | NDUFS5 (0.217)	1.34	1	21	AKIRIN1 (0.438) | MACF1 (0.314) | NDUFS5 (0.200)	NA	AKIRIN1 (rs35796260;1e-06) | RHBDL2 (rs2147594;4e-05)	NDUFS5 (rs4427397;7e-07)	AKIRIN1 (11;2e-20) | NDUFS5 (3;4e-08)	NDUFS5 (27/49;2e-39)	NDUFS5 (0.73) | AKIRIN1 (0.18) | RHBDL2 (0.15)	NA	NDUFS5	Novel	-
2	1	gap_wm	1	153888217	rs552429854	T	TA	0.3675	0.14181831	0.02251521	3e-10	54890	0.0019	0.3651	0.3691	+++	0	0.598	2	0.7415	intronic	GATAD2B	0	GATAD2B	1q21.3	protein_coding	GATA zinc finger domain containing 2B	0.14099	0.0225243	3.8636e-10	-0.00732633	rs552429854	0	1	T/TA	1	153888217	1	1	0.69	6	GATAD2B (0.721) | DENND4B (0.149) | LOC343052 (0.135)	1	0.87	6	GATAD2B (0.892) | LOC343052 (0.044) | SLC39A1 (0.018)	1.16	1	5	GATAD2B (0.896) | LOC343052 (0.041) | SLC39A1 (0.017)	NA	NA	NA	CREB3L4 (21;3e-33) | DENND4B (7;4e-07) | ENSG00000272030 (5;2e-07) | NUP210L (4;3e-06) | CRTC2 (4;5e-06) | SLC39A1 (3;5e-09) | RAB13 (2;8e-07) | SLC27A3 (2;5e-06) | S100A16 (2;1e-05) | S100A14 (1;5e-06) | S100A1 (1;8e-06) | CHTOP (1;2e-05) | S100A13 (1;2e-05) | SNAPIN (1;2e-05) | C1orf43 (1;1e-04)	NUP210L (25/29;3e-41) | CREB3L4 (38/49;1e-274) | ENSG00000272030 (38/49;1e-46) | CRTC2 (28/49;4e-27) | DENND4B (26/49;3e-52)	S100A4 (0.67) | RAB13 (0.47) | NPR1 (0.27)	Height	DENND4B	Smith_2020 (rs12133923)	S
2	2	gap_gwm	1	153888217	rs552429854	T	TA	0.3675	0.13140573	0.02156296	1.101e-09	54890	0.0019	0.3651	0.3691	+++	0	1.114	2	0.5728	intronic	GATAD2B	0	GATAD2B	1q21.3	protein_coding	GATA zinc finger domain containing 2B	0.131406	0.0215706	1.11585e-09	0	rs552429854	0	1	T/TA	1	153888217	1	1	0.63	9	GATAD2B (0.615) | LOC343052 (0.161) | DENND4B (0.122) | SLC39A1 (0.075)	1	0.87	4	GATAD2B (0.924) | SLC39A1 (0.015) | LOC343052 (0.013)	1.36	1	4	GATAD2B (0.933) | SLC39A1 (0.014) | LOC343052 (0.012)	NA	NA	NA	NA	NA	RAB13 (0.54) | S100A4 (0.54) | TPM3 (0.19)	NA	RAB13	Smith_2020 (rs12133923)	S
3	1	gap_wm	1	180956936	rs35306826	A	T	0.5941	-0.22362235	0.02131966	9.703e-26	54890	0.0034	0.5821	0.598	---	34.7	3.063	2	0.2162	intronic	STX6	0	STX6	1q25.3	protein_coding	syntaxin 6	-0.223622	0.0213409	1.08343e-25	0	rs35306826	0	1	A/T	1	180956936	1	1	0.68	6	STX6 (1.013)	1	0.98	30	STX6 (0.962)	1.74	2	30 | 258	STX6 (0.985) | IER5 (0.790) | MR1 (0.109) | KIAA1614 (0.013) | XPR1 (0.012) | LINC01732 (0.005) | KIAA1614-AS1 (0.003) | LINC01699 (0.001)	NA	STX6 (rs11586493;5e-20)	STX6 (rs57113693;1e-07)	STX6 (10;2e-13) | KIAA1614 (5;1e-12) | ENSG00000243155 (4;6e-08) | KIAA1614-AS1 (1;2e-07) | MR1 (1;1e-04)	NA	IER5 (0.89) | STX6 (0.86) | MR1 (0.56)	Age at menopause | aseg lh intensity Accumbens-area | aseg lh number HolesBeforeFixing | aseg lh volume CerebralWhiteMatter | aseg rh intensity Accumbens-area | aseg rh intensity Cerebellum-Cortex | aseg rh number HolesBeforeFixing | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Cortical thickness | Creutzfeldt-Jakob disease (sporadic) | Educational attainment | Height | IDP T1 FAST ROIs L ventral striatum | Intralaminar thalamic nuclei volume | KLK6/MOG protein level ratio | Lower thalamus volume | Medial temporal thickness (unadjusted for global measures) | Menopause (age at onset) | Paralaminar nucleus volume | Progressive supranuclear palsy | QC T2 FLAIR-to-T1 linear alignment discrepancy | Regional cortical thickness (rostralmiddlefrontal) | Regional cortical thickness (superiorfrontal) | Subcortical volume (MOSTest) | Vertex-wise cortical thickness | wg lh intensity-contrast caudalmiddlefrontal | wg lh intensity-contrast entorhinal | wg lh intensity-contrast frontalpole | wg lh intensity-contrast fusiform | wg lh intensity-contrast inferiorparietal | wg lh intensity-contrast inferiortemporal | wg lh intensity-contrast insula | wg lh intensity-contrast isthmuscingulate | wg lh intensity-contrast lateraloccipital | wg lh intensity-contrast lateralorbitofrontal | wg lh intensity-contrast lingual | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast middletemporal | wg lh intensity-contrast parahippocampal | wg lh intensity-contrast parsopercularis | wg lh intensity-contrast parsorbitalis | wg lh intensity-contrast parstriangularis | wg lh intensity-contrast posteriorcingulate | wg lh intensity-contrast precuneus | wg lh intensity-contrast rostralanteriorcingulate | wg lh intensity-contrast rostralmiddlefrontal | wg lh intensity-contrast superiorfrontal | wg lh intensity-contrast superiorparietal | wg lh intensity-contrast superiortemporal | wg lh intensity-contrast supramarginal | wg lh intensity-contrast temporalpole | wg rh intensity-contrast bankssts | wg rh intensity-contrast caudalmiddlefrontal | wg rh intensity-contrast frontalpole | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiorparietal | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast insula | wg rh intensity-contrast isthmuscingulate | wg rh intensity-contrast lateraloccipital | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast medialorbitofrontal | wg rh intensity-contrast middletemporal | wg rh intensity-contrast parahippocampal | wg rh intensity-contrast parsopercularis | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast parstriangularis | wg rh intensity-contrast posteriorcingulate | wg rh intensity-contrast precuneus | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast rostralmiddlefrontal | wg rh intensity-contrast superiorfrontal | wg rh intensity-contrast superiorparietal | wg rh intensity-contrast superiortemporal | wg rh intensity-contrast supramarginal | wg rh intensity-contrast temporalpole | White matter microstructure (mode of anisotropy) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	STX6	Smith_2020 (rs6665134), Kim_2023 (rs534102361)	S,K
3	2	gap_gwm	1	180956936	rs35306826	A	T	0.5942	-0.16650624	0.02042709	3.602e-16	54890	0.0034	0.5821	0.598	---	0	1.579	2	0.454	intronic	STX6	0	STX6	1q25.3	protein_coding	syntaxin 6	-0.166506	0.0204393	3.74984e-16	0	rs35306826	0	1	A/T	1	180956936	1	1	0.72	2	STX6 (0.988)	1	0.78	35	STX6 (0.978)	1.26	1	35	STX6 (0.961)	NA	STX6 (rs11586493;2e-13)	STX6 (rs57113693;1e-06)	STX6 (10;2e-13) | KIAA1614 (5;1e-12) | ENSG00000243155 (4;6e-08) | KIAA1614-AS1 (1;1e-07) | MR1 (1;1e-04)	NA	IER5 (0.72) | STX6 (0.68) | MR1 (0.67)	Age at menopause | aseg lh intensity Accumbens-area | aseg lh number HolesBeforeFixing | aseg lh volume CerebralWhiteMatter | aseg rh intensity Accumbens-area | aseg rh intensity Cerebellum-Cortex | aseg rh number HolesBeforeFixing | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Cortical thickness | Creutzfeldt-Jakob disease (sporadic) | Educational attainment | Height | IDP T1 FAST ROIs L ventral striatum | Intralaminar thalamic nuclei volume | KLK6/MOG protein level ratio | Lower thalamus volume | Medial temporal thickness (unadjusted for global measures) | Menopause (age at onset) | Paralaminar nucleus volume | Progressive supranuclear palsy | QC T2 FLAIR-to-T1 linear alignment discrepancy | Regional cortical thickness (rostralmiddlefrontal) | Regional cortical thickness (superiorfrontal) | Subcortical volume (MOSTest) | Vertex-wise cortical thickness | wg lh intensity-contrast caudalmiddlefrontal | wg lh intensity-contrast entorhinal | wg lh intensity-contrast frontalpole | wg lh intensity-contrast fusiform | wg lh intensity-contrast inferiorparietal | wg lh intensity-contrast inferiortemporal | wg lh intensity-contrast insula | wg lh intensity-contrast isthmuscingulate | wg lh intensity-contrast lateraloccipital | wg lh intensity-contrast lateralorbitofrontal | wg lh intensity-contrast lingual | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast middletemporal | wg lh intensity-contrast parahippocampal | wg lh intensity-contrast parsopercularis | wg lh intensity-contrast parsorbitalis | wg lh intensity-contrast parstriangularis | wg lh intensity-contrast posteriorcingulate | wg lh intensity-contrast precuneus | wg lh intensity-contrast rostralanteriorcingulate | wg lh intensity-contrast rostralmiddlefrontal | wg lh intensity-contrast superiorfrontal | wg lh intensity-contrast superiorparietal | wg lh intensity-contrast superiortemporal | wg lh intensity-contrast supramarginal | wg lh intensity-contrast temporalpole | wg rh intensity-contrast bankssts | wg rh intensity-contrast caudalmiddlefrontal | wg rh intensity-contrast frontalpole | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiorparietal | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast insula | wg rh intensity-contrast isthmuscingulate | wg rh intensity-contrast lateraloccipital | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast medialorbitofrontal | wg rh intensity-contrast middletemporal | wg rh intensity-contrast parahippocampal | wg rh intensity-contrast parsopercularis | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast parstriangularis | wg rh intensity-contrast posteriorcingulate | wg rh intensity-contrast precuneus | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast rostralmiddlefrontal | wg rh intensity-contrast superiorfrontal | wg rh intensity-contrast superiorparietal | wg rh intensity-contrast superiortemporal | wg rh intensity-contrast supramarginal | wg rh intensity-contrast temporalpole | White matter microstructure (mode of anisotropy) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	STX6	Smith_2020 (rs6665134), Kim_2023 (rs534102361)	S,K
4	1	gap_wm	1	212557599	rs3767867	T	C	0.6179	-0.13722613	0.02147043	1.644e-10	54890	0.0018	0.6088	0.6186	---	0	1.194	2	0.5506	intronic	PACC1	0	PACC1	1q32.3	protein_coding	proton activated chloride channel 1	-0.137109	0.0214782	1.7293e-10	0.000879213	rs3767867	0	1	T/C	1	212557599	1	NA	NA	NA	NA	NA	NA	NA	NA	1.49	1	24	PACC1 (0.757) | PPP2R5A (0.113) | NENF (0.059) | LINC02608 (0.027)	NA	PACC1 (rs6540738;2e-08)	TMEM206 (rs765364;8e-06)	LINC02608 (15;2e-18) | PACC1 (14;1e-18) | PPP2R5A (5;1e-19) | ENSG00000229832 (3;2e-09) | NENF (2;1e-04) | LINC02771 (1;1e-04)	LINC02608 (17/25;2e-115) | ENSG00000229832 (21/39;1e-27)	PPP2R5A (0.44) | NENF (0.38) | TMEM206 (0.36)	Height	PACC1	Novel	-
4	2	gap_gwm	1	212557599	rs3767867	T	C	0.6179	-0.12561551	0.0205648	1.007e-09	54890	0.0017	0.6088	0.6186	---	0	1.523	2	0.4669	intronic	PACC1	0	PACC1	1q32.3	protein_coding	proton activated chloride channel 1	-0.124331	0.0205727	1.50835e-09	-0.0103847	rs3767867	0	1	T/C	1	212557599	1	NA	NA	NA	NA	NA	NA	NA	NA	1.63	2	93 | 119	NENF (0.732) | LINC02608 (0.514) | PACC1 (0.374) | LINC01740 (0.226) | PPP2R5A (0.045) | ATF3 (0.011)	NA	PACC1 (rs6540738;4e-08)	TMEM206 (rs765364;1e-05)	LINC02608 (15;2e-18) | PACC1 (14;1e-18) | PPP2R5A (5;1e-19) | ENSG00000229832 (3;2e-09) | NENF (2;1e-04) | LINC02771 (1;1e-04)	LINC02608 (17/25;2e-115) | ENSG00000229832 (21/39;1e-27)	ATF3 (0.50) | TMEM206 (0.38) | NENF (0.27)	Height	TMEM206	Novel	-
5	1	gap_gm	1	215139887	rs1452628	A	T	0.6216	0.1945586	0.02164881	2.54e-19	54890	0.0058	0.6204	0.6535	+++	14.9	2.351	2	0.3086	intergenic	KCNK2	38998	CENPF(dist=301973),KCNK2(dist=38998)	1q41	protein_coding	potassium two pore domain channel subfamily K member 2	0.198913	0.0216795	4.50934e-20	-0.0372191	rs1452628	0	1	A/T	1	215139887	1	1	0.88	7	KCNK2 (0.956)	1	0.97	4	KCNK2 (1.000)	2.27	2	2 | 13	KCNK2 (1.914)	NA	NA	NA	KCNK2 (1;2e-05)	NA	KCNK2 (0.95) | CENPF (0.45)	aparc-a2009s lh thickness S-cingul-Marginalis | aparc-a2009s lh thickness S-intrapariet+P-trans | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Cortical surface area | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Edge-level brain connectivity (multivariate analysis) | Extensive hippocampal perivascular space burden | Extensive white matter perivascular space burden | Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivity | Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivity | Node-level brain connectivity (multivariate analysis) | Regional cortical thickness (precuneus) | Regional cortical thickness (superiorparietal) | Superior parietal thickness (unadjusted for global measures) | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	KCNK2	Wen_2024 (rs1452628), Jonsson_2019 (rs1452628)	W,J
5	3	gap_wm	1	215147374	rs78300504	A	G	0.0684	-0.2584537	0.04146299	4.565e-10	54890	0.0014	0.0652	0.0702	---	79.6	9.803	2	0.007437	intergenic	KCNK2	31511	CENPF(dist=309460),KCNK2(dist=31511)	1q41	protein_coding	potassium two pore domain channel subfamily K member 2	-0.258222	0.0414773	4.79679e-10	0	rs1452628	7.49	0.119	TA/AG	1	215139887	1	1	0.84	6	KCNK2 (0.962)	1	0.79	10	KCNK2 (0.986)	1.32	1	9	KCNK2 (0.953)	NA	NA	NA	KCTD3 (1;6e-05)	NA	KCNK2 (0.22) | CENPF (0.05)	Brain morphology (MOSTest) | Brain region volumes | IDP dMRI ProbtrackX ISOVF slf l | IDP dMRI ProbtrackX ISOVF slf r | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)	KCNK2	Wen_2024 (rs1452628), Jonsson_2019 (rs1452628)	W,J
6	1	gap_wm	2	56116193	2:56116193_TTGATTCTTGGCCTCCCTCCC_T	T	TTGATTCTTGGCCTCCCTCCC	0.0955	0.20201504	0.03609678	2.187e-08	54890	0.0038	0.0727	0.0967	+++	49.2	3.94	2	0.1394	intronic	EFEMP1	0	EFEMP1	2p16.1	protein_coding	EGF containing fibulin extracellular matrix protein 1	0.202015	0.036107	2.20755e-08	0	2:56116193_TTGATTCTTGGCCTCCCTCCC_T	0	1	T/TTGATTCTTGGCCTCCCTCCC	2	56116193	1	NA	NA	NA	NA	NA	NA	NA	NA	1.95	2	35 | 390	EFEMP1 (0.916) | CCDC88A (0.899) | MIR217HG (0.023) | MTIF2 (0.021) | CFAP36 (0.021) | PNPT1 (0.009) | PPP4R3B (0.006) | CLHC1 (0.004) | PRORSD1P (0.002) | LINC01813 (0.000) | RPS27A (0.000)	NA	NA	NA	EFEMP1 (1;6e-05)	NA	CCDC104 (0.21) | PNPT1 (0.16) | SMEK2 (0.13)	Extensive white matter perivascular space burden | Inguinal hernia | Periventricular white matter hyperintensities | White matter hyperintensities | White matter hyperintensity volume | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	EFEMP1	Novel	-
7	1	gap_gm	2	188028317	rs62172472	A	G	0.2021	-0.1513803	0.02616551	7.23e-09	54890	0.0042	0.2011	0.2244	---	0	1.045	2	0.593	intergenic	CALCRL	178375	ZSWIM2(dist=314420),CALCRL(dist=178375)	2q32.1	protein_coding	calcitonin receptor like receptor	-0.15138	0.0261733	7.30419e-09	0	rs62172472	0	1	A/G	2	188028317	1	1	0.77	5	CALCRL (0.909) | TFPI (0.104)	1	0.68	176	CALCRL (0.936) | TFPI (0.015)	1.1	1	171	CALCRL (0.936) | TFPI (0.015)	TFPI (1;rs7586970;20.200)	NA	NA	CALCRL-AS1 (9;4e-11) | CALCRL (7;1e-70) | TFPI (7;4e-07) | FAM171B (2;2e-06)	CALCRL-AS1 (23/45;6e-62)	CALCRL (0.90) | TFPI (0.88)	A body shape index | Aspartate aminotransferase levels | Cancer (pleiotropy) | Eczema | Heel bone mineral density | Height | High density lipoprotein cholesterol levels | Lymphocyte count | Resting heart rate | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98) | Waist circumference adjusted for body mass index | Waist-hip index | Waist-to-hip ratio adjusted for BMI | White blood cell count | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | Whole brain free water diffusion (multivariate analysis)	TFPI	Novel	-
8	1	gap_wm	2	190694175	rs1233297	T	C	0.2649	0.16370119	0.02356731	3.755e-12	54890	0.0034	0.2642	0.2827	+++	0	1.161	2	0.5595	intronic	PMS1	0	PMS1	2q32.2	protein_coding	PMS1 homolog 1%2C mismatch repair system component	0.163701	0.0235773	3.83423e-12	0	rs1233297	0	1	T/C	2	190694175	1	1	0.63	32	PMS1 (0.423) | ORMDL1 (0.200) | ANKAR (0.166) | ASNSD1 (0.062) | ASDURF (0.046) | OSGEPL1 (0.044) | OSGEPL1-AS1 (0.021)	1	0.54	67	PMS1 (0.557) | ANKAR (0.215) | ORMDL1 (0.088) | OSGEPL1 (0.034) | ASDURF (0.029) | OSGEPL1-AS1 (0.020) | ASNSD1 (0.008)	1.19	1	66	PMS1 (0.564) | ANKAR (0.210) | ORMDL1 (0.087) | OSGEPL1 (0.034) | ASDURF (0.028) | OSGEPL1-AS1 (0.020) | ASNSD1 (0.008)	NA	ORMDL1 (rs6741074;2e-10) | AC013468.1 (rs10197331;3e-10) | OSGEPL1-AS1 (rs757537817;4e-07)	ORMDL1 (rs1233272;4e-08) | PMS1 (rs10210345;6e-08) | OSGEPL1-AS1 (rs10210345;6e-06)	ORMDL1 (47;7e-99) | ASNSD1 (46;6e-80) | OSGEPL1-AS1 (33;2e-22) | ENSG00000273240 (32;6e-20) | PMS1 (17;7e-42) | ANKAR (3;1e-05) | OSGEPL1 (3;6e-05) | HIBCH (1;5e-05)	ORMDL1 (48/49;0e+00) | OSGEPL1-AS1 (47/49;7e-227) | HIBCH (46/49;7e-20) | ASNSD1 (42/49;0e+00) | ENSG00000273240 (42/49;2e-302) | PMS1 (29/49;8e-151) | ANKAR (29/49;2e-26) | OSGEPL1 (28/49;2e-20)	C2orf88 (0.25) | ANKAR (0.16) | OSGEPL1 (0.15)	p53 and DNA damage-regulated protein 1 levels	ORMDL1	Smith_2020 (rs151052089)	S
8	2	gap_gwm	2	190700494	rs1233245	A	G	0.2528	0.14012091	0.02300453	1.122e-09	54890	0.0038	0.2521	0.2737	+++	0	0.616	2	0.7349	intronic	PMS1	0	PMS1	2q32.2	protein_coding	PMS1 homolog 1%2C mismatch repair system component	0.139147	0.0230126	1.47957e-09	0.00691106	rs1233297	6.32	0.908	TA/CG	2	190694175	1	1	0.59	11	ORMDL1 (0.464) | PMS1 (0.288) | ASDURF (0.125) | OSGEPL1-AS1 (0.049) | ANKAR (0.045)	NA	NA	NA	NA	1.25	1	115	PMS1 (0.550) | ANKAR (0.210) | ORMDL1 (0.081) | ASDURF (0.038) | OSGEPL1 (0.033) | ASNSD1 (0.021) | OSGEPL1-AS1 (0.018)	NA	ORMDL1 (rs6741074;4e-08) | AC013468.1 (rs10197331;5e-08) | ASNSD1 (rs2289226;6e-08) | OSGEPL1-AS1 (rs757537817;4e-06)	PMS1 (rs10210345;2e-07) | ORMDL1 (rs1233272;8e-07) | OSGEPL1-AS1 (rs10210345;3e-05)	ORMDL1 (47;2e-73) | ASNSD1 (46;6e-56) | OSGEPL1-AS1 (33;7e-20) | ENSG00000273240 (32;1e-13) | PMS1 (16;5e-33) | ANKAR (3;2e-05) | OSGEPL1 (3;6e-05) | HIBCH (1;4e-05)	ORMDL1 (48/49;0e+00) | HIBCH (47/49;4e-27) | OSGEPL1-AS1 (46/49;7e-184) | ASNSD1 (41/49;0e+00) | ENSG00000273240 (40/49;4e-198) | ANKAR (29/49;2e-26) | OSGEPL1 (28/49;2e-20) | PMS1 (26/49;7e-112)	ASNSD1 (0.14) | ANKAR (0.14) | HIBCH (0.13)	p53 and DNA damage-regulated protein 1 levels	ORMDL1	Smith_2020 (rs151052089)	S
9	1	gap_gm	2	198567638	rs12619333	C	G	0.6678	0.137745	0.02259225	1.081e-09	53057	2e-04	0.6676	0.668	++?	0	0.386	1	0.5342	intergenic	MARS2	2455	RFTN2(dist=27327),MARS2(dist=2455)	2q33.1	protein_coding	methionyl-tRNA synthetase 2%2C mitochondrial	0.140205	0.022603	5.54247e-10	-0.0169785	rs12619333	0	1	C/G	2	198567638	1	1	0.59	17	SF3B1 (0.293) | PLCL1 (0.198) | RFTN2 (0.156) | HSPD1 (0.120) | ANKRD44-IT1 (0.097) | ANKRD44 (0.049) | HSPE1-MOB4 (0.047)	NA	NA	NA	NA	1.27	1	436	PLCL1 (0.373) | RFTN2 (0.279) | BOLL (0.147) | SF3B1 (0.057) | MARS2 (0.056) | HSPE1-MOB4 (0.025) | HSPD1 (0.007) | COQ10B (0.007)	NA	NA	NA	SF3B1 (20;5e-19) | ANKRD44 (6;1e-20) | PLCL1 (5;5e-13) | RFTN2 (4;4e-08) | ANKRD44-AS1 (3;6e-14) | MARS2 (2;6e-05) | ENSG00000222017 (1;6e-05) | HSPD1 (1;2e-04)	SF3B1 (44/49;3e-154)	PLCL1 (1.38) | RFTN2 (0.49) | HSPD1 (0.30)	Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | Bipolar disorder or glomerular filtration rate estimated from cystatin (MTAG) | Bipolar disorder or major depressive disorder | Brain morphology (MOSTest) | Cortical surface area | Depression | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Inferior parietal area (unadjusted for global measures) | Intracranial aneurysm | Motor premotor area (unadjusted for global measures) | Orbitofrontal area (unadjusted for global measures) | Parsopercularis area (unadjusted for global measures) | Platelet count | Precuneus area (unadjusted for global measures) | Right molecular layer hippocampal volume (head) | Schizophrenia | Superior temporal area (unadjusted for global measures) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	SF3B1	Novel	-
9	2	gap_gwm	2	198245965	rs55775495	T	C	0.6477	0.12655777	0.02091293	1.434e-09	54890	9e-04	0.6468	0.6508	++-	36.8	3.165	2	0.2054	intergenic	SF3B1	10733	ANKRD44(dist=70461),SF3B1(dist=10733)	2q33.1	protein_coding	splicing factor 3b subunit 1	0.128153	0.0209237	9.08102e-10	-0.018385	rs12619333	-322	0.696	GC/CT	2	198567638	1	1	0.6	16	PLCL1 (0.389) | SF3B1 (0.388) | RFTN2 (0.086) | HSPE1-MOB4 (0.056) | HSPD1 (0.032)	1	0.75	279	PLCL1 (0.766) | RFTN2 (0.428) | SF3B1 (0.241) | BOLL (0.210) | HSPE1-MOB4 (0.129) | MARS2 (0.110) | HSPD1 (0.041) | COQ10B (0.036)	1.07	1	279	PLCL1 (0.349) | RFTN2 (0.180) | SF3B1 (0.143) | BOLL (0.143) | MARS2 (0.062) | HSPE1-MOB4 (0.041) | HSPD1 (0.018) | COQ10B (0.017)	NA	SF3B1 (rs2914983;6e-07)	SF3B1 (rs2565163;7e-05)	SF3B1 (21;1e-16) | ANKRD44 (7;1e-23) | PLCL1 (4;2e-08) | RFTN2 (4;4e-05) | ANKRD44-AS1 (3;1e-17) | ENSG00000222017 (1;7e-05) | HSPD1 (1;1e-04)	SF3B1 (42/49;3e-143)	PLCL1 (1.31) | HSPD1 (0.72) | HSPE1 (0.37)	Autism spectrum disorder or schizophrenia | Bipolar disorder (MTAG) | Bipolar disorder or glomerular filtration rate estimated from cystatin (MTAG) | Brain morphology (MOSTest) | Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) | Cortical surface area | Cortical thickness | Depression | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Edge-level brain connectivity (multivariate analysis) | Hay fever and/or eczema | Insomnia | Major depressive disorder (broad) | Motor premotor area (unadjusted for global measures) | Orbitofrontal area (unadjusted for global measures) | Parsopercularis area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Schizophrenia | Schizophrenia (MTAG) | Superior temporal area (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Whole brain restricted isotropic diffusion (multivariate analysis)	SF3B1	Novel	-
10	1	gap_gm	2	201160771	rs1367858	T	C	0.3362	0.14620146	0.02213611	3.984e-11	54890	0.0091	0.2847	0.3385	++-	48.4	3.877	2	0.1439	intergenic	SPATS2L	9831	MAIP1(dist=331931),SPATS2L(dist=9831)	2q33.1	protein_coding	spermatogenesis associated serine rich 2 like	0.147213	0.0221484	2.99825e-11	-0.00808423	rs1367858	0	1	T/C	2	201160771	1	1	0.66	8	SPATS2L (0.961)	NA	NA	NA	NA	1.61	2	309 | 523	SPATS2L (1.159) | MAIP1 (0.478) | C2orf69 (0.103) | TYW5 (0.098) | FTCDNL1 (0.059) | SGO2 (0.002) | KCTD18 (0.001)	NA	NA	NA	FTCDNL1 (21;9e-09) | C2orf69 (6;2e-08) | SPATS2L (5;1e-18) | TYW5 (2;3e-05) | MAIP1 (1;2e-07) | ENSG00000232732 (1;9e-05)	FTCDNL1 (46/49;5e-118) | C2orf69 (31/49;4e-39) | TYW5 (31/49;5e-26)	SPATS2L (0.46) | C2orf69 (0.27) | TYW5 (0.22)	Bipolar disorder (MTAG) | Cognitive performance (MTAG) | Highest math class taken (MTAG) | Reaction time | Schizophrenia	SPATS2L	Novel	-
10	2	gap_gwm	2	201160771	rs1367858	T	C	0.3364	0.13277712	0.02112852	3.294e-10	54890	0.0087	0.2847	0.3385	++-	45.1	3.644	2	0.1617	intergenic	SPATS2L	9831	MAIP1(dist=331931),SPATS2L(dist=9831)	2q33.1	protein_coding	spermatogenesis associated serine rich 2 like	0.133861	0.0211401	2.41894e-10	-0.00808423	rs1367858	0	1	T/C	2	201160771	1	1	0.7	6	SPATS2L (0.954)	NA	NA	NA	NA	1.31	1	123	SPATS2L (0.912) | MAIP1 (0.021) | TYW5 (0.013) | C2orf69 (0.005)	NA	NA	NA	FTCDNL1 (21;9e-09) | C2orf69 (6;2e-08) | SPATS2L (5;1e-18) | TYW5 (2;3e-05) | MAIP1 (1;2e-07) | ENSG00000232732 (1;9e-05)	FTCDNL1 (46/49;5e-118) | C2orf69 (31/49;4e-39) | TYW5 (31/49;5e-26)	SPATS2L (0.59) | C2orf69 (0.30) | TYW5 (0.17)	Bipolar disorder (MTAG) | Cognitive performance (MTAG) | Highest math class taken (MTAG) | Reaction time | Schizophrenia	SPATS2L	Novel	-
11	1	gap_gwm	2	203877365	rs530464314	CA	C	0.1432	-0.22801074	0.02917442	5.477e-15	54890	0.0021	0.1327	0.1449	---	0	0.023	2	0.9885	intergenic	NBEAL1	2237	CARF(dist=24379),NBEAL1(dist=2237)	2q33.2	protein_coding	neurobeachin like 1	-0.226589	0.0291919	8.35714e-15	0	rs530464314	0	1	CA/C	2	203877365	1	1	0.71	6	CARF (0.505) | NBEAL1 (0.392) | WDR12 (0.058)	1	0.89	262	CARF (0.479) | NBEAL1 (0.393) | ICA1L (0.388) | WDR12 (0.224) | CYP20A1 (0.065) | ABI2 (0.007)	1.1	1	264	CARF (0.273) | NBEAL1 (0.265) | ICA1L (0.227) | WDR12 (0.129) | CYP20A1 (0.053) | ABI2 (0.005)	WDR12 (1;rs35212307;15.630) | CARF (1;rs72932557;1.747)	ICA1L (rs72932772;6e-12) | CARF (rs143805266;7e-10) | NBEAL1 (rs72932588;1e-09)	ICA1L (rs72932780;4e-11) | CARF (rs72934745;5e-10) | NBEAL1 (rs115400054;4e-07)	CARF (22;1e-35) | ICA1L (18;8e-33) | NBEAL1 (13;4e-69) | FAM117B (6;2e-09) | WDR12 (2;3e-05) | BMPR2 (1;8e-06) | ENSG00000273456 (1;1e-04) | CYP20A1 (1;3e-04)	CARF (38/49;4e-217) | ICA1L (25/49;3e-195)	CYP20A1 (0.33) | ICA1L (0.26) | WDR12 (0.19)	Alzheimer's disease | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Angina pectoris | Body fat percentage or coronary artery disease (MTAG) | Brain morphology (MOSTest) | Cholesterol, total | Coronary artery disease | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | Coronary artery disease or fibrinogen levels (pleiotropy) | Coronary artery disease or ischemic stroke | Coronary artery disease or large artery stroke | Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | Coronary heart disease | Cortical surface area | Cortical thickness | Extensive basal ganglia perivascular space burden | Headache or migraine | Hemoglobin concentration | IDP dMRI TBSS ISOVF External capsule L | IDP dMRI TBSS L2 Anterior limb of internal capsule R | Insomnia | Migraine | Migraine (MTAG) | Myocardial infarction | Myocardial infarction (early onset) | Non-lobar intracerebral hemorrhage (MTAG) | Periventricular white matter hyperintensities | Personality traits or cognitive traits (multivariate analysis) | Pulse pressure | Renin levels | Small vessel stroke (MTAG) | Smoking initiation | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | Vertex-wise cortical thickness | White matter fractional anisotropy x age interaction (2df) | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | White matter integrity (fractional anisotropy) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities)	CARF	Wen_2024 (rs186399184)	W
11	2	gap_gm	2	203877365	rs530464314	CA	C	0.1432	-0.22575127	0.03056844	1.523e-13	54890	0.0021	0.1327	0.1449	---	0	0.064	2	0.9684	intergenic	NBEAL1	2237	CARF(dist=24379),NBEAL1(dist=2237)	2q33.2	protein_coding	neurobeachin like 1	-0.224092	0.0305849	2.35548e-13	0	rs530464314	0	1	CA/C	2	203877365	1	1	0.69	9	CARF (0.342) | ICA1L (0.311) | NBEAL1 (0.224) | WDR12 (0.102)	1	0.90	265	ICA1L (0.565) | CARF (0.470) | NBEAL1 (0.352) | WDR12 (0.214) | CYP20A1 (0.008)	1.08	1	267	ICA1L (0.361) | CARF (0.249) | NBEAL1 (0.224) | WDR12 (0.112) | CYP20A1 (0.005)	WDR12 (1;rs35212307;15.630) | CARF (1;rs72932557;1.747)	ICA1L (rs72932772;6e-11) | CARF (rs143805266;4e-09) | NBEAL1 (rs72932588;7e-09)	ICA1L (rs72932780;4e-10) | CARF (rs72934745;3e-09) | NBEAL1 (rs115400054;7e-07)	CARF (22;1e-35) | ICA1L (18;8e-33) | NBEAL1 (13;4e-69) | FAM117B (6;2e-09) | WDR12 (2;3e-05) | BMPR2 (1;8e-06) | ENSG00000273456 (1;1e-04) | CYP20A1 (1;3e-04)	CARF (38/49;4e-217) | ICA1L (25/49;3e-195)	NBEAL1 (0.28) | CYP20A1 (0.27) | WDR12 (0.27)	Alzheimer's disease | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Angina pectoris | Body fat percentage or coronary artery disease (MTAG) | Brain morphology (MOSTest) | Cholesterol, total | Coronary artery disease | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | Coronary artery disease or fibrinogen levels (pleiotropy) | Coronary artery disease or ischemic stroke | Coronary artery disease or large artery stroke | Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | Coronary heart disease | Cortical surface area | Cortical thickness | Extensive basal ganglia perivascular space burden | Headache or migraine | Hemoglobin concentration | IDP dMRI TBSS ISOVF External capsule L | IDP dMRI TBSS L2 Anterior limb of internal capsule R | Insomnia | Migraine | Migraine (MTAG) | Myocardial infarction | Myocardial infarction (early onset) | Non-lobar intracerebral hemorrhage (MTAG) | Periventricular white matter hyperintensities | Personality traits or cognitive traits (multivariate analysis) | Pulse pressure | Renin levels | Small vessel stroke (MTAG) | Smoking initiation | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | Vertex-wise cortical thickness | White matter fractional anisotropy x age interaction (2df) | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | White matter integrity (fractional anisotropy) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities)	CARF	Wen_2024 (rs186399184)	W
11	3	gap_wm	2	204127320	2:204127320_AAC_A	A	AAC	0.1238	-0.22856316	0.03188675	7.612e-13	54890	0.0026	0.1106	0.1257	---	0	0.413	2	0.8133	intronic	CYP20A1	0	CYP20A1	2q33.2	protein_coding	cytochrome P450 family 20 subfamily A member 1	-0.228563	0.0319015	7.79832e-13	0	rs530464314	250	0.842	CAA/CAAC	2	203877365	1	1	0.63	5	CARF (0.481) | NBEAL1 (0.371) | WDR12 (0.222)	1	0.89	253	CARF (0.449) | NBEAL1 (0.351) | ICA1L (0.313) | WDR12 (0.210) | CYP20A1 (0.136) | ABI2 (0.016)	1.31	1	253	CARF (0.261) | NBEAL1 (0.240) | ICA1L (0.182) | CYP20A1 (0.129) | WDR12 (0.125) | ABI2 (0.014)	WDR12 (1;rs35212307;15.630) | CARF (1;rs72932557;1.747)	ICA1L (rs72932772;4e-10) | CARF (rs143805266;1e-08) | NBEAL1 (rs72932588;2e-08)	CARF (rs72934745;8e-09) | ICA1L (rs72932767;9e-09) | NBEAL1 (rs115400054;2e-06)	CARF (22;4e-28) | ICA1L (18;4e-26) | NBEAL1 (13;1e-58) | FAM117B (6;5e-09) | WDR12 (2;3e-05) | ENSG00000273456 (2;1e-04) | BMPR2 (1;3e-05) | CYP20A1 (1;3e-04)	CARF (45/49;3e-205) | ICA1L (25/49;3e-195)	WDR12 (0.29) | CYP20A1 (0.28) | CARF (0.27)	Alzheimer's disease | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Angina pectoris | Apolipoprotein B levels | Appendicular lean mass | Attention deficit hyperactivity disorder or risk-taking behavior (pleiotropy) | Body fat percentage or coronary artery disease (MTAG) | Brain morphology (MOSTest) | Cholesterol, total | Coronary artery disease | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | Coronary artery disease or factor VII levels (pleiotropy) | Coronary artery disease or factor VIII levels (pleiotropy) | Coronary artery disease or factor XI levels (pleiotropy) | Coronary artery disease or fibrinogen levels (pleiotropy) | Coronary artery disease or ischemic stroke | Coronary artery disease or large artery stroke | Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | Coronary artery disease or von Willebrand factor levels (pleiotropy) | Coronary heart disease | Cortical surface area | Cortical thickness | Educational attainment | Extensive basal ganglia perivascular space burden | Headache or migraine | Hemoglobin concentration | IDP dMRI TBSS ISOVF External capsule L | IDP dMRI TBSS L2 Anterior limb of internal capsule R | Insomnia | Ischemic heart disease (PheCode 411) | Lacunar stroke | Low density lipoprotein cholesterol levels | Migraine | Migraine (MTAG) | Myocardial infarction | Myocardial infarction (early onset) | Non-lobar intracerebral hemorrhage (MTAG) | Periventricular white matter hyperintensities | Personality traits or cognitive traits (multivariate analysis) | Pulse pressure | Renin levels | Respiratory diseases | Serum alkaline phosphatase levels | Small vessel stroke (MTAG) | Smoking initiation | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | Total cholesterol levels | Vertex-wise cortical thickness | White matter fractional anisotropy x age interaction (2df) | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | White matter integrity (fractional anisotropy) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities)	CARF	Wen_2024 (rs186399184)	W
12	1	gap_wm	3	69893971	rs62252239	T	G	0.2116	-0.15314242	0.02566184	2.406e-09	54890	0.0025	0.1982	0.2127	--+	50.7	4.053	2	0.1318	intronic	MITF	0	MITF	3p13	protein_coding	melanocyte inducing transcription factor	-0.153055	0.02567	2.48535e-09	0.000696299	rs62252239	0	1	T/G	3	69893971	1	1	0.72	11	MITF (0.972)	1	0.8	95	MITF (1.413)	1.13	1	94	MITF (0.951)	NA	NA	NA	MITF (1;9e-05)	NA	MITF (1.91)	Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Estimated glomerular filtration rate (creatinine) | High density lipoprotein cholesterol levels | Interventricular septum cross-sectional area | JT interval | Left ventricular end systole anterolateral wall thickness | Left ventricular end systole inferolateral wall thickness | Neutrophil count | QRS duration | QT interval | Subcortical volume (MOSTest) | Supranormal left ventricular ejection fraction | Vertex-wise cortical thickness	MITF	Novel	-
13	1	gap_wm	3	121628658	3:121628658_AT_A	A	AT	0.4777	-0.14347238	0.02094897	7.455e-12	54890	0.0087	0.4331	0.4818	---	0	0.329	2	0.8481	intronic	SLC15A2	0	SLC15A2	3q13.33	protein_coding	solute carrier family 15 member 2	-0.143472	0.0209577	7.6051e-12	0	3:121628658_AT_A	0	1	A/AT	3	121628658	1	1	0.6	14	SLC15A2 (0.917) | ILDR1 (0.046)	1	0.99	139	SLC15A2 (0.954)	1.13	1	139	SLC15A2 (0.955)	SLC15A2 (1;rs2257212;15.490)	SLC15A2 (rs1920318;8e-10)	SLC15A2 (rs874741;2e-06)	IQCB1 (27;4e-11) | SLC15A2 (18;2e-44) | GOLGB1 (3;2e-10) | EAF2 (3;1e-06) | WDR5B-DT (3;2e-05) | HCLS1 (2;5e-07) | RN7SL172P (1;5e-07) | CD86 (1;3e-05) | MIX23 (1;2e-04)	IQCB1 (47/49;4e-170) | WDR5B-DT (32/49;6e-30) | HCLS1 (32/49;4e-21) | GOLGB1 (25/49;2e-33) | EAF2 (25/49;5e-33)	SLC15A2 (0.74) | CCDC58 (0.34) | CASR (0.26)	Allergic disease (asthma, hay fever or eczema) | Atopic asthma | Blood urea nitrogen levels | Creatinine levels | Eczema | Estimated glomerular filtration rate | Estimated glomerular filtration rate (creatinine) | Estimated glomerular filtration rate (cystatin c) | Glomerular filtration rate | Hay fever and/or eczema | Height | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Platelet count | Plateletcrit | Serum creatinine levels | Serum urate levels | Serum uric acid levels | Systolic blood pressure	SLC15A2	Novel	-
14	1	gap_wm	3	171040852	rs776970253	CTCATTCCTTTGTG	C	0.7396	-0.14284632	0.0239277	2.374e-09	54890	7e-04	0.7389	0.7425	---	0	0.214	2	0.8986	intronic	TNIK	0	TNIK	3q26.31	protein_coding	TRAF2 and NCK interacting kinase	-0.139516	0.0239433	5.64535e-09	0.0259448	rs776970253	0	1	CTCATTCCTTTGTG/C	3	171040852	1	1	0.92	7	TNIK (0.959)	1	0.87	7	TNIK (0.979)	1.89	2	7 | 192	TNIK (1.922) | PLD1 (0.014)	NA	NA	NA	TNIK (3;3e-07)	NA	PLD1 (1.01) | TNIK (0.49) | EIF5A2 (0.22)	Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness	TNIK	Novel	-
14	2	gap_gwm	3	171040899	rs73171590	C	G	0.2651	0.13064008	0.02268998	8.531e-09	54890	0.0016	0.2572	0.2665	+++	0	0.011	2	0.9946	intronic	TNIK	0	TNIK	3q26.31	protein_coding	TRAF2 and NCK interacting kinase	0.127419	0.0227043	1.99894e-08	-0.0260935	rs776970253	0.047	0.977	CC/CTCATTCCTTTGTGG	3	171040852	1	1	0.82	5	TNIK (1.006)	1	0.87	6	TNIK (0.973)	1.65	2	7 | 666	TNIK (1.900) | PLD1 (0.031)	NA	NA	NA	TNIK (3;3e-07)	NA	PLD1 (0.97) | TNIK (0.36) | EIF5A2 (0.24)	Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness	TNIK	Novel	-
15	1	gap_gwm	3	171500441	rs72622537	A	C	0.3494	-0.11798658	0.02106249	2.122e-08	54890	0.0035	0.3395	0.3521	---	0	0.914	2	0.6332	intronic	PLD1	0	PLD1	3q26.31	protein_coding	phospholipase D1	-0.114909	0.0210755	4.97389e-08	0	rs72622537	0	1	A/C	3	171500441	1	1	0.58	15	PLD1 (0.958)	1	0.62	35	PLD1 (0.950)	1.12	1	26	PLD1 (0.950)	NA	NA	NA	PLD1 (9;1e-22)	NA	PLD1 (0.97) | FNDC3B (0.20) | PP13439 (0.01)	NA	PLD1	Novel	-
16	1	gap_wm	3	193549408	rs1146045	T	C	0.5917	-0.11826768	0.0211914	2.392e-08	54890	0.0059	0.5883	0.6223	---	0	0.008	2	0.9961	intergenic	LINC02038	9209	OPA1(dist=133808),LINC02038(dist=9209)	3q29	lncRNA	long intergenic non-protein coding RNA 2038	-0.118268	0.0211972	2.41336e-08	0	rs1146045	0	1	T/C	3	193549408	1	1	0.76	12	LINC02038 (0.954)	1	0.53	42	LINC02038 (1.134)	1.22	1	37	LINC02038 (0.950)	NA	NA	NA	NA	NA	OPA1 (0.39) | ATP13A4 (0.03)	Age of onset of childhood onset asthma	LINC02038	Novel	-
17	1	gap_gwm	4	2944571	rs66571798	CGT	C	0.41	-0.11760443	0.02073403	1.411e-08	53057	0.0025	0.4068	0.412	--?	0	0.003	1	0.9543	ncRNA_intronic	NOP14-AS1	0	NOP14-AS1	4p16.3	lncRNA	NOP14 antisense RNA 1	-0.117604	0.0207401	1.4248e-08	0	rs66571798	0	1	CGT/C	4	2944571	1	1	0.62	12	NOP14 (0.433) | GRK4 (0.373) | NOP14-AS1 (0.137) | ADD1 (0.040)	1	0.67	101	GRK4 (0.498) | NOP14 (0.270) | NOP14-AS1 (0.187)	1.68	2	121 | 719	ADD1 (0.603) | GRK4 (0.553) | NOP14-AS1 (0.289) | NOP14 (0.252) | MFSD10 (0.125) | HTT (0.041) | SH3BP2 (0.011) | TNIP2 (0.010) | HTT-AS (0.008) | FAM193A (0.006) | MSANTD1 (0.001)	GRK4 (2;rs2960306;22.700) | NOP14 (2;rs2515960;9.464)	NA	NA	GRK4 (38;1e-67) | NOP14 (9;2e-21) | ADD1 (3;1e-07) | NOP14-AS1 (2;4e-30) | MFSD10 (2;2e-20) | HTT (2;3e-06) | SH3BP2 (1;1e-04)	GRK4 (33/49;0e+00)	SH3BP2 (0.45) | ADD1 (0.38) | MFSD10 (0.36)	Cigarettes smoked per day (MTAG) | Educational attainment | Height (standard GWA) | Household income (MTAG)	GRK4	Novel	-
18	1	gap_gwm	4	38680015	rs13132853	A	G	0.634	-0.26036678	0.02085811	9.272e-36	54890	0.0093	0.6303	0.6861	---	0	1.723	2	0.4225	intronic	KLF3	0	KLF3	4p14	protein_coding	Kruppel like factor 3	-0.260367	0.0208877	1.15785e-35	0	rs13132853	0	1	A/G	4	38680015	1	1	0.89	1	KLF3 (1.000)	1	0.97	12	KLF3-AS1 (0.642) | KLF3 (0.325)	1.25	1	12	KLF3-AS1 (0.641) | KLF3 (0.327)	NA	NA	NA	KLF3-AS1 (11;9e-06) | TLR1 (1;4e-05)	KLF3-AS1 (42/49;5e-45)	KLF3 (0.74) | TLR10 (0.46) | TLR6 (0.24)	Body fat percentage | Body fat percentage (adjusted for testosterone and SHBG) | Body mass index | Body size at age 10 | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Cortical surface area | Cortical thickness | Edge-level brain connectivity (multivariate analysis) | Hand grip strength | IDP dMRI TBSS MD Genu of corpus callosum | IDP SWI T2star left putamen | IDP SWI T2star right putamen | Lower thalamus volume | Metabolic biomarkers (multivariate analysis) | Platelet-to-lymphocyte ratio | Red cell distribution width | Relative brain age | Reticulocyte count | Reticulocyte fraction of red cells | Serum alkaline phosphatase levels | Subcortical volume (MOSTest) | Type 1 diabetes | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast postcentral | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast supramarginal | White blood cell count | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	KLF3-AS1	Leonardsen_2023 (rs13132853), Kim_2023 (rs201791735), Smith_2020 (rs140659812), Ning_2021 (rs337638)	L,K,S,N
18	2	gap_wm	4	38680015	rs13132853	A	G	0.6342	-0.25250026	0.02178342	4.556e-31	54890	0.0097	0.6303	0.6861	---	0	1.851	2	0.3964	intronic	KLF3	0	KLF3	4p14	protein_coding	Kruppel like factor 3	-0.252905	0.0218102	4.33165e-31	0	rs13132853	0	1	A/G	4	38680015	1	1	0.72	1	KLF3-AS1 (1.000)	1	0.97	12	KLF3-AS1 (0.750) | KLF3 (0.222)	1.4	1	12	KLF3-AS1 (0.753) | KLF3 (0.217)	NA	NA	NA	KLF3-AS1 (11;9e-06) | TLR1 (1;4e-05)	KLF3-AS1 (42/49;5e-45)	KLF3 (0.74) | TLR10 (0.60) | TLR1 (0.32)	Body fat percentage | Body fat percentage (adjusted for testosterone and SHBG) | Body mass index | Body size at age 10 | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Cortical surface area | Cortical thickness | Edge-level brain connectivity (multivariate analysis) | Hand grip strength | IDP dMRI TBSS MD Genu of corpus callosum | IDP SWI T2star left putamen | IDP SWI T2star right putamen | Lower thalamus volume | Metabolic biomarkers (multivariate analysis) | Platelet-to-lymphocyte ratio | Red cell distribution width | Relative brain age | Reticulocyte count | Reticulocyte fraction of red cells | Serum alkaline phosphatase levels | Subcortical volume (MOSTest) | Type 1 diabetes | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast postcentral | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast supramarginal | White blood cell count | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	KLF3-AS1	Leonardsen_2023 (rs13132853), Kim_2023 (rs201791735), Smith_2020 (rs140659812), Ning_2021 (rs337638)	L,K,S,N
18	3	gap_gm	4	38626522	rs13102095	T	C	0.3584	0.23276483	0.0218722	1.899e-26	54890	0.0102	0.3039	0.3627	+++	0	0.327	2	0.8491	ncRNA_exonic	KLF3-AS1	0	KLF3-AS1	4p14	lncRNA	KLF3 antisense RNA 1	0.232765	0.0218945	2.13395e-26	0	rs13132853	-53.5	0.949	GT/AC	4	38680015	1	1	0.92	2	KLF3-AS1 (0.669) | KLF3 (0.322)	1	0.94	13	KLF3-AS1 (0.841) | KLF3 (0.113)	1.17	1	13	KLF3-AS1 (0.842) | KLF3 (0.113)	NA	NA	NA	KLF3-AS1 (11;8e-07) | TLR1 (1;2e-05)	KLF3-AS1 (39/49;2e-51)	KLF3 (0.70) | FAM114A1 (0.11) | TLR1 (0.06)	Body fat percentage | Body fat percentage (adjusted for testosterone and SHBG) | Body mass index | Body size at age 10 | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Cortical surface area | Cortical thickness | Edge-level brain connectivity (multivariate analysis) | Hand grip strength | IDP dMRI TBSS MD Genu of corpus callosum | IDP SWI T2star left putamen | IDP SWI T2star right putamen | Lower thalamus volume | Metabolic biomarkers (multivariate analysis) | Platelet-to-lymphocyte ratio | Red cell distribution width | Relative brain age | Reticulocyte count | Reticulocyte fraction of red cells | Serum alkaline phosphatase levels | Subcortical volume (MOSTest) | Type 1 diabetes | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast postcentral | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast supramarginal | White blood cell count | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	KLF3-AS1	Leonardsen_2023 (rs13132853), Kim_2023 (rs201791735), Smith_2020 (rs140659812), Ning_2021 (rs337638)	L,K,S,N
19	1	gap_wm	4	115534729	rs75563007	T	C	0.9747	-0.40007188	0.06678	2.087e-09	54890	0.0023	0.9649	0.9761	---	0	0.195	2	0.9071	intronic	UGT8	0	UGT8	4q26	protein_coding	UDP glycosyltransferase 8	-0.400072	0.0668013	2.11159e-09	0	rs75563007	0	1	T/C	4	115534729	1	1	0.88	8	UGT8 (0.953)	1	0.87	26	UGT8 (0.958)	1.12	1	25	UGT8 (0.951)	NA	NA	NA	NA	NA	UGT8 (1.07) | NDST4 (0.04)	T1 FreeSurfer BA rh V2 exvivo thickness	UGT8	Novel	-
19	2	gap_gwm	4	115534729	rs75563007	T	C	0.9748	-0.36303192	0.06400067	1.409e-08	54890	0.0022	0.9649	0.9761	---	0	0.359	2	0.8357	intronic	UGT8	0	UGT8	4q26	protein_coding	UDP glycosyltransferase 8	-0.363032	0.0640189	1.42214e-08	0	rs75563007	0	1	T/C	4	115534729	1	1	0.82	11	UGT8 (0.958)	1	0.87	28	UGT8 (0.959)	1.13	1	28	UGT8 (0.961)	UGT8 (1;rs4148254;29.000)	NA	NA	NA	NA	UGT8 (0.85) | NDST4 (0.26)	NA	UGT8	Novel	-
20	1	gap_gwm	5	72257180	rs2548331	T	G	0.4836	0.11536314	0.0199658	7.558e-09	54890	0.0034	0.4784	0.488	++-	66.1	5.898	2	0.05239	intronic	FCHO2	0	FCHO2	5q13.2	protein_coding	FCH and mu domain containing endocytic adaptor 2	0.115363	0.0199716	7.63392e-09	0	rs2548331	0	1	T/G	5	72257180	1	1	0.68	18	FCHO2 (0.784) | TNPO1 (0.186)	NA	NA	NA	NA	1.19	1	89	FCHO2 (0.727) | TMEM171 (0.119) | TNPO1 (0.101) | LINC02056 (0.002)	NA	NA	NA	FCHO2 (26;8e-30) | FCHO2-DT (10;7e-08) | TMEM171 (4;1e-07) | ENSG00000271926 (4;2e-05) | TNPO1 (2;1e-04)	FCHO2-DT (25/41;3e-52) | FCHO2 (29/49;2e-219)	FOXD1 (0.26) | FCHO2 (0.21) | TNPO1 (0.20)	NA	FCHO2	Novel	-
21	1	gap_gm	5	90567689	5:90567689_TTAAATAAATAAATAAATAAA_T	T	TTAAATAAATAAATAAATAAA	0.9339	-0.23875542	0.04220794	1.544e-08	54890	0.0017	0.9322	0.9409	---	78.4	9.265	2	0.00973	intergenic	LUCAT1	31114	ADGRV1(dist=107415),LUCAT1(dist=31114)	5q14.3	lncRNA	lung cancer associated transcript 1	-0.238755	0.0422198	1.55797e-08	0	5:90567689_TTAAATAAATAAATAAATAAA_T	0	1	T/TTAAATAAATAAATAAATAAA	5	90567689	1	1	0.79	12	LUCAT1 (0.941) | ADGRV1 (0.017)	1	0.71	18	LUCAT1 (0.886) | ADGRV1 (0.139)	1.33	1	18	LUCAT1 (0.834) | ADGRV1 (0.121)	NA	NA	NA	NA	NA	NA	NA	LUCAT1	Novel	-
22	1	gap_gm	5	122879901	rs36048468	T	C	0.2098	0.1559121	0.02572461	1.354e-09	54890	0.0043	0.1905	0.2125	+++	0	0.581	2	0.748	intronic	CSNK1G3	0	CSNK1G3	5q23.2	protein_coding	casein kinase 1 gamma 3	0.155912	0.0257329	1.37096e-09	0	rs36048468	0	1	T/C	5	122879901	1	1	0.72	15	CSNK1G3 (0.925) | CEP120 (0.032)	1	0.87	32	CSNK1G3 (1.066)	1.41	1	37	CSNK1G3 (0.950)	NA	NA	CSNK1G3 (rs10062103;2e-05)	KRT8P33 (4;7e-07) | CSNK1G3 (3;1e-05) | CEP120 (3;2e-05) | PRDM6 (1;6e-05)	NA	PRDM6 (0.33) | CSNK1G3 (0.18)	NA	CSNK1G3	Novel	-
22	2	gap_gwm	5	122912461	rs4546375	T	C	0.2245	0.13322809	0.02395491	2.673e-08	54890	0.0052	0.2003	0.2277	+++	13.3	2.308	2	0.3154	intronic	CSNK1G3	0	CSNK1G3	5q23.2	protein_coding	casein kinase 1 gamma 3	0.133228	0.0239614	2.69603e-08	0	rs36048468	32.6	0.925	TT/CC	5	122879901	1	1	0.66	15	CSNK1G3 (0.891) | CEP120 (0.073)	1	0.70	53	CSNK1G3 (0.951)	1.2	1	51	CSNK1G3 (0.952)	NA	NA	CSNK1G3 (rs10062103;6e-05)	KRT8P33 (4;6e-07) | CEP120 (3;2e-05) | CSNK1G3 (2;1e-06) | PRDM6 (1;5e-05)	NA	PRDM6 (0.26) | CSNK1G3 (0.09)	NA	CSNK1G3	Novel	-
23	1	gap_gwm	5	159528663	rs55790564	A	AT	0.4035	-0.12281813	0.02042274	1.812e-09	54890	3e-04	0.4032	0.4039	---	0	0.716	2	0.699	intronic	PWWP2A	0	PWWP2A	5q33.3	protein_coding	PWWP domain containing 2A	-0.122818	0.0204293	1.83398e-09	0	rs55790564	0	1	A/AT	5	159528663	1	1	0.73	12	PWWP2A (0.725) | TTC1 (0.232)	1	0.98	36	PWWP2A (0.600) | TTC1 (0.516)	1.25	1	35	PWWP2A (0.479) | TTC1 (0.473)	NA	NA	NA	PWWP2A (5;6e-09) | TTC1 (1;3e-05)	PWWP2A (29/49;8e-43)	PTTG1 (0.24) | ATP10B (0.20) | PWWP2A (0.19)	Facial morphology (segment 5) | Lung function (FEV1/FVC) | Prostate cancer | Smoking initiation	PWWP2A	Novel	-
23	2	gap_wm	5	159528663	rs55790564	A	AT	0.4035	-0.12383574	0.02132384	6.346e-09	54890	3e-04	0.4032	0.4039	---	0	0.363	2	0.834	intronic	PWWP2A	0	PWWP2A	5q33.3	protein_coding	PWWP domain containing 2A	-0.123836	0.0213302	6.41149e-09	0	rs55790564	0	1	A/AT	5	159528663	1	1	0.74	12	PWWP2A (0.612) | TTC1 (0.352)	1	0.98	36	PWWP2A (0.603) | TTC1 (0.512)	1.26	1	35	PWWP2A (0.481) | TTC1 (0.471)	NA	NA	NA	PWWP2A (5;2e-09) | TTC1 (1;4e-05)	PWWP2A (28/49;2e-42)	PWWP2A (0.27) | ADRA1B (0.21) | TTC1 (0.19)	Facial morphology (segment 5) | Lung function (FEV1/FVC) | Prostate cancer | Smoking initiation	PWWP2A	Novel	-
24	1	gap_gwm	6	31249217	rs2253491	A	G	0.2062	-0.15813565	0.02463731	1.376e-10	54890	3e-04	0.2061	0.2081	---	0	0.42	2	0.8107	intergenic	HLA-C	9304	HLA-C(dist=9304),LINC02571(dist=12468)	6p21.33	protein_coding	major histocompatibility complex%2C class I%2C C	-0.158136	0.0246462	1.397e-10	0	rs2253491	0	1	A/G	6	31249217	1	NA	NA	NA	NA	1	0.85	20	HLA-C (0.925) | HLA-B (0.030)	1.13	1	19	HLA-C (0.932) | HLA-B (0.022)	NA	NA	NA	HLA-C (46;6e-24) | C4A (40;3e-15) | CYP21A1P (32;3e-10) | CCHCR1 (28;9e-16) | MICB (27;1e-16) | PSORS1C1 (24;1e-13) | FLOT1 (20;2e-09) | NOTCH4 (15;8e-09) | HLA-S (14;2e-10) | MIR6891 (13;3e-08) | STK19B (12;5e-06) | VARS2 (12;9e-06) | ENSG00000271581 (10;3e-07) | C4B (9;7e-15) | CYP21A2 (8;6e-10) | HCG22 (8;9e-10) | HCP5 (6;3e-07) | RNF5 (6;5e-06) | PSORS1C2 (6;4e-05) | LY6G5B (5;9e-05) | POU5F1 (4;1e-06) | TNXA (4;2e-06) | LINC00243 (4;3e-06) | PPP1R18 (4;4e-06) | ENSG00000280128 (3;1e-05) | MSH5 (3;2e-05) | SKIC2 (3;3e-05) | SFTA2 (2;9e-08) | APOM (2;2e-06) | GPANK1 (2;1e-05) | TCF19 (2;1e-05) | WASF5P (1;9e-10) | LY6G6C (1;5e-09) | DDR1-DT (1;1e-08) | LINC01149 (1;1e-06) | MUC22 (1;4e-06) | SNHG32 (1;7e-06) | HCG20 (1;8e-06) | HLA-B (1;1e-05) | MPIG6B (1;1e-05) | IER3 (1;3e-05) | ENSG00000272501 (1;4e-05) | HLA-E (1;9e-05) | ATP6V1G2 (1;9e-05) | ENSG00000272221 (1;1e-04) | CLIC1 (1;1e-04) | LST1 (1;2e-04) | LINC02570 (1;2e-04) | BAG6 (1;3e-04) | MICA (1;4e-04)	C4A (49/49;2e-292) | CYP21A1P (49/49;3e-157) | TNXA (43/43;4e-39) | HLA-C (48/49;3e-273) | STK19B (46/47;6e-68) | VARS2 (47/49;2e-51) | MSH5 (47/49;8e-36) | MIR6891 (31/33;5e-76) | MICA (46/49;9e-30) | ENSG00000280128 (46/49;1e-24) | LY6G5B (45/49;6e-32) | PSORS1C1 (42/48;1e-150) | RNF5 (41/49;2e-36) | MICB (40/49;9e-195) | NOTCH4 (38/49;2e-87) | ATP6V1G2 (38/49;7e-13) | ENSG00000272221 (37/49;2e-24) | CCHCR1 (35/49;1e-215) | HLA-E (35/49;4e-08) | PSORS1C2 (33/47;6e-34) | HCG20 (33/47;7e-14) | FLOT1 (34/49;4e-60) | HCP5 (31/49;3e-47) | HLA-S (15/24;3e-30) | ENSG00000271581 (13/22;1e-24) | GPANK1 (28/49;1e-22) | SKIC2 (28/49;4e-21) | HCG22 (23/41;2e-59) | APOM (27/49;1e-29) | CLIC1 (26/49;6e-13) | LINC00243 (16/32;3e-24)	CLIC1 (0.54) | HLA-B (0.36) | BAG6 (0.26)	CLEC4D/OSM protein level ratio | Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome) | Seropositivity for streptococcus pneumoniae peptide (agilent_220184)	CLIC1	Smith_2020 (rs3129787)	S
24	2	gap_gm	6	31249217	rs2253491	A	G	0.2062	-0.16280478	0.02580844	2.823e-10	54890	3e-04	0.2061	0.2081	---	0	0.506	2	0.7764	intergenic	HLA-C	9304	HLA-C(dist=9304),LINC02571(dist=12468)	6p21.33	protein_coding	major histocompatibility complex%2C class I%2C C	-0.161112	0.0258196	4.37791e-10	0.0128552	rs2253491	0	1	A/G	6	31249217	1	NA	NA	NA	NA	1	0.85	26	HLA-C (0.825) | HLA-B (0.128)	1.16	1	30	HLA-C (0.830) | HLA-B (0.119) | HLA-DQA1 (0.003)	NA	NA	NA	HLA-C (46;6e-24) | C4A (40;3e-15) | CYP21A1P (32;3e-10) | CCHCR1 (28;9e-16) | MICB (27;1e-16) | PSORS1C1 (24;1e-13) | FLOT1 (20;2e-09) | NOTCH4 (15;8e-09) | HLA-S (14;2e-10) | MIR6891 (13;3e-08) | STK19B (12;5e-06) | VARS2 (12;9e-06) | ENSG00000271581 (10;3e-07) | C4B (9;7e-15) | CYP21A2 (8;6e-10) | HCG22 (8;9e-10) | HCP5 (6;3e-07) | RNF5 (6;5e-06) | PSORS1C2 (6;4e-05) | LY6G5B (5;9e-05) | POU5F1 (4;1e-06) | TNXA (4;2e-06) | LINC00243 (4;3e-06) | PPP1R18 (4;4e-06) | ENSG00000280128 (3;1e-05) | MSH5 (3;2e-05) | SKIC2 (3;3e-05) | SFTA2 (2;9e-08) | APOM (2;2e-06) | GPANK1 (2;1e-05) | TCF19 (2;1e-05) | WASF5P (1;9e-10) | LY6G6C (1;5e-09) | DDR1-DT (1;1e-08) | LINC01149 (1;1e-06) | MUC22 (1;4e-06) | SNHG32 (1;7e-06) | HCG20 (1;8e-06) | HLA-B (1;1e-05) | MPIG6B (1;1e-05) | IER3 (1;3e-05) | ENSG00000272501 (1;4e-05) | HLA-E (1;9e-05) | ATP6V1G2 (1;9e-05) | ENSG00000272221 (1;1e-04) | CLIC1 (1;1e-04) | LST1 (1;2e-04) | LINC02570 (1;2e-04) | BAG6 (1;3e-04) | MICA (1;4e-04)	C4A (49/49;2e-292) | CYP21A1P (49/49;3e-157) | HLA-C (48/49;3e-273) | STK19B (46/47;6e-68) | VARS2 (47/49;2e-51) | TNXA (41/43;4e-39) | MIR6891 (31/33;5e-76) | MICA (46/49;9e-30) | ENSG00000280128 (46/49;1e-24) | MSH5 (45/49;8e-36) | LY6G5B (45/49;6e-32) | PSORS1C1 (42/48;1e-150) | RNF5 (41/49;2e-36) | MICB (40/49;9e-195) | NOTCH4 (38/49;2e-87) | ENSG00000272221 (37/49;2e-24) | CCHCR1 (35/49;1e-215) | SKIC2 (35/49;4e-21) | HLA-E (35/49;4e-08) | PSORS1C2 (33/47;6e-34) | HCG20 (33/47;7e-14) | FLOT1 (34/49;4e-60) | ATP6V1G2 (32/49;7e-13) | HCP5 (31/49;3e-47) | HLA-S (15/24;3e-30) | ENSG00000271581 (13/22;1e-24) | GPANK1 (28/49;1e-22) | HCG22 (23/41;2e-59) | APOM (27/49;1e-29) | CLIC1 (26/49;6e-13) | LINC00243 (16/32;3e-24)	LST1 (0.54) | HLA-B (0.36) | PRRC2A (0.31)	CLEC4D/OSM protein level ratio | Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome) | Seropositivity for streptococcus pneumoniae peptide (agilent_220184)	LST1	Smith_2020 (rs3129787)	S
24	3	gap_wm	6	31249217	rs2253491	A	G	0.2062	-0.14182302	0.02572622	3.532e-08	54890	3e-04	0.2061	0.2081	---	0	0.47	2	0.7907	intergenic	HLA-C	9304	HLA-C(dist=9304),LINC02571(dist=12468)	6p21.33	protein_coding	major histocompatibility complex%2C class I%2C C	-0.141616	0.0257331	3.72781e-08	0.00158246	rs2253491	0	1	A/G	6	31249217	1	NA	NA	NA	NA	NA	NA	NA	NA	1.13	1	913	HLA-C (0.579) | HLA-B (0.121) | TRIM26 (0.033) | HCG17 (0.029) | HCP5 (0.025) | MICA-AS1 (0.015) | RPP21 (0.014) | HCG20 (0.012) | MUC21 (0.012) | HLA-L (0.008) | MUC22 (0.007) | MICB-DT (0.007) | DDR1 (0.005) | LINC01149 (0.004) | LINC00240 (0.004) | LINC02570 (0.003) | MICB (0.003) | HLA-DQA1 (0.002) | TRIM31-AS1 (0.002) | LINC00243 (0.002) | ZNRD1ASP (0.002) | TRIM15 (0.002) | HCG4B (0.002) | HLA-H (0.002) | LINC02571 (0.002) | C6orf15 (0.002) | TRIM39 (0.002) | HCG27 (0.002) | HLA-DRB5 (0.002) | TRIM10 (0.002) | HCG22 (0.001) | ZSCAN12 (0.001) | HLA-DRA (0.001) | PSORS1C1 (0.001) | BTN3A1 (0.001) | GTF2H4 (0.001) | MSH5-SAPCD1 (0.001) | HIST1H4C (0.001) | ATP6V1G2-DDX39B (0.001) | HIST1H2BD (0.001) | RNF39 (0.001) | TRIM31 (0.001) | BTN2A1 (0.001) | HLA-DOB (0.001) | MICA (0.001) | ZNF322 (0.001) | HCG21 (0.001) | TRIM40 (0.001) | SNHG32 (0.001) | TSBP1-AS1 (0.001) | ZNRD1 (0.001) | GUSBP2 (0.001) | PPP1R18 (0.001) | VARS (0.001) | NCR3 (0.001) | LSM2 (0.001) | AIF1 (0.001) | TNF (0.001) | APOM (0.001) | VWA7 (0.000) | HSPA1B (0.000) | GNL1 (0.000) | HCG9 (0.000) | ATAT1 (0.000) | ABT1 (0.000) | VARS2 (0.000) | HLA-E (0.000) | BTN3A3 (0.000) | LOC105374988 (0.000) | UBD (0.000) | BTN1A1 (0.000) | ABHD16A (0.000) | TRIM39-RPP21 (0.000) | GPX6 (0.000) | C2 (0.000) | HLA-DRB1 (0.000) | LOC285819 (0.000) | SLC17A2 (0.000) | ZNF204P (0.000) | HCG26 (0.000) | ZNF391 (0.000) | ABCF1 (0.000) | ZFP57 (0.000) | SLC17A3 (0.000) | PPP1R10 (0.000) | OR2H2 (0.000) | TNXB (0.000) | SNORD32B (0.000) | SFTA2 (0.000) | LINC01012 (0.000) | BTN2A2 (0.000) | HCG18 (0.000) | SLC44A4 (0.000) | LY6G6F (0.000) | HSPA1A (0.000) | NRM (0.000) | NEU1 (0.000) | CLIC1 (0.000) | C6orf136 (0.000) | CSNK2B (0.000) | FLOT1 (0.000) | LINC02569 (0.000) | HMGN4 (0.000) | PRRC2A (0.000) | HLA-A (0.000) | HCG11 (0.000) | HCG14 (0.000) | LINC00533 (0.000) | CDSN (0.000) | GABBR1 (0.000) | HCG4 (0.000) | HSPA1L (0.000) | LINC01623 (0.000) | POM121L2 (0.000) | MDC1 (0.000) | BTN2A3P (0.000) | MSH5 (0.000) | VN1R10P (0.000) | TCF19 (0.000) | STK19 (0.000) | HLA-G (0.000) | SLC17A1 (0.000) | HIST1H2AA (0.000) | HIST1H2AB (0.000) | CFB (0.000) | TUBB (0.000) | HIST1H2BJ (0.000) | HLA-DQB2 (0.000) | PPT2-EGFL8 (0.000) | BTN3A2 (0.000) | LOC100129636 (0.000) | ZNF184 (0.000) | MIR3143 (0.000) | HIST1H4D (0.000) | HLA-DQB1 (0.000) | HLA-DMB (0.000) | IER3 (0.000) | HLA-DRB6 (0.000) | HIST1H4H (0.000)	NA	NA	NA	C4A (32;3e-15) | HLA-C (30;6e-24) | MICB (25;1e-16) | CYP21A1P (22;3e-10) | MIR6891 (10;3e-08) | NOTCH4 (9;8e-09) | HCG22 (8;9e-10) | FLOT1 (7;2e-09) | C4B (6;7e-15) | HLA-S (6;8e-06) | CYP21A2 (5;6e-10) | CCHCR1 (5;8e-06) | HCP5 (4;3e-07) | ENSG00000271581 (4;1e-06) | STK19B (4;5e-06) | VARS2 (4;8e-05) | LINC00243 (3;3e-06) | PPP1R18 (3;4e-06) | RNF5 (2;2e-05) | LY6G5B (2;9e-05) | WASF5P (1;9e-10) | LY6G6C (1;5e-09) | DDR1-DT (1;1e-08) | APOM (1;2e-06) | MUC22 (1;4e-06) | HCG20 (1;8e-06) | ENSG00000280128 (1;1e-05) | PSORS1C1 (1;1e-05) | ENSG00000272501 (1;4e-05) | GPANK1 (1;5e-05) | SFTA2 (1;6e-05) | ENSG00000272221 (1;1e-04) | CLIC1 (1;1e-04) | LINC02570 (1;2e-04)	C4A (49/49;2e-292) | CYP21A1P (49/49;3e-157) | HLA-C (48/49;3e-273) | STK19B (46/47;6e-68) | VARS2 (47/49;2e-51) | MIR6891 (31/33;5e-76) | ENSG00000280128 (46/49;1e-24) | LY6G5B (45/49;6e-32) | RNF5 (41/49;2e-36) | MICB (40/49;9e-195) | NOTCH4 (38/49;2e-87) | ENSG00000272221 (37/49;2e-24) | FLOT1 (34/49;4e-60) | HCP5 (31/49;3e-47) | HLA-S (15/24;3e-30) | ENSG00000271581 (13/22;1e-24) | GPANK1 (28/49;1e-22) | HCG22 (23/41;2e-59) | CLIC1 (26/49;6e-13)	TNF (0.35) | DDX39B (0.28) | CLIC1 (0.28)	NA	TNF	Smith_2020 (rs3129787)	S
25	1	gap_gwm	6	45410312	rs910586	T	C	0.3615	-0.21086173	0.02108166	1.491e-23	54890	0.0053	0.3307	0.3635	---	0	0.627	2	0.731	intronic	RUNX2	0	RUNX2	6p21.1	protein_coding	RUNX family transcription factor 2	-0.210862	0.0211011	1.63682e-23	0	rs910586	0	1	T/C	6	45410312	1	1	0.85	2	RUNX2 (1.059)	1	0.96	34	RUNX2 (1.026)	1.26	1	35	RUNX2 (0.953)	NA	RUNX2 (rs2790100;3e-14)	NA	RUNX2 (4;3e-11)	NA	RUNX2 (3.86)	aseg lh intensity Putamen | aseg lh intensity Thalamus-Proper | aseg lh volume CerebralWhiteMatter | aseg rh intensity Putamen | aseg rh intensity Thalamus-Proper | Brain age gap | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Hip shape (DXA scan) | Regional cortical thickness (medialorbitofrontal) | Regional cortical thickness (rostralanteriorcingulate) | Relative brain age | Subcortical volume (MOSTest) | Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness | Youthful appearance (self-reported)	RUNX2	Smith_2020 (rs2790103), Leonardsen_2023 (rs2790102), Jonsson_2019 (rs2790099), Ning_2021 (rs2677110)	S,L,J,N
25	2	gap_wm	6	45439307	rs2790095	C	G	0.6461	0.20724205	0.02208568	6.379e-21	54890	0.0046	0.6436	0.6709	+++	16.3	2.391	2	0.3026	intronic	RUNX2	0	RUNX2	6p21.1	protein_coding	RUNX family transcription factor 2	0.207242	0.0221035	6.85425e-21	0	rs910586	29	0.97	TG/CC	6	45410312	1	1	0.65	5	RUNX2 (1.004)	1	0.95	35	RUNX2 (0.961)	1.27	1	36	RUNX2 (0.953)	NA	RUNX2 (rs2790100;2e-13)	NA	RUNX2 (4;6e-12)	NA	RUNX2 (3.65) | CLIC5 (0.14)	aseg lh intensity Putamen | aseg lh intensity Thalamus-Proper | aseg lh volume CerebralWhiteMatter | aseg rh intensity Putamen | aseg rh intensity Thalamus-Proper | Brain age gap | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Hip shape (DXA scan) | Regional cortical thickness (medialorbitofrontal) | Regional cortical thickness (rostralanteriorcingulate) | Relative brain age | Subcortical volume (MOSTest) | Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness | Youthful appearance (self-reported)	RUNX2	Smith_2020 (rs2790103), Leonardsen_2023 (rs2790102), Jonsson_2019 (rs2790099), Ning_2021 (rs2677110)	S,L,J,N
25	3	gap_gm	6	45410312	rs910586	T	C	0.3614	-0.19053984	0.02209205	6.42e-18	54890	0.0055	0.3307	0.3635	---	0	0.725	2	0.6959	intronic	RUNX2	0	RUNX2	6p21.1	protein_coding	RUNX family transcription factor 2	-0.19054	0.0221071	6.75862e-18	0	rs910586	0	1	T/C	6	45410312	1	1	0.72	39	RUNX2 (0.956)	1	0.95	39	RUNX2 (1.125)	1.25	1	39	RUNX2 (0.950)	NA	RUNX2 (rs2790100;4e-12)	NA	RUNX2 (4;3e-11)	NA	RUNX2 (3.63)	aseg lh intensity Putamen | aseg lh intensity Thalamus-Proper | aseg lh volume CerebralWhiteMatter | aseg rh intensity Putamen | aseg rh intensity Thalamus-Proper | Brain age gap | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Hip shape (DXA scan) | Regional cortical thickness (medialorbitofrontal) | Regional cortical thickness (rostralanteriorcingulate) | Relative brain age | Subcortical volume (MOSTest) | Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness | Youthful appearance (self-reported)	RUNX2	Smith_2020 (rs2790103), Leonardsen_2023 (rs2790102), Jonsson_2019 (rs2790099), Ning_2021 (rs2677110)	S,L,J,N
26	1	gap_gm	6	126690257	6:126690257_AT_A	A	AT	0.4417	0.11864517	0.02121429	2.236e-08	54890	2e-04	0.4415	0.442	+++	0	0.384	2	0.8254	intergenic	CENPW	20235	CENPW(dist=20235),NONE(dist=NONE)	6q22.32	protein_coding	centromere protein W	0.118645	0.0212202	2.25573e-08	0	6:126690257_AT_A	0	1	A/AT	6	126690257	1	1	0.69	10	MIR588 (0.860) | CENPW (0.136)	1	0.89	93	CENPW (0.480) | MIR588 (0.471)	1.08	1	92	CENPW (0.486) | MIR588 (0.465)	NA	CENPW (rs2326451;1e-05)	NA	CENPW (7;2e-11)	NA	CENPW (0.82)	aparc-a2009s lh area S-orbital-med-olfact | aparc-pial rh area lateralorbitofrontal | Brain region volumes | Cortical surface area | Free androgen index | Height | Hip circumference adjusted for BMI | Optic disc size | Soy sauce liking | Type 1 diabetes | Type 2 diabetes | Vertical cup-disc ratio | Whole body fat free mass (UKB data field 23101) | Whole brain restricted directional diffusion (multivariate analysis)	CENPW	Jonsson_2019 (rs2184968)	J
26	2	gap_gwm	6	126726295	rs9398805	T	C	0.4537	0.11040618	0.02001217	3.449e-08	54890	0.001	0.4487	0.4545	+++	10.7	2.24	2	0.3264	intergenic	CENPW	56274	CENPW(dist=56274),MIR588(dist=79482)	6q22.32	protein_coding	centromere protein W	0.110406	0.0200175	3.47809e-08	0	6:126690257_AT_A	36	0.954	AT/ATC	6	126690257	1	1	0.6	9	MIR588 (0.873) | CENPW (0.082)	1	0.93	93	MIR588 (0.536) | CENPW (0.418)	1.08	1	91	MIR588 (0.532) | CENPW (0.418)	NA	CENPW (rs2326451;1e-05)	NA	CENPW (7;3e-11)	NA	CENPW (0.95) | TRMT11 (0.01)	Cortical surface area | Free androgen index | Height | Soy sauce liking	CENPW	Jonsson_2019 (rs2184968)	J
27	1	gap_gwm	7	1213127	rs1543985	A	G	0.3624	0.11603812	0.02088168	2.746e-08	54890	0.0015	0.3582	0.3635	+++	39.7	3.317	2	0.1904	intergenic	LOC101927021	7533	LOC101927021(dist=7533),UNCX(dist=59381)	7p22.3	NA	NA	0.116038	0.0208874	2.76949e-08	0	rs1543985	0	1	A/G	7	1213127	1	1	0.66	17	LOC101927021 (0.533) | ZFAND2A (0.220) | C7orf50 (0.118) | GPER1 (0.100)	1	0.87	107	LOC101927021 (1.180) | ZFAND2A (0.077) | C7orf50 (0.005)	1.7	2	106 | 659	LOC101927021 (1.669) | C7orf50 (0.092) | ZFAND2A (0.077) | UNCX (0.042) | MICALL2 (0.009) | COX19 (0.004) | ADAP1 (0.003) | GPER1 (0.002) | GPR146 (0.002) | CYP2W1 (0.001)	NA	ZFAND2A-DT (rs2960837;9e-08)	AC091729.9 (rs6969322;7e-08)	ZFAND2A-DT (49;1e-165) | ZFAND2A (36;2e-107) | GPER1 (7;4e-17) | ENSG00000224079 (6;1e-16) | C7orf50 (5;3e-09) | GPR146 (4;4e-10) | CYP2W1 (3;4e-21) | COX19 (1;8e-14) | ENSG00000226291 (1;3e-11) | ADAP1 (1;2e-06)	ZFAND2A-DT (49/49;0e+00) | ZFAND2A (35/49;0e+00) | ENSG00000224079 (13/26;4e-45)	ZFAND2A (0.83) | PSMG3 (0.37) | MAFK (0.31)	NA	ZFAND2A-DT	Novel	-
27	2	gap_gm	7	1213127	rs1543985	A	G	0.3624	0.11951566	0.02187699	4.68e-08	54890	0.0015	0.3582	0.3635	+++	36.6	3.155	2	0.2065	intergenic	LOC101927021	7533	LOC101927021(dist=7533),UNCX(dist=59381)	7p22.3	NA	NA	0.119516	0.0218828	4.71765e-08	0	rs1543985	0	1	A/G	7	1213127	1	1	0.58	26	C7orf50 (0.465) | ZFAND2A (0.259) | LOC101927021 (0.216) | GPER1 (0.035)	1	0.83	113	LOC101927021 (0.994) | C7orf50 (0.088) | ZFAND2A (0.059)	1.48	1	106	LOC101927021 (0.840) | C7orf50 (0.065) | ZFAND2A (0.042) | GPER1 (0.003)	NA	ZFAND2A-DT (rs2960837;2e-07)	AC091729.9 (rs2949185;2e-07)	ZFAND2A-DT (49;1e-165) | ZFAND2A (35;2e-107) | GPER1 (7;4e-17) | ENSG00000224079 (5;1e-16) | GPR146 (4;4e-10) | C7orf50 (4;3e-09) | CYP2W1 (3;4e-21) | COX19 (1;8e-14) | ENSG00000226291 (1;3e-11) | ADAP1 (1;2e-06)	ZFAND2A-DT (49/49;0e+00) | ZFAND2A (35/49;0e+00) | ENSG00000224079 (13/26;4e-45)	ZFAND2A (0.64) | MICALL2 (0.20) | PSMG3 (0.19)	NA	ZFAND2A-DT	Novel	-
28	1	gap_gm	7	120803286	rs35789132	A	G	0.6464	-0.13419985	0.02194366	9.616e-10	54890	0.0011	0.6462	0.6525	---	0	1.111	2	0.5739	intronic	CPED1	0	CPED1	7q31.31	protein_coding	cadherin like and PC-esterase domain containing 1	-0.1342	0.0219509	9.73895e-10	0	rs35789132	0	1	A/G	7	120803286	1	1	0.66	11	CPED1 (0.967)	2	0.87 | 0.74	20 | 95	CPED1 (0.953) | FAM3C (0.749) | WNT16 (0.214)	2.02	2	95 | 19	CPED1 (0.951) | FAM3C (0.717) | WNT16 (0.242)	NA	NA	NA	CPED1 (3;3e-22) | WNT16 (3;2e-05)	NA	CPED1 (0.79) | FAM3C (0.25) | WNT16 (0.25)	Body surface area | Bone mineral density (paediatric, upper limb) | Bone mineral density mean | Height (standard GWA) | Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype) | Pediatric areal bone mineral density (radius) | Pierre Robin Sequence endophenotypic score | Total body bone mineral density | Vertex-wise sulcal depth | Waist circumference adjusted for body mass index | Waist-hip index | White matter microstructure (radial diusivities)	CPED1	Novel	-
28	2	gap_gwm	7	120908822	rs2536149	A	G	0.1135	0.17671234	0.03177303	2.671e-08	54890	0.0025	0.099	0.1141	+++	66.7	6.009	2	0.04955	intronic	CPED1	0	CPED1	7q31.31	protein_coding	cadherin like and PC-esterase domain containing 1	0.176712	0.0317818	2.69503e-08	0	rs35789132	106	0.15	GA/AG	7	120803286	1	NA	NA	NA	NA	1	0.87	19	FAM3C (0.693) | WNT16 (0.273)	2.02	2	114 | 19	CPED1 (0.950) | FAM3C (0.685) | WNT16 (0.278)	NA	NA	NA	WNT16 (2;1e-09) | CPED1 (2;2e-04)	NA	CPED1 (0.42) | TSPAN12 (0.24) | WNT16 (0.18)	White matter microstructure (radial diusivities)	WNT16	Novel	-
29	1	gap_wm	8	10813904	rs10096381	T	G	0.5205	0.12688279	0.02088898	1.246e-09	54890	0.0021	0.5198	0.5321	+++	0	0.35	2	0.8395	intronic	XKR6	0	XKR6	8p23.1	protein_coding	XK related 6	0.126883	0.0208958	1.26189e-09	0	rs10096381	0	1	T/G	8	10813904	1	NA	NA	NA	NA	NA	NA	NA	NA	1.41	1	372	XKR6 (0.794) | TNKS (0.087) | FAM167A-AS1 (0.019) | LOC102723313 (0.012) | MIR124-1 (0.008) | LINC00208 (0.008) | MFHAS1 (0.008) | PRAG1 (0.006) | MSRA (0.004) | PINX1 (0.001) | DEFB136 (0.001) | BLK (0.001) | SOX7 (0.001) | LINC00599 (0.000) | CTSB (0.000) | FAM167A (0.000)	NA	NA	NA	ENSG00000255310 (38;3e-29) | ENSG00000269918 (33;3e-27) | FAM167A (11;1e-10) | ENSG00000272505 (11;7e-07) | TDH (9;7e-12) | CTSB (9;3e-07) | TDH-AS1 (7;2e-13) | MTMR9 (7;6e-09) | SLC35G5 (7;7e-07) | BLK (6;3e-18) | FDFT1 (6;3e-15) | NEIL2 (6;1e-06) | MSRA (5;2e-06) | ENSG00000255046 (5;4e-05) | ENSG00000280273 (4;2e-07) | ENSG00000280294 (4;3e-06) | RP1L1 (4;1e-05) | LINC03022 (4;6e-05) | FAM167A-AS1 (3;2e-06) | ENSG00000261451 (3;4e-05) | ENSG00000269954 (2;2e-22) | ENSG00000254774 (2;7e-21) | ENSG00000255518 (2;1e-20) | PRSS55 (2;4e-05) | SUB1P1 (2;9e-05) | ENSG00000255354 (1;3e-18) | LINC00208 (1;2e-07) | ENSG00000248896 (1;4e-05) | OR7E161P (1;5e-05) | ENSG00000254556 (1;2e-04)	ENSG00000255310 (46/49;0e+00) | ENSG00000269918 (45/49;0e+00) | SLC35G5 (41/49;2e-55) | RP1L1 (13/16;1e-23) | ENSG00000272505 (38/49;3e-50) | ENSG00000261451 (33/43;2e-23) | MTMR9 (34/49;1e-50) | CTSB (32/49;3e-49) | TDH-AS1 (14/24;9e-65) | TDH (26/46;9e-62) | ENSG00000280294 (25/47;1e-23) | NEIL2 (26/49;2e-42) | ENSG00000255046 (24/48;4e-24) | LINC03022 (24/48;2e-23) | BLK (16/32;3e-39)	XKR6 (0.32) | SOX7 (0.15) | PINX1 (0.10)	A body shape index | Carotid intima media thickness (maximum) | Carotid intima media thickness (mean) | Carotid intima media thickness (minimum) | CDKN1A/TXLNA protein level ratio | Cholesteryl esters to total lipids ratio in medium LDL | Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity | Estimated glomerular filtration rate | F-fatty food liking (derived food-liking factor) | Hip circumference adjusted for BMI | Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) | Neuroticism | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | PPP1R2/STK4 protein level ratio | PPP1R2/USP8 protein level ratio | REG1A/REG4 protein level ratio | Restless legs syndrome | Risk-taking behavior (multivariate analysis) | Supranormal left ventricular ejection fraction | Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) | Systolic blood pressure x alcohol consumption interaction (2df test) | Waist circumference adjusted for body mass index | White matter microstructure (radial diusivities)	XKR6	Smith_2020 (rs907183)	S
30	1	gap_wm	8	116635942	rs2721939	T	C	0.5983	0.16464833	0.02130776	1.1e-14	54890	0.0024	0.5975	0.6115	+++	0	0.602	2	0.7401	UTR5	TRPS1	0	TRPS1(NM_014112:c.-78G>A,NM_001282903:c.-85G>A)	8q23.3	protein_coding	transcriptional repressor GATA binding 1	0.164648	0.0213191	1.13591e-14	0	rs2721939	0	1	T/C	8	116635942	1	1	0.79	4	TRPS1 (1.096)	1	0.96	15	TRPS1 (0.958)	1.31	1	15	TRPS1 (0.959)	NA	NA	TRPS1 (rs2142331;5e-12)	TRPS1-AS1 (1;9e-05)	NA	TRPS1 (1.28)	Appendicular lean mass | Basal cell carcinoma (MTAG) | Body surface area | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl esters in HDL (UKB data field 23418) | Cholesteryl esters in large HDL (UKB data field 23562) | Concentration of large HDL particles (UKB data field 23558) | Free cholesterol in HDL (UKB data field 23422) | Free cholesterol in large HDL (UKB data field 23563) | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | HDL cholesterol levels (UKB data field 23406) | Height | Multi-trait sex score | Neuroticism | Phospholipids in large HDL (UKB data field 23560) | Ratio of triglycerides to phosphoglycerides | Subcortical volume (MOSTest) | Total lipids in large HDL (UKB data field 23559) | Triglyceride to HDL cholesterol ratio | Type 2 diabetes | Weight | Whole body fat free mass (UKB data field 23101) | Whole brain restricted isotropic diffusion (multivariate analysis)	TRPS1	Novel	-
30	2	gap_gwm	8	116635942	rs2721939	T	C	0.5983	0.13995092	0.02040894	7.016e-12	54890	0.0023	0.5975	0.6115	+++	0	1.287	2	0.5256	UTR5	TRPS1	0	TRPS1(NM_014112:c.-78G>A,NM_001282903:c.-85G>A)	8q23.3	protein_coding	transcriptional repressor GATA binding 1	0.138849	0.0204186	1.0452e-11	-0.0104942	rs2721939	0	1	T/C	8	116635942	1	1	0.9	3	TRPS1 (0.972)	1	0.98	15	TRPS1 (0.961)	1.19	1	15	TRPS1 (0.962)	NA	NA	TRPS1 (rs2142331;4e-10)	TRPS1-AS1 (1;6e-05)	NA	TRPS1 (1.27)	Appendicular lean mass | Basal cell carcinoma (MTAG) | Body surface area | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl esters in HDL (UKB data field 23418) | Cholesteryl esters in large HDL (UKB data field 23562) | Concentration of large HDL particles (UKB data field 23558) | Free cholesterol in HDL (UKB data field 23422) | Free cholesterol in large HDL (UKB data field 23563) | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | HDL cholesterol levels (UKB data field 23406) | Height | Multi-trait sex score | Neuroticism | Phospholipids in large HDL (UKB data field 23560) | Ratio of triglycerides to phosphoglycerides | Subcortical volume (MOSTest) | Total lipids in large HDL (UKB data field 23559) | Triglyceride to HDL cholesterol ratio | Type 2 diabetes | Weight | Whole body fat free mass (UKB data field 23101) | Whole brain restricted isotropic diffusion (multivariate analysis)	TRPS1	Novel	-
31	1	gap_gm	8	130903153	rs12548781	A	T	0.7929	0.1495835	0.02585641	7.244e-09	54890	0.0015	0.7922	0.8007	+++	44.1	3.577	2	0.1672	intronic	FAM49B	0	FAM49B	8q24.21	protein_coding	CYFIP related Rac1 interactor B	0.149584	0.025864	7.31806e-09	0	rs12548781	0	1	A/T	8	130903153	1	1	0.82	12	FAM49B (0.950)	1	0.62	60	GSDMC (0.487) | FAM49B (0.465)	1.12	1	60	GSDMC (0.487) | FAM49B (0.468)	NA	NA	NA	NA	NA	FAM49B (0.30) | ASAP1 (0.26)	NA	FAM49B	Novel	-
32	1	gap_gwm	9	123543953	rs5021405	T	C	0.4701	0.12021654	0.02181108	3.553e-08	54890	0.0046	0.4443	0.472	++-	0	1.566	2	0.4571	intronic	FBXW2	0	FBXW2	9q33.2	protein_coding	F-box and WD repeat domain containing 2	0.120357	0.021818	3.45972e-08	-0.00131078	rs5021405	0	1	T/C	9	123543953	1	NA	NA	NA	NA	NA	NA	NA	NA	1.25	1	98	FBXW2 (0.877) | MEGF9 (0.021) | PSMD5 (0.016) | B3GNT10 (0.013) | PHF19 (0.012) | CUTALP (0.006) | CDK5RAP2 (0.005)	NA	NA	NA	NA	NA	PHF19 (0.31) | CDK5RAP2 (0.24) | MEGF9 (0.16)	NA	PHF19	Novel	-
33	1	gap_wm	9	128010901	rs755594165	CA	C	0.6104	-0.1237548	0.02233313	3.002e-08	54890	0.0063	0.5773	0.6139	--+	0	1.624	2	0.4441	intergenic	HSPA5	7278	HSPA5(dist=7278),GAPVD1(dist=13204)	9q33.3	protein_coding	heat shock protein family A (Hsp70) member 5	-0.122842	0.02234	3.82548e-08	-0.00332425	rs755594165	0	1	CA/C	9	128010901	1	NA	NA	NA	NA	NA	NA	NA	NA	1.22	1	244	GAPVD1 (0.441) | HSPA5 (0.388) | RABEPK (0.058) | PPP6C (0.035) | SCAI (0.015) | LOC105376271 (0.011) | MAPKAP1 (0.002)	NA	NA	NA	NA	NA	HSPA5 (0.89) | PBX3 (0.80) | OLFML2A (0.30)	NA	HSPA5	Novel	-
34	1	gap_gm	10	94839642	rs2068888	A	G	0.4492	-0.13245681	0.02099787	2.825e-10	54890	0.0047	0.4466	0.4726	--+	0	1.726	2	0.4218	intergenic	CYP26A1	2000	CYP26A1(dist=2000),MYOF(dist=226544)	10q23.33	protein_coding	cytochrome P450 family 26 subfamily A member 1	-0.132457	0.0210052	2.86521e-10	0	rs2068888	0	1	A/G	10	94839642	1	NA	NA	NA	NA	1	1.00	2	CYP26A1 (0.976)	2.11	2	2 | 237	CYP26A1 (1.175) | MYOF (0.724) | EXOC6 (0.023) | CYP26C1 (0.001)	NA	NA	NA	CYP26C1 (1;1e-06) | FRA10AC1 (1;3e-05) | MARK2P9 (1;2e-04)	FRA10AC1 (25/49;1e-14) | CYP26C1 (11/22;1e-16)	MYOF (0.22) | EXOC6 (0.04) | HHEX (0.03)	Apolipoprotein B levels | Average diameter for HDL particles | Average diameter for HDL particles (UKB data field 23433) | Blood urea nitrogen levels | Body fat percentage (adjusted for testosterone and SHBG) | C-reactive protein | C-reactive protein levels | Caffeine consumption from coffee or tea | Cholesterol in large HDL (UKB data field 23561) | Cholesterol levels in large HDL | Cholesterol levels in very large HDL | Cholesterol to total lipids ratio in large HDL | Cholesterol to total lipids ratio in medium HDL | Cholesteryl ester levels in large HDL | Cholesteryl ester levels in very large HDL | Cholesteryl esters in large HDL (UKB data field 23562) | Cholesteryl esters to total lipids ratio in large HDL | Cholesteryl esters to total lipids ratio in medium HDL | Citrate levels | Concentration of large HDL particles | Concentration of very large HDL particles | Diastolic blood pressure | Estimated glomerular filtration rate | Estimated glomerular filtration rate (creatinine) | Estimated glomerular filtration rate (cystatin c) | Familial combined hyperlipidemia defined by Consensus criteria | Familial combined hyperlipidemia defined by Dutch criteria | Free cholesterol levels in large HDL | Free cholesterol levels in very large HDL | Free cholesterol to total lipids ratio in large HDL | Free cholesterol to total lipids ratio in large LDL | Free cholesterol to total lipids ratio in medium LDL | Gamma glutamyl transferase levels | Gamma glutamyl transpeptidase | HDL cholesterol levels | HDL cholesterol levels in current drinkers | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | High density lipoprotein cholesterol levels | LDL cholesterol | LDL cholesterol levels | LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | Liver enzyme levels (gamma-glutamyl transferase) | Low density lipoprotein cholesterol levels | Low-density lipoprotein levels (MTAG) | Mean diameter of HDL particles | Medication use (agents acting on the renin-angiotensin system) | Medication use (HMG CoA reductase inhibitors) | Metabolic signature | Monocyte percentage of white cells | Node-level brain connectivity (multivariate analysis) | Non-HDL cholesterol levels | Omega-3 fatty acid levels | Omega-3 fatty acids levels | Omega-3 fatty acids levels (UKB data field 23444) | Phospholipid levels in large HDL | Phospholipid levels in large VLDL | Phospholipid levels in very large HDL | Phospholipids in very large HDL | Phospholipids to total lipids ratio in large HDL | Phospholipids to total lipids ratio in large VLDL | Phospholipids to total lipids ratio in very large HDL | Platelet count | Plateletcrit | Ratio of omega-6 fatty acids to omega-3 fatty acids | Ratio of omega-6 fatty acids to total fatty acids | Saturated fatty acids | Serum 25-Hydroxyvitamin D levels | Serum creatinine levels | Serum total protein levels | Sex hormone-binding globulin levels | Sex hormone-binding globulin levels adjusted for BMI | Sex hormone-binding globulin levels in postmenopausal women | Sex hormone-binding globulin levels in premenopausal women | Tea intake (UKB data field 1488) | Total bilirubin levels | Total cholesterol levels | Total cholesterol to total lipids ratio in large HDL | Total fatty acids | Total lipid levels in large HDL | Total lipid levels in very large HDL | Total triglycerides levels | Triglyceride levels | Triglyceride levels (MTAG) | Triglyceride levels in current drinkers | Triglyceride levels in IDL | Triglyceride levels in large LDL | Triglyceride levels in LDL | Triglyceride levels in medium LDL | Triglyceride levels in medium VLDL | Triglyceride levels in non-type 2 diabetes | Triglyceride levels in small HDL | Triglyceride levels in small LDL | Triglyceride levels in small VLDL | Triglyceride levels in very large VLDL | Triglyceride levels in very small VLDL | Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | Triglyceride to HDL cholesterol ratio | Triglycerides | Triglycerides in medium HDL | Triglycerides to total lipids ratio in small HDL | Triglycerides to total lipids ratio in very large HDL | Triglycerides x physical activity interaction (2df test) | Urinary albumin-to-creatinine ratio	FRA10AC1	Novel	-
35	1	gap_wm	10	98115019	rs41306852	A	G	0.0184	0.42270341	0.07730685	4.555e-08	54890	9e-04	0.0176	0.0221	++-	51.7	4.142	2	0.1261	exonic	OPALIN	0	OPALIN	10q24.1	protein_coding	oligodendrocytic myelin paranodal and inner loop protein	0.424636	0.0773278	3.98826e-08	-0.00482526	rs41306852	0	1	A/G	10	98115019	1	NA	NA	NA	NA	1	1	1	OPALIN (0.970)	1.91	2	1 | 116	OPALIN (1.525) | TLL2 (0.266) | BLNK (0.113) | DNTT (0.021)	NA	NA	OPALIN (rs41306852;9e-08)	NA	NA	BLNK (0.66) | OPALIN (0.21) | TLL2 (0.10)	NA	OPALIN	Novel	-
36	1	gap_gwm	10	105454043	rs2863994	T	G	0.5135	0.11800244	0.02007527	4.153e-09	54890	0.0058	0.5096	0.5451	+++	0	0.388	2	0.8237	intronic	SH3PXD2A	0	SH3PXD2A	10q24.33	protein_coding	SH3 and PX domains 2A	0.118002	0.0200814	4.19792e-09	0	rs2863994	0	1	T/G	10	105454043	1	1	0.78	16	SH3PXD2A (0.966)	1	0.50	7	SH3PXD2A (0.930) | NEURL1 (0.025)	1.55	2	3 | 985	SH3PXD2A (1.328) | STN1 (0.470) | NEURL1-AS1 (0.035) | NEURL1 (0.029) | NT5C2 (0.028) | SLK (0.020) | CNNM2 (0.004) | RPEL1 (0.003) | CALHM1 (0.002) | PDCD11 (0.002) | INA (0.002) | CALHM3 (0.002) | PCGF6 (0.002) | TAF5 (0.001) | SH3PXD2A-AS1 (0.001) | ATP5MD (0.000) | CALHM2 (0.000)	NA	NA	NA	BORCS7 (2;1e-04) | NEURL1 (1;3e-05) | AS3MT (1;3e-04)	BORCS7 (43/49;1e-40) | AS3MT (26/49;3e-17)	COL17A1 (0.49) | OBFC1 (0.39) | SH3PXD2A (0.29)	IDP dMRI TBSS FA Anterior limb of internal capsule R | Periventricular white matter hyperintensities | White matter mean diffusivity x age interaction (2df)	SH3PXD2A	Novel	-
36	2	gap_gm	10	105454043	rs2863994	T	G	0.5136	0.11981643	0.02103355	1.223e-08	54890	0.006	0.5096	0.5451	+++	0	1.784	2	0.4099	intronic	SH3PXD2A	0	SH3PXD2A	10q24.33	protein_coding	SH3 and PX domains 2A	0.119816	0.0210396	1.23511e-08	0	rs2863994	0	1	T/G	10	105454043	1	1	0.61	17	SH3PXD2A (0.961)	1	0.50	4	SH3PXD2A (0.953) | NEURL1 (0.017)	1.53	1	8	SH3PXD2A (0.843) | NEURL1 (0.110)	NA	NA	NA	BORCS7 (2;1e-04) | NEURL1 (1;3e-05) | AS3MT (1;3e-04)	BORCS7 (43/49;1e-40) | AS3MT (26/49;3e-17)	COL17A1 (0.42) | SH3PXD2A (0.39) | NEURL1 (0.39)	IDP dMRI TBSS FA Anterior limb of internal capsule R | Periventricular white matter hyperintensities | White matter mean diffusivity x age interaction (2df)	SH3PXD2A	Novel	-
37	1	gap_wm	10	134573767	rs12258248	A	G	0.7506	-0.22325941	0.02428762	3.845e-20	54890	0.0043	0.7498	0.7788	---	0	0.812	2	0.6663	intronic	INPP5A	0	INPP5A	10q26.3	protein_coding	inositol polyphosphate-5-phosphatase A	-0.223259	0.0243063	4.10523e-20	0	rs12258248	0	1	A/G	10	134573767	1	1	0.89	3	INPP5A (0.984)	1	0.96	16	INPP5A (1.010)	1.2	1	16	INPP5A (0.953)	NA	NKX6-2 (rs12766928;4e-07)	NA	NKX6-2 (1;4e-08) | INPP5A (1;4e-05)	NA	INPP5A (0.67) | PWWP2B (0.18) | TTC40 (0.16)	Cortical surface area | Regional cortical thickness (paracentral)	INPP5A	Ning_2021 (rs12775208), Leonardsen_2023 (rs4880424), Kim_2023 (10:134559486_CGCCTACCCT_C)	N,L,K
37	2	gap_gwm	10	134575836	rs12775990	T	C	0.2492	0.18855451	0.02326433	5.28e-16	54890	0.0042	0.2204	0.25	+++	0	1.065	2	0.5872	intronic	INPP5A	0	INPP5A	10q26.3	protein_coding	inositol polyphosphate-5-phosphatase A	0.188555	0.0232782	5.49315e-16	0	rs12258248	2.07	0.998	GT/AC	10	134573767	1	1	0.76	10	INPP5A (0.909) | NKX6-2 (0.043)	1	0.87	34	INPP5A (0.952)	1.18	1	33	INPP5A (0.952)	NA	NKX6-2 (rs12766928;1e-06)	NA	NKX6-2 (1;3e-08) | INPP5A (1;4e-05)	NA	INPP5A (0.52) | PWWP2B (0.06) | NKX6-2 (0.06)	Cortical surface area | Regional cortical thickness (paracentral)	NKX6-2	Ning_2021 (rs12775208), Leonardsen_2023 (rs4880424), Kim_2023 (10:134559486_CGCCTACCCT_C)	N,L,K
38	1	gap_gwm	11	32758240	rs10767960	A	G	0.5381	-0.11653005	0.02034221	1.013e-08	54890	0.001	0.5373	0.5427	---	0	0.879	2	0.6443	intronic	CCDC73	0	CCDC73	11p13	protein_coding	coiled-coil domain containing 73	-0.11653	0.0203482	1.02351e-08	0	rs10767960	0	1	A/G	11	32758240	1	1	0.71	17	EIF3M (0.667) | CCDC73 (0.293)	1	0.88	166	CCDC73 (0.815) | EIF3M (0.135)	1.5	2	162 | 545	EIF3M (1.047) | CCDC73 (0.831) | WT1-AS (0.009) | QSER1 (0.009) | PRRG4 (0.006)	NA	NA	EIF3M (rs201874;7e-07)	HNRNPA3P9 (13;2e-15) | EIF3M (3;4e-05) | CCDC73 (1;2e-12)	NA	WT1 (0.62)	NA	EIF3M	Novel	-
39	1	gap_wm	12	32526829	rs6488048	T	C	0.65	0.12652449	0.02187137	7.254e-09	54890	0.0055	0.621	0.6516	+++	82	11.12	2	0.003849	intronic	BICD1	0	BICD1	12p11.21	protein_coding	BICD cargo adaptor 1	0.126524	0.0218778	7.32767e-09	0	rs6488048	0	1	T/C	12	32526829	1	1	0.73	18	BICD1 (0.963)	NA	NA	NA	NA	1.74	2	50 | 166	BICD1 (1.886) | FGD4 (0.015)	NA	NA	NA	ENSG00000274964 (6;4e-08) | FGD4 (2;4e-05)	ENSG00000274964 (33/49;1e-51)	BICD1 (1.39) | FGD4 (0.63) | DNM1L (0.03)	Brain morphology (MOSTest) | Height	ENSG00000274964	Novel	-
40	1	gap_wm	12	106476805	rs12146713	T	C	0.9051	-0.24643662	0.03564338	4.713e-12	54890	0.0029	0.9037	0.9217	---	0	0.132	2	0.936	intronic	NUAK1	0	NUAK1	12q23.3	protein_coding	NUAK family kinase 1	-0.239325	0.0356783	1.97497e-11	-0.033322	rs12146713	0	1	T/C	12	106476805	1	1	0.99	1	NUAK1 (0.999)	1	1	1	NUAK1 (0.990)	1.17	1	1	NUAK1 (0.990)	NA	NA	NA	ENSG00000257890 (7;8e-10)	ENSG00000257890 (13/15;8e-47)	RFX4 (0.82) | NUAK1 (0.57) | CKAP4 (0.19)	aseg global volume 3rd-Ventricle | aseg global volume VentricleChoroid | aseg lh intensity Inf-Lat-Vent | aseg lh intensity Lateral-Ventricle | aseg lh volume Inf-Lat-Vent | aseg lh volume Lateral-Ventricle | aseg rh intensity Lateral-Ventricle | aseg rh volume Lateral-Ventricle | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 7) | Corpus callosum central volume | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Corpus callosum volume (MOSTest) | Cortical surface area | Cortical surface area (MOSTest) | Cortical thickness | Corticoamygdaloid transition area volume | Edge-level brain connectivity (multivariate analysis) | Fornix white matter microstructure (diffusion tensor mode) | Fornix white matter microstructure (intra-cellular volume fraction) | Fornix white matter microstructure (isotropic or free water volume fraction) | Fornix white matter microstructure (orientation dispersion index) | IDP dMRI ProbtrackX FA str l | IDP dMRI ProbtrackX FA str r | IDP dMRI ProbtrackX OD str l | IDP dMRI ProbtrackX OD str r | IDP dMRI TBSS FA Fornix | IDP dMRI TBSS FA Posterior limb of internal capsule L | IDP dMRI TBSS FA Posterior limb of internal capsule R | IDP dMRI TBSS ISOVF Fornix | IDP dMRI TBSS L2 Anterior limb of internal capsule R | IDP dMRI TBSS L2 Fornix | IDP dMRI TBSS L2 Posterior limb of internal capsule R | IDP dMRI TBSS L3 Fornix | IDP dMRI TBSS MD Fornix | IDP dMRI TBSS MO Anterior corona radiata R | IDP dMRI TBSS MO Body of corpus callosum | IDP dMRI TBSS MO Fornix | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | IDP dMRI TBSS OD Fornix | IDP dMRI TBSS OD Posterior limb of internal capsule R | IDP T1 SIENAX CSF normalised volume | IDP T1 SIENAX CSF unnormalised volume | Lateral ventricular volume in normal aging | Left-hemisphere control network to putamen white-matter structural connectivity | Left-hemisphere control network to thalamus white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere default mode network to thalamus white-matter structural connectivity | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Left-hemisphere limbic network to thalamus white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | Left-hemisphere visual network to thalamus white-matter structural connectivity | Medial thalamic nuclei volume | MRI-derived phenotypes (MOSTest) (pleiotropy) | Node-level brain connectivity (multivariate analysis) | QC T1-to-standard linear alignment discrepancy | Right-hemisphere control network to thalamus white-matter structural connectivity | Right-hemisphere default mode network to thalamus white-matter structural connectivity | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Right-hemisphere limbic network to putamen white-matter structural connectivity | Right-hemisphere limbic network to thalamus white-matter structural connectivity | Right-hemisphere somatomotor network to pallidum white-matter structural connectivity | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | sMRI-derived phenotypes (MOSTest) (pleiotropy) | Subcortical volume (min-P) | Subcortical volume (MOSTest) | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	ENSG00000257890	Wen_2024 (rs12146713), Smith_2020 (rs12146713)	W,S
40	2	gap_gwm	12	106476805	rs12146713	T	C	0.9051	-0.21943044	0.03413306	1.287e-10	54890	0.0028	0.9037	0.9217	---	0	0.014	2	0.993	intronic	NUAK1	0	NUAK1	12q23.3	protein_coding	NUAK family kinase 1	-0.213245	0.0341659	4.3348e-10	0.0345343	rs12146713	0	1	T/C	12	106476805	1	1	0.98	1	NUAK1 (0.991)	1	1.00	1	NUAK1 (0.976)	1.43	1	1	NUAK1 (0.976)	NA	NA	NA	ENSG00000257890 (7;8e-10)	ENSG00000257890 (13/15;8e-47)	NUAK1 (0.67) | RFX4 (0.60)	aseg global volume 3rd-Ventricle | aseg global volume VentricleChoroid | aseg lh intensity Inf-Lat-Vent | aseg lh intensity Lateral-Ventricle | aseg lh volume Inf-Lat-Vent | aseg lh volume Lateral-Ventricle | aseg rh intensity Lateral-Ventricle | aseg rh volume Lateral-Ventricle | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 7) | Corpus callosum central volume | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Corpus callosum volume (MOSTest) | Cortical surface area | Cortical surface area (MOSTest) | Cortical thickness | Corticoamygdaloid transition area volume | Edge-level brain connectivity (multivariate analysis) | Fornix white matter microstructure (diffusion tensor mode) | Fornix white matter microstructure (intra-cellular volume fraction) | Fornix white matter microstructure (isotropic or free water volume fraction) | Fornix white matter microstructure (orientation dispersion index) | IDP dMRI ProbtrackX FA str l | IDP dMRI ProbtrackX FA str r | IDP dMRI ProbtrackX OD str l | IDP dMRI ProbtrackX OD str r | IDP dMRI TBSS FA Fornix | IDP dMRI TBSS FA Posterior limb of internal capsule L | IDP dMRI TBSS FA Posterior limb of internal capsule R | IDP dMRI TBSS ISOVF Fornix | IDP dMRI TBSS L2 Anterior limb of internal capsule R | IDP dMRI TBSS L2 Fornix | IDP dMRI TBSS L2 Posterior limb of internal capsule R | IDP dMRI TBSS L3 Fornix | IDP dMRI TBSS MD Fornix | IDP dMRI TBSS MO Anterior corona radiata R | IDP dMRI TBSS MO Body of corpus callosum | IDP dMRI TBSS MO Fornix | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | IDP dMRI TBSS OD Fornix | IDP dMRI TBSS OD Posterior limb of internal capsule R | IDP T1 SIENAX CSF normalised volume | IDP T1 SIENAX CSF unnormalised volume | Lateral ventricular volume in normal aging | Left-hemisphere control network to putamen white-matter structural connectivity | Left-hemisphere control network to thalamus white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere default mode network to thalamus white-matter structural connectivity | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Left-hemisphere limbic network to thalamus white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | Left-hemisphere visual network to thalamus white-matter structural connectivity | Medial thalamic nuclei volume | MRI-derived phenotypes (MOSTest) (pleiotropy) | Node-level brain connectivity (multivariate analysis) | QC T1-to-standard linear alignment discrepancy | Right-hemisphere control network to thalamus white-matter structural connectivity | Right-hemisphere default mode network to thalamus white-matter structural connectivity | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Right-hemisphere limbic network to putamen white-matter structural connectivity | Right-hemisphere limbic network to thalamus white-matter structural connectivity | Right-hemisphere somatomotor network to pallidum white-matter structural connectivity | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | sMRI-derived phenotypes (MOSTest) (pleiotropy) | Subcortical volume (min-P) | Subcortical volume (MOSTest) | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	ENSG00000257890	Wen_2024 (rs12146713), Smith_2020 (rs12146713)	W,S
41	1	gap_wm	12	107349294	rs2287163	T	C	0.3735	0.13416078	0.02159947	5.255e-10	54890	0.0018	0.3725	0.383	+++	0	1.256	2	0.5336	upstream	TMEM263	0	TMEM263(dist=206)	12q23.3	protein_coding	transmembrane protein 263	0.129329	0.0216188	2.20089e-09	0	rs2287163	0	1	T/C	12	107349294	1	1	0.62	15	TMEM263 (0.872) | MTERF2 (0.049) | RIC8B (0.045)	1	0.52	110	TMEM263 (0.718) | LOC100287944 (0.224) | RIC8B (0.029) | LOC100505978 (0.008) | RFX4 (0.003)	1.51	2	114 | 454	TMEM263 (0.806) | LOC100287944 (0.644) | RIC8B (0.411) | CRY1 (0.028) | LOC100505978 (0.006) | MTERF2 (0.003) | RFX4 (0.002)	NA	TMEM263 (rs10735418;4e-06)	NA	TMEM263-DT (21;2e-30) | TMEM263 (13;6e-18) | ENSG00000257918 (2;2e-05) | MTERF2 (1;2e-07)	TMEM263-DT (41/49;2e-221) | TMEM263 (26/49;8e-96)	RFX4 (0.82) | CRY1 (0.48) | RIC8B (0.26)	Intrinsic epigenetic age acceleration | Waist-hip index | Waist-to-hip ratio adjusted for BMI	TMEM263	Novel	-
42	1	gap_wm	14	73297741	rs2215590	T	C	0.2529	0.14296069	0.02408342	2.919e-09	54890	0.0051	0.2248	0.2545	++-	0	1.626	2	0.4436	intronic	DPF3	0	DPF3	14q24.2	protein_coding	double PHD fingers 3	0.142961	0.0240909	2.95263e-09	0	rs2215590	0	1	T/C	14	73297741	1	1	0.86	8	DPF3 (0.951)	1	0.73	5	DPF3 (0.969)	1.28	1	5	DPF3 (0.958)	NA	NA	NA	DCAF4 (17;2e-07) | MIDEAS-AS1 (3;3e-05) | DPF3 (2;3e-17) | ENSG00000259015 (1;1e-05)	MIDEAS-AS1 (49/49;4e-58) | DCAF4 (35/49;4e-39)	DPF3 (0.51) | PSEN1 (0.41) | NUMB (0.38)	Pulse pressure | Serum urate levels	DPF3	Novel	-
42	2	gap_gwm	14	73297741	rs2215590	T	C	0.253	0.1314441	0.02306496	1.206e-08	54890	0.0049	0.2248	0.2545	++-	0	1.411	2	0.4939	intronic	DPF3	0	DPF3	14q24.2	protein_coding	double PHD fingers 3	0.131444	0.0230716	1.2177e-08	0	rs2215590	0	1	T/C	14	73297741	1	1	0.66	27	DPF3 (0.958)	1	0.73	8	DPF3 (0.981)	1.17	1	7	DPF3 (0.951)	NA	NA	NA	DCAF4 (3;2e-07) | MIDEAS-AS1 (3;3e-05) | DPF3 (2;3e-17)	MIDEAS-AS1 (49/49;4e-58) | DCAF4 (35/49;4e-39)	NUMB (0.53) | PSEN1 (0.37) | DPF3 (0.34)	Pulse pressure | Serum urate levels	DPF3	Novel	-
43	1	gap_wm	14	88433660	rs413420	T	C	0.5182	-0.15644714	0.02087427	6.643e-14	54890	7e-04	0.5146	0.5188	---	0	0.589	2	0.745	intronic	GALC	0	GALC	14q31.3	protein_coding	galactosylceramidase	-0.156447	0.0208847	6.83536e-14	0	rs413420	0	1	T/C	14	88433660	1	1	0.68	23	GALC (0.941) | GPR65 (0.013)	1	0.93	82	GALC (1.273)	1.25	1	85	GALC (0.953)	GALC (1;rs398607;22.900)	NA	GALC (rs4904408;5e-07)	GALC (12;2e-19) | GPR65 (2;6e-11) | ENSG00000258407 (1;1e-04)	NA	GALC (0.90) | GPR65 (0.45) | SPATA7 (0.06)	Intralaminar thalamic nuclei volume	GALC	Leonardsen_2023 (rs17203398)	L
43	2	gap_gwm	14	88454691	rs2245387	T	C	0.3477	-0.13072899	0.0210401	5.187e-10	54890	0.001	0.3468	0.349	---	0	1.961	2	0.3751	intronic	GALC	0	GALC	14q31.3	protein_coding	galactosylceramidase	-0.130729	0.0210473	5.25821e-10	0	rs413420	21	0.494	CC/TT	14	88433660	1	1	0.83	8	GALC (0.784) | GPR65 (0.192)	1	0.67	122	GALC (0.838) | GPR65 (0.063) | LINC01147 (0.049)	1.25	1	122	GALC (0.839) | GPR65 (0.063) | LINC01147 (0.050)	NA	NA	NA	GALC (17;5e-28)	NA	GALC (0.80) | GPR65 (0.23) | SPATA7 (0.11)	Brain age gap	GALC	Leonardsen_2023 (rs17203398)	L
44	1	gap_wm	15	71169352	rs2031017	A	T	0.3994	-0.14386754	0.02128452	1.387e-11	54890	0.0039	0.3967	0.4154	---	23.6	2.619	2	0.27	intronic	LRRC49	0	LRRC49	15q23	protein_coding	leucine rich repeat containing 49	-0.143868	0.0212931	1.41339e-11	0	rs2031017	0	1	A/T	15	71169352	1	1	0.74	9	LRRC49 (0.974)	1	0.98	51	LRRC49 (0.952)	1.13	1	51	LRRC49 (0.953)	NA	LARP6 (rs1534615;3e-10) | AC009269.4 (rs2249595;5e-06)	LARP6 (rs11853599;2e-07) | LRRC49 (rs4777326;2e-05)	LARP6 (18;2e-27) | ENSG00000259744 (4;4e-11) | ENSG00000274297 (1;2e-05)	NA	LARP6 (0.32) | UACA (0.25) | THSD4 (0.17)	Brain region volumes | Corpus callosum Mid-posterior volume | Corpus callosum volume (MOSTest) | Vertex-wise cortical thickness	LARP6	Smith_2020 (rs4777315)	S
44	2	gap_gwm	15	71159216	rs11072229	A	G	0.3994	-0.12346863	0.02037636	1.366e-09	54890	0.0039	0.3968	0.4152	---	39.3	3.296	2	0.1925	intronic	LRRC49	0	LRRC49	15q23	protein_coding	leucine rich repeat containing 49	-0.123469	0.0203829	1.38295e-09	0	rs2031017	-10.1	1	AA/TG	15	71169352	1	1	0.76	11	LRRC49 (0.938) | THAP10 (0.028)	1	0.98	53	LRRC49 (0.953)	1.13	1	53	LRRC49 (0.955)	NA	LARP6 (rs1534615;1e-08) | AC009269.4 (rs2249595;2e-05)	LARP6 (rs11853599;1e-06) | LRRC49 (rs4777326;6e-05)	LARP6 (17;6e-26) | ENSG00000259744 (4;2e-10) | ENSG00000274297 (1;6e-06)	NA	UACA (0.48) | THSD4 (0.42) | LARP6 (0.14)	Brain region volumes | Corpus callosum Mid-posterior volume | Corpus callosum volume (MOSTest) | Vertex-wise cortical thickness	LARP6	Smith_2020 (rs4777315)	S
45	1	gap_gm	16	30122181	rs536906899	CAAAAAAAAAAAAA	C	0.4006	-0.12168831	0.02221572	4.312e-08	54890	0.0063	0.3994	0.4359	---	24	2.632	2	0.2683	intronic	GDPD3	0	GDPD3	16p11.2	protein_coding	glycerophosphodiester phosphodiesterase domain containing 3	-0.121688	0.022222	4.34995e-08	0	rs536906899	0	1	CAAAAAAAAAAAAA/C	16	30122181	1	1	0.55	39	KCTD13 (0.338) | MAPK3 (0.289) | TMEM219 (0.120) | TBX6 (0.110) | TAOK2 (0.062) | DOC2A (0.021) | INO80E (0.013)	1	0.53	72	KCTD13 (0.563) | MAPK3 (0.234) | GDPD3 (0.075) | TMEM219 (0.058) | TAOK2 (0.052) | DOC2A (0.007) | INO80E (0.007)	1.32	1	67	KCTD13 (0.476) | MAPK3 (0.302) | GDPD3 (0.111) | TMEM219 (0.028) | TAOK2 (0.027) | DOC2A (0.004) | INO80E (0.004)	NA	MAPK3 (rs55732507;2e-07)	NA	NA	NA	MAPK3 (1.22) | CORO1A (0.84) | MYLPF (0.42)	NA	MAPK3	Novel	-
46	1	gap_gm	16	90051269	rs76839250	A	G	0.9066	0.24620312	0.0361571	9.81e-12	54890	0.0021	0.8997	0.9091	+++	0	1.502	2	0.472	ncRNA_intronic	AFG3L1P	0	AFG3L1P	16q24.3	transcribed_pseudogene	AFG3 like matrix AAA peptidase subunit 1%2C pseudogene	0.246203	0.0361721	1.00046e-11	0	rs76839250	0	1	A/G	16	90051269	1	1	0.71	6	MC1R (0.701) | DEF8 (0.129) | FANCA (0.073) | SPIRE2 (0.037) | TUBB3 (0.028)	1	0.60	15	AFG3L1P (0.570) | TCF25 (0.148) | DEF8 (0.084) | FANCA (0.077) | MC1R (0.038) | DBNDD1 (0.011) | TUBB3 (0.010) | SPIRE2 (0.009) | CPNE7 (0.008)	1.19	1	14	AFG3L1P (0.579) | TCF25 (0.148) | DEF8 (0.082) | FANCA (0.070) | MC1R (0.037) | DBNDD1 (0.010) | TUBB3 (0.009) | SPIRE2 (0.008) | CPNE7 (0.008)	MC1R (1;rs1805008;24.500) | FANCA (1;rs1800282;17.100)	NA	DEF8 (rs6500462;4e-10)	CDK10 (47;2e-60) | VPS9D1 (24;5e-13) | CPNE7 (13;3e-09) | FANCA (10;5e-15) | DEF8 (9;3e-09) | CENPBD1P (9;1e-05) | SPIRE2 (8;5e-08) | LINC02166 (7;3e-14) | TCF25 (5;3e-05) | VPS9D1-AS1 (4;2e-05) | CHMP1A (3;6e-08) | GAS8 (3;7e-08) | CICP25 (2;2e-07) | TUBB3 (2;5e-05) | URAHP (2;1e-04) | ENSG00000261172 (1;2e-08) | DBNDD1 (1;2e-07) | SPATA33 (1;7e-06) | FAM157C (1;2e-05) | SPATA2L (1;2e-05) | LINC00304 (1;2e-05) | ENSG00000275734 (1;6e-05) | SPG7 (1;1e-04) | ZNF276 (1;1e-04) | MC1R (1;2e-04)	CDK10 (47/49;0e+00) | CENPBD1P (46/49;4e-64) | CHMP1A (41/49;2e-45) | DEF8 (39/49;5e-53) | VPS9D1 (35/49;3e-131) | TCF25 (35/49;7e-36) | LINC02166 (27/47;5e-55) | MC1R (27/49;2e-15) | LINC00304 (25/46;2e-27) | URAHP (26/49;9e-29) | CPNE7 (24/46;1e-64) | SPIRE2 (25/49;2e-43)	FANCA (0.17) | TUBB3 (0.17) | GAS8 (0.14)	Basal cell carcinoma | Educational attainment (years of education) | Highest math class taken | Highest math class taken (MTAG) | Melanocyte protein PMEL levels | Monobrow | Self-reported math ability (MTAG)	DEF8	Smith_2020 (rs4625719)	S
46	2	gap_gwm	16	90051269	rs76839250	A	G	0.9066	0.20426079	0.03451462	3.257e-09	54890	0.0021	0.8997	0.9091	+++	8.7	2.189	2	0.3346	ncRNA_intronic	AFG3L1P	0	AFG3L1P	16q24.3	transcribed_pseudogene	AFG3 like matrix AAA peptidase subunit 1%2C pseudogene	0.204261	0.0345254	3.29358e-09	0	rs76839250	0	1	A/G	16	90051269	1	1	0.65	13	MC1R (0.604) | FANCA (0.136) | TCF25 (0.047) | SPIRE2 (0.045) | TUBB3 (0.030) | CDK10 (0.024) | CPNE7 (0.023) | DPEP1 (0.022) | DEF8 (0.017) | CHMP1A (0.015)	NA	NA	NA	NA	1.16	1	29	AFG3L1P (0.346) | TCF25 (0.211) | PRDM7 (0.076) | FANCA (0.064) | DEF8 (0.056) | CDK10 (0.049) | MC1R (0.047) | DBNDD1 (0.026) | TUBB3 (0.025) | SPIRE2 (0.023) | CPNE7 (0.021) | CHMP1A (0.005)	MC1R (1;rs1805008;24.500) | FANCA (1;rs1800282;17.100)	NA	DEF8 (rs6500462;7e-08)	CDK10 (47;2e-60) | VPS9D1 (24;5e-13) | CPNE7 (12;3e-09) | FANCA (10;5e-15) | DEF8 (8;3e-09) | SPIRE2 (8;5e-08) | LINC02166 (7;3e-14) | CENPBD1P (7;1e-05) | TCF25 (5;3e-05) | VPS9D1-AS1 (4;2e-05) | CHMP1A (3;6e-08) | GAS8 (3;7e-08) | CICP25 (2;2e-07) | TUBB3 (2;5e-05) | ENSG00000261172 (1;2e-08) | DBNDD1 (1;2e-07) | SPATA33 (1;7e-06) | FAM157C (1;2e-05) | SPATA2L (1;2e-05) | LINC00304 (1;2e-05) | ENSG00000275734 (1;6e-05) | SPG7 (1;1e-04) | URAHP (1;1e-04) | ZNF276 (1;1e-04) | MC1R (1;2e-04)	CDK10 (47/49;0e+00) | CENPBD1P (46/49;4e-64) | CHMP1A (41/49;2e-45) | DEF8 (39/49;5e-53) | VPS9D1 (35/49;3e-131) | TCF25 (35/49;7e-36) | LINC02166 (27/47;5e-55) | MC1R (27/49;2e-15) | LINC00304 (25/46;2e-27) | CPNE7 (24/46;1e-64) | SPIRE2 (25/49;2e-43)	TUBB3 (0.41) | ZNF276 (0.26) | SPATA33 (0.24)	Basal cell carcinoma | Educational attainment (years of education) | Highest math class taken | Highest math class taken (MTAG) | Melanocyte protein PMEL levels | Monobrow | Self-reported math ability (MTAG)	DEF8	Smith_2020 (rs4625719)	S
47	1	gap_wm	17	19889274	rs111513543	A	T	0.6428	-0.13072402	0.02269179	8.369e-09	54890	0.0056	0.6401	0.6714	---	0	0.092	2	0.9549	intergenic	AKAP10	8105	AKAP10(dist=8105),SPECC1(dist=23398)	17p11.2	protein_coding	A-kinase anchoring protein 10	-0.132884	0.0227008	4.80743e-09	-0.00794462	rs111513543	0	1	A/T	17	19889274	1	1	0.64	30	AKAP10 (0.840) | SPECC1 (0.118)	1	0.75	47	AKAP10 (0.956)	1.16	1	47	AKAP10 (0.958)	AKAP10 (1;rs2108978;8.872)	NA	NA	NA	NA	SLC47A1 (0.76) | SPECC1 (0.52) | AKAP10 (0.34)	NA	AKAP10	Novel	-
47	2	gap_gwm	17	19824272	17:19824272_CT_C	CT	C	0.605	-0.11704411	0.02055721	1.244e-08	54890	0.0037	0.6036	0.6255	---	0	0.237	2	0.8883	intronic	AKAP10	0	AKAP10	17p11.2	protein_coding	A-kinase anchoring protein 10	-0.118431	0.0205638	8.45284e-09	0.00548792	rs111513543	-65	0.714	TC/ACT	17	19889274	1	1	0.8	4	AKAP10 (0.925) | SPECC1 (0.054)	1	0.75	48	AKAP10 (0.930) | SPECC1 (0.023)	1.13	1	48	AKAP10 (0.934) | SPECC1 (0.022)	AKAP10 (2;rs203462;8.255)	NA	AKAP10 (rs203465;3e-06)	ENSG00000270091 (24;1e-15) | AKAP10 (20;1e-28) | CCDC144CP (8;6e-09) | LGALS9B (6;2e-15) | USP32P3 (6;3e-06) | SPECC1-DT (3;5e-17) | SPECC1 (2;1e-05) | KRT16P3 (1;2e-21) | ENSG00000266126 (1;1e-06) | NOS2P3 (1;5e-06) | ENSG00000260907 (1;1e-04) | SRP68P3 (1;1e-04)	ENSG00000270091 (46/49;7e-229) | CCDC144CP (34/42;4e-68) | AKAP10 (37/49;4e-176) | LGALS9B (11/16;2e-59) | USP32P3 (31/49;3e-42) | NOS2P3 (9/18;2e-15)	SPECC1 (0.40) | SLC47A1 (0.38) | SLC47A2 (0.22)	Neutrophil count | Whole brain restricted directional diffusion (multivariate analysis)	AKAP10	Novel	-
48	1	gap_gm	17	27962571	17:27962571_GCCC_G	G	GCCC	0.471	0.13800755	0.02247594	8.24e-10	53057	3e-04	0.4707	0.4712	++?	0	0.022	1	0.8823	intronic	SSH2	0	SSH2	17q11.2	protein_coding	slingshot protein phosphatase 2	0.138008	0.0224845	8.36239e-10	0	17:27962571_GCCC_G	0	1	G/GCCC	17	27962571	1	1	0.74	10	SSH2 (0.749) | ANKRD13B (0.157) | CORO6 (0.058)	1	0.52	79	SSH2 (0.438) | CORO6 (0.305) | ANKRD13B (0.183) | EFCAB5 (0.026) | NSRP1 (0.000)	1.72	2	43 | 785	TAOK1 (0.817) | SSH2 (0.423) | CORO6 (0.307) | ANKRD13B (0.221) | MIR4523 (0.061) | EFCAB5 (0.027) | GOSR1 (0.012) | CPD (0.012) | BLMH (0.006) | TMIGD1 (0.003) | GIT1 (0.003) | NSRP1 (0.002) | SLC6A4 (0.002) | ABHD15 (0.002) | SMURF2P1-LRRC37BP1 (0.001) | TP53I13 (0.001)	SSH2 (1;rs2289629;23.700)	NA	NA	EFCAB5 (23;1e-34) | SSH2 (10;3e-35) | CORO6 (9;4e-124) | ANKRD13B (8;4e-33) | NSRP1 (7;2e-05) | GOSR1 (6;2e-06) | TP53I13 (5;5e-20) | GIT1 (4;1e-23) | SLC6A4 (4;2e-05) | ENSG00000266876 (3;1e-05) | ENSG00000264290 (2;3e-04) | ENSG00000264007 (1;6e-58) | ENSG00000265625 (1;3e-05) | BLMH (1;5e-05) | DHRS13 (1;1e-04)	EFCAB5 (31/38;5e-200) | GOSR1 (35/49;2e-26) | CORO6 (32/49;4e-252) | ENSG00000266876 (7/12;3e-13) | SSH2 (25/49;4e-91)	GIT1 (0.43) | TAOK1 (0.33) | CORO6 (0.20)	Body mass index | Brain morphology (MOSTest) | Coronary artery disease | Cortical thickness (MOSTest) | Lymphocyte count | Subcortical volume (MOSTest) | Whole brain restricted directional diffusion (multivariate analysis)	SSH2	Novel	-
48	2	gap_gwm	17	27959903	rs2289629	A	G	0.3488	0.12582505	0.02099577	2.062e-09	54890	0.0015	0.3437	0.35	++-	50.3	4.021	2	0.1339	exonic	SSH2	0	SSH2	17q11.2	protein_coding	slingshot protein phosphatase 2	0.135944	0.0210602	1.08191e-10	-0.00783215	17:27962571_GCCC_G	-2.67	0.565	GA/GCCCG	17	27962571	1	1	0.88	3	SSH2 (0.812) | CORO6 (0.205)	2	0.91 | 0.64	33 | 16	TAOK1 (0.832) | SSH2 (0.629) | CORO6 (0.189) | EFCAB5 (0.121) | MIR4523 (0.121) | ANKRD13B (0.015)	2.03	2	13 | 32	TAOK1 (0.819) | SSH2 (0.704) | MIR4523 (0.132) | CORO6 (0.127) | EFCAB5 (0.125)	SSH2 (1;rs2289629;23.700)	NA	NA	EFCAB5 (19;3e-19) | ANKRD13B (10;1e-17) | TP53I13 (9;4e-19) | SSH2 (7;8e-25) | CORO6 (6;1e-54) | GIT1 (4;2e-14) | SLC6A4 (3;2e-04) | ENSG00000264007 (2;3e-36) | ENSG00000266876 (2;1e-04) | BLMH (2;1e-04) | GOSR1 (1;2e-07) | PROCA1 (1;2e-05) | ENSG00000264290 (1;2e-05) | NSRP1 (1;1e-04) | ABHD15 (1;1e-04) | CPD (1;2e-04)	EFCAB5 (33/38;7e-126) | GOSR1 (36/49;2e-22) | ENSG00000266876 (6/12;1e-11)	GIT1 (0.55) | ABHD15 (0.38) | SSH2 (0.36)	Brain region volumes | Chronic obstructive pulmonary disease	SSH2	Novel	-
49	1	gap_wm	17	44305199	rs2260227	T	C	0.7774	-0.48347721	0.02508808	9.375e-83	54890	0.0055	0.7764	0.8103	---	43.7	3.553	2	0.1692	intergenic	KANSL1	2459	KANSL1(dist=2459),ARL17B(dist=46351)	17q21.31	protein_coding	KAT8 regulatory NSL complex subunit 1	-0.324977	0.0306216	2.6016e-26	0.610645	rs2260227	0	1	T/C	17	44305199	1	1	0.63	5	KANSL1 (0.923) | MAPT (0.148)	1	0.95	1760	KANSL1 (0.517) | MAPT (0.309) | MAPT-AS1 (0.083) | CRHR1 (0.013) | LINC02210-CRHR1 (0.012) | MAPT-IT1 (0.007) | ARL17B (0.003) | SPPL2C (0.002) | MAPK8IP1P2 (0.001) | LINC02210 (0.001) | STH (0.001) | KANSL1-AS1 (0.001)	1.27	1	1750	KANSL1 (0.518) | MAPT (0.309) | MAPT-AS1 (0.083) | CRHR1 (0.012) | LINC02210-CRHR1 (0.011) | MAPT-IT1 (0.007) | ARL17B (0.003) | SPPL2C (0.002) | MAPK8IP1P2 (0.001) | LINC02210 (0.001) | STH (0.001) | KANSL1-AS1 (0.001)	MAPT (1;rs17651549;34.000) | KANSL1 (2;rs17585974;24.700)	MAPT (rs2222746;7e-17)	KANSL1 (rs2696532;6e-55) | KANSL1-AS1 (rs199456;3e-46) | MAPT (rs2732599;1e-26) | LRRC37A4P (rs62061817;4e-23) | PLEKHM1 (rs1052594;8e-21) | ARL17A (rs199528;1e-20) | CRHR1-IT1 (rs2668690;2e-17) | MAPT-AS1 (rs62063670;3e-08) | AC005829.1 (rs199441;7e-08)	LINC02210 (49;4e-222) | LRRC37A4P (49;2e-193) | KANSL1-AS1 (49;6e-158) | ENSG00000262539 (49;4e-155) | MAPK8IP1P2 (49;2e-153) | DND1P1 (49;1e-136) | LRRC37A2 (49;2e-118) | ARL17A (47;2e-47) | LRRC37A (46;7e-44) | ENSG00000261575 (44;7e-63) | ENSG00000280022 (39;9e-104) | MAPK8IP1P1 (37;3e-128) | WNT3 (32;2e-41) | ENSG00000266918 (31;9e-23) | PLEKHM1 (27;5e-40) | KANSL1 (24;4e-22) | MAPT (21;4e-117) | NSF (17;1e-09) | FAM215B (16;3e-29) | ARHGAP27 (15;2e-34) | CRHR1 (15;5e-23) | MAPT-AS1 (11;3e-20) | ARL17B (10;5e-34) | DCAKD (7;2e-05) | MAPT-IT1 (6;1e-13) | ENSG00000236234 (6;3e-12) | LRRC37A17P (5;2e-10) | ENSG00000267344 (5;3e-08) | NMT1 (5;3e-06) | SPPL2C (4;5e-24) | ENSG00000267198 (4;1e-09) | RPS26P8 (3;1e-44) | ENSG00000262372 (3;5e-08) | ENSG00000262881 (2;2e-30) | FMNL1 (2;2e-22) | FMNL1-DT (2;5e-10) | NSFP1 (2;3e-06) | FMNL1-AS1 (2;7e-05) | ENSG00000131484 (2;2e-04) | ACBD4 (2;2e-04) | ENSG00000274883 (1;2e-17) | ENSG00000265964 (1;2e-05) | MAP3K14 (1;2e-04) | GOSR2 (1;3e-04)	ENSG00000262539 (49/49;0e+00) | KANSL1-AS1 (49/49;0e+00) | LRRC37A4P (49/49;0e+00) | MAPK8IP1P2 (49/49;0e+00) | MAPK8IP1P1 (37/37;0e+00) | ARL17A (48/49;0e+00) | LRRC37A2 (48/49;0e+00) | DND1P1 (47/49;0e+00) | LINC02210 (46/49;0e+00) | LRRC37A (45/49;0e+00) | ENSG00000266918 (44/48;1e-194) | ENSG00000261575 (43/48;0e+00) | FAM215B (19/22;6e-150) | WNT3 (38/49;3e-269) | KANSL1 (38/49;1e-180) | DCAKD (38/49;2e-35) | ENSG00000280022 (35/49;0e+00) | NMT1 (35/49;1e-36) | ACBD4 (31/49;8e-18) | NSFP1 (27/49;4e-11) | MAPT-IT1 (11/20;2e-44) | PLEKHM1 (25/49;3e-276) | ENSG00000262372 (25/49;5e-28) | ENSG00000267198 (23/46;9e-32)	MAPT (0.38) | STH (0.12) | KANSL1 (0.10)	Accelerometer-based physical activity measurement (average acceleration) | Age at first birth | Albumin levels | Alcohol consumption | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | Alcohol consumption (drinks per week) | Alcohol consumption (drinks per week) (MTAG) | Alcohol consumption (heavy vs. light/non-drinkers) | Alcohol frequency weekly (standard GWA) | Alcohol liking | Alcohol use disorder (consumption score) | Alcohol use disorder (total score) | Alzheimer's disease | Alzheimer's disease in APOE e4- carriers | Alzheimer's disease or educational attainment (pleiotropy) | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Anteromedial temporal area (unadjusted for global measures) | aparc-a2009s lh area S-collat-transv-ant | aparc-a2009s lh area S-orbital-H-Shaped | aparc-a2009s lh thickness S-orbital-H-Shaped | aparc-a2009s rh area G-oc-temp-lat-fusifor | aparc-a2009s rh area G+S-occipital-inf | aparc-Desikan lh area fusiform | aparc-Desikan lh area TotalSurface | aparc-Desikan lh thickness inferiortemporal | aparc-Desikan rh area lateraloccipital | aparc-Desikan rh area TotalSurface | aparc-Desikan rh volume fusiform | aparc-DKTatlas lh area fusiform | aparc-DKTatlas rh area lateraloccipital | aparc-DKTatlas rh area lingual | aparc-DKTatlas rh volume fusiform | aparc-pial lh area TotalSurface | aparc-pial rh area TotalSurface | aseg global volume BrainSeg | aseg global volume BrainSegNotVent | aseg global volume BrainSegNotVentSurf | aseg global volume SupraTentorial | aseg global volume SupraTentorialNotVent | aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy) | Automobile speeding propensity | Average diameter for HDL particles | Avocado liking | BA-exvivo rh area V2 | Baked/steamed fish liking | Beans liking | Bioavailable testosterone levels | Bitter alcoholic beverage consumption | Brain age (difference between predicted and chronological age) | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Breast cancer | Breast cancer or critical COVID-19 (pleiotropy) | Breast cancer or hospitalized COVID-19 (pleiotropy) | Breast cancer or ovarian cancer (pleiotropy) | Broad bean liking | Brussel sprout liking | CALCOCO1/IKBKG protein level ratio | CALCOCO1/TJAP1 protein level ratio | Cancer (pleiotropy) | Capers liking | Cardiorespiratory fitness (vo2 max) | CASP2/NUB1 protein level ratio | CDKN2D/CNPY4 protein level ratio | Chronic obstructive pulmonary disease | Circulating docosahexaenoic acid levels | Cognitive ability | Cognitive ability (MTAG) | Cognitive aspects of educational attainment | Common executive function | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Cortical surface area | Cortical surface area (global PC1) | Cortical surface area (MOSTest) | Cortical thickness | Cortical volume | Corticobasal degeneration | COVID-19 (critical illness vs population or mild symptoms) | COVID-19 (critical illness vs population) | COVID-19 (hospitalized covid vs population) | COVID-19 (hospitalized vs population) | COVID-19 hospitalization or systemic lupus erythematosus (MTAG) | COVID-19 severity | CTF1/ITGB1BP2 protein level ratio | Daytime nap | Depressed affect | Dietary macronutrient intake (multi-trait analysis) | Disruptive behavior (multivariate analysis) | Docosahexaenoic acid levels | Docosahexaenoic acid levels (UKB data field 23450) | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsolateral prefrontal thickness (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Drinks per week | Ease of getting up in the morning | ECG cardiac MRI latent space | ECG latent space | Edge-level brain connectivity (multivariate analysis) | Educational attainment | Educational attainment (MTAG) | Educational attainment (years of education) | Eosinophil counts | Eosinophil percentage of white cells | Experiencing mood swings | Externalizing behaviour (multivariate analysis) | Eye color | F-acquired taste liking (derived food-liking factor) | F-bitter food liking (derived food-liking factor) | F-cheese liking (derived food-liking factor) | F-cooking vegetables liking (derived food-liking factor) | F-fatty/salty food liking (derived food-liking factor) | F-fish liking (derived food-liking factor) | F-oily fish liking (derived food-liking factor) | F-savoury food liking (derived food-liking factor) | F-seafood liking (derived food-liking factor) | F-sharp flavour liking (derived food-liking factor) | F-small fish liking (derived food-liking factor) | F-strong flavour liking (derived food-liking factor) | F-strong vegetable liking (derived food-liking factor) | Feeling fed-up | Feeling guilty | Feeling hurt | Feeling miserable | Feeling nervous | Feeling worry | FEV1 | Fornix volume | FOXO1/NUB1 protein level ratio | Free testosterone levels | Frontal QRS-T angle | FVC | General cognitive ability | General factor of neuroticism | Generalized anxiety disorder (mental health questionnaire or predicted) | Generalized anxiety disorder (phenotype risk score) | Globe artichoke liking | Goat cheese liking | Granulocyte count | Hand grip strength | Handedness (left-handed vs. right-handed) | Headache | Headache or migraine | Heel bone mineral density | Height | Height (standard GWA) | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Herring liking | High light scatter reticulocyte count | High light scatter reticulocyte percentage of red cells | Highest math class taken | Highest math class taken (MTAG) | Hip circumference adjusted for BMI | Horseradish liking | Household income | Household income (MTAG) | Hypertrophic cardiomyopathy | Hypertrophic cardiomyopathy (MTAG) | Hypertrophic cardiomyopathy (sarcomere negative) | Idiopathic pulmonary fibrosis | IDP dMRI ProbtrackX ICVF atr l | IDP dMRI ProbtrackX ICVF atr r | IDP dMRI ProbtrackX ICVF slf l | IDP dMRI ProbtrackX ICVF slf r | IDP dMRI ProbtrackX ICVF str l | IDP dMRI ProbtrackX ICVF str r | IDP dMRI ProbtrackX L1 atr l | IDP dMRI ProbtrackX L1 ptr l | IDP dMRI ProbtrackX L1 slf l | IDP dMRI ProbtrackX L1 slf r | IDP dMRI ProbtrackX L1 str r | IDP dMRI ProbtrackX L2 atr l | IDP dMRI ProbtrackX MD atr l | IDP dMRI ProbtrackX MD str l | IDP dMRI ProbtrackX MD str r | IDP dMRI TBSS ICVF Anterior corona radiata L | IDP dMRI TBSS ICVF Anterior corona radiata R | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | IDP dMRI TBSS ICVF External capsule L | IDP dMRI TBSS ICVF External capsule R | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | IDP dMRI TBSS ICVF Superior corona radiata R | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Anterior corona radiata L | IDP dMRI TBSS L1 External capsule L | IDP dMRI TBSS L1 External capsule R | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | IDP dMRI TBSS L1 Uncinate fasciculus L | IDP dMRI TBSS L2 Genu of corpus callosum | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | IDP dMRI TBSS L3 Anterior limb of internal capsule L | IDP dMRI TBSS L3 Anterior limb of internal capsule R | IDP dMRI TBSS L3 Genu of corpus callosum | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Anterior corona radiata L | IDP dMRI TBSS MD Anterior corona radiata R | IDP dMRI TBSS MD Anterior limb of internal capsule L | IDP dMRI TBSS MD Anterior limb of internal capsule R | IDP dMRI TBSS MD Cingulum cingulate gyrus L | IDP dMRI TBSS MD Cingulum cingulate gyrus R | IDP dMRI TBSS MD Genu of corpus callosum | IDP dMRI TBSS MD Posterior limb of internal capsule R | IDP dMRI TBSS MD Superior corona radiata L | IDP dMRI TBSS MD Superior corona radiata R | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | IDP SWI T2star left putamen | IDP T1 SIENAX brain-normalised volume | IDP T1 SIENAX brain-unnormalised volume | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Immature fraction of reticulocytes | Inferior parietal area (unadjusted for global measures) | Inferior parietal thickness (unadjusted for global measures) | Intelligence (MTAG) | Interstitial lung disease | Interventricular septum cross-sectional area | Intracranial volume | Irritable mood | ITGB1BP2/MITD1 protein level ratio | Joint mobility (Beighton score) | Lager liking | Left hippocampal volume (body) | Left molecular layer hippocampal volume (head) | Left ventricle wall thickness | Left ventricular end diastole anterior wall thickness | Left ventricular end diastole anterospetal wall thickness | Left ventricular end diastole inferolateral wall thickness | Left ventricular end diastole inferoseptal wall thickness | Left ventricular end diastolic mass | Left-handedness | Left-hemisphere limbic network to caudate white-matter structural connectivity | Left–right brain asymmetry | Lifetime smoking (without educational attainment) | Liver enzyme levels (alkaline phosphatase) | Liver liking | Loneliness | Low testosterone levels | Lower thalamus volume | Lumbar spine bone mineral density | Lung function (FEV1) | Lung function (FVC) | Lung function in never smokers (low FEV1 vs high FEV1) | Lymphocyte percentage of white cells | Lymphocyte-to-monocyte ratio | Mackerel liking | Macular thickness | Major depressive disorder or hospitalized COVID-19 (pleiotropy) | Major depressive disorder or severe COVID-19 (pleiotropy) | Male puberty timing (age at voice breaking MTAG) | Male puberty timing (late vs. average onset facial hair) | Male puberty timing (late vs. average onset voice breaking) | Male-pattern baldness | Maximum habitual alcohol consumption | Maximum habitual alcohol consumption (MTAG) | Mean corpuscular volume | Mean reticulocyte volume | Mean spheric corpuscular volume | Medial temporal thickness (unadjusted for global measures) | Medication use (anilides) | Medication use (antithrombotic agents) | Menarche (age at onset) | Middle temporal thickness (unadjusted for global measures) | Moderate to vigorous physical activity duration | Mood instability | Motor premotor area (unadjusted for global measures) | Mouth ulcers | Myeloid white cell count | Neurociticism | Neuroticism | Neutrophil count | Neutrophil percentage of white cells | Neutrophil-to-lymphocyte ratio | Node-level brain connectivity (multivariate analysis) | Number of sexual partners | Number of sexual partners in opposite-sex sexual behavior | Obstructive sleep apnea | Occipital area (unadjusted for global measures) | Occipital thickness (unadjusted for global measures) | Occupational attainment | Omega-3 fatty acid levels | Omega-3 fatty acids levels (UKB data field 23444) | Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451) | Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459) | Orbitofrontal area (unadjusted for global measures) | Osteoarthritis (hip) | Osteoarthrosis (time to event) | Ovarian cancer or critical COVID-19 (pleiotropy) | Ovarian cancer or hospitalized COVID-19 (pleiotropy) | Pain (pleiotropy) | Parkinson's disease | Parsopercularis area (unadjusted for global measures) | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | Phospholipid levels in large HDL | Phospholipids to total lipids ratio in small HDL | Phospholipids to total lipids ratio in very large HDL | Photoreceptor cell layer thickness phenotypes (MTAG) | Physical activity | Physical activity (overall physical activity time) | Physical activity (Total log acceleration) | Post-traumatic stress disorder (mental health questionnaire or predicted) | Post-traumatic stress disorder (phenotype risk score) | Post-traumatic stress disorder symptom severity (avoidance) | Post-traumatic stress disorder symptom severity (hyperarousal) | Post-traumatic stress disorder symptom severity (total) | Posterolateral temporal area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Primary biliary cirrhosis | Primary open angle glaucoma (MTAG) | Primary open angle glaucoma (multi-trait analysis) | Problematic alcohol use (MTAG) | Progressive supranuclear palsy | Ratio of docosahexaenoic acid to total fatty acid levels | Ratio of omega-3 fatty acids to total fatty acids | Ratio of omega-6 fatty acids to omega-3 fatty acids | Red blood cell count | Red cell distribution width | Refractive error | Regional cortical thickness (inferiorparietal) | Regional cortical thickness (inferiortemporal) | Regional cortical thickness (lateraloccipital) | Regional cortical thickness (middletemporal) | Reticulocyte count | Reticulocyte fraction of red cells | Right molecular layer hippocampal volume (head) | Risk-taking behavior (multivariate analysis) | Risk-taking tendency (4-domain principal component model) | Salad dressing liking | Salami liking | Sardines liking | Schizophrenia | Schizophrenia or breast cancer (pleiotropy) | Schizophrenia or ER positive breast cancer (pleiotropy) | Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)) | Self-reported math ability | Sensitivity to environmental stress and adversity | Seropositivity for lactobacillus rhamnosus GG peptide (agilent_192425) | Severe COVID-19 or systemic lupus erythematosus (MTAG) | Sleep duration | Sleep duration (long sleep) | Smoking initiation | Snoring | Stool frequency | Subcortical brain region volumes | Sum basophil neutrophil counts | Sum neutrophil eosinophil counts | Superior parietal area (unadjusted for global measures) | Superior temporal area (unadjusted for global measures) | Systemic lupus erythematosus (MTAG) | Systolic blood pressure | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | ThalamNuclei lh volume VAmc | Thalamus volume | Thyroid stimulating hormone levels | Total omega-3 fatty acid levels | Total testosterone levels | Turnip liking | Type 1 diabetes | Ventral frontal thickness (unadjusted for global measures) | Ventromedial occipital thickness (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Waist-hip index | Waist-hip ratio | Waist-to-hip ratio adjusted for BMI | White matter integrity (mean diffusivity) | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis) | Worry | Worry too long after an embarrassing experience	MAPT	Ning_2021 (rs2696671), Wen_2024 (rs62064415), Leonardsen_2023 (rs2106786), Kim_2023 (rs147431626), Smith_2020 (rs62064364), Jonsson_2019 (rs2435204)	N,W,L,K,S,J
49	2	gap_gwm	17	44021717	rs4327091	A	G	0.2208	0.44592484	0.02413043	3.005e-76	54890	0.005	0.1897	0.2217	+++	5	2.106	2	0.349	intronic	MAPT	0	MAPT	17q21.31	protein_coding	microtubule associated protein tau	0.306391	0.0292905	1.3131e-25	-0.286379	rs2260227	-283	0.984	CA/TG	17	44305199	1	1	0.69	8	KANSL1 (0.842) | KANSL1-AS1 (0.123)	1	0.95	1698	KANSL1 (0.472) | MAPT (0.337) | MAPT-AS1 (0.106) | CRHR1 (0.012) | MAPT-IT1 (0.009) | LINC02210-CRHR1 (0.007) | MAPK8IP1P2 (0.002) | SPPL2C (0.001) | LINC02210 (0.001) | STH (0.001) | ARL17B (0.001) | KANSL1-AS1 (0.001)	1.22	1	1688	KANSL1 (0.473) | MAPT (0.337) | MAPT-AS1 (0.106) | CRHR1 (0.011) | MAPT-IT1 (0.009) | LINC02210-CRHR1 (0.007) | MAPK8IP1P2 (0.002) | SPPL2C (0.001) | LINC02210 (0.001) | STH (0.001) | ARL17B (0.001) | KANSL1-AS1 (0.001)	NA	MAPT (rs2222746;1e-16)	KANSL1 (rs2696532;5e-52) | KANSL1-AS1 (rs199456;2e-44) | MAPT (rs2732599;9e-26) | LRRC37A4P (rs62061817;1e-22) | PLEKHM1 (rs1052594;2e-20) | ARL17A (rs199528;3e-20) | CRHR1-IT1 (rs2668690;4e-17) | MAPT-AS1 (rs62063670;3e-08) | AC005829.1 (rs199441;7e-08)	LINC02210 (49;1e-218) | LRRC37A4P (49;2e-191) | KANSL1-AS1 (49;1e-153) | ENSG00000262539 (49;6e-150) | MAPK8IP1P2 (49;1e-149) | DND1P1 (49;2e-134) | LRRC37A2 (49;5e-115) | ARL17A (47;2e-47) | LRRC37A (46;1e-43) | ENSG00000261575 (44;1e-62) | ENSG00000280022 (39;4e-103) | MAPK8IP1P1 (37;4e-128) | WNT3 (32;2e-41) | ENSG00000266918 (31;5e-22) | PLEKHM1 (27;5e-40) | KANSL1 (24;2e-21) | MAPT (21;3e-111) | NSF (17;4e-09) | FAM215B (16;3e-29) | ARHGAP27 (15;4e-35) | CRHR1 (15;3e-22) | MAPT-AS1 (11;3e-20) | ARL17B (10;2e-33) | DCAKD (7;4e-05) | MAPT-IT1 (6;3e-14) | ENSG00000236234 (6;3e-12) | LRRC37A17P (5;2e-10) | ENSG00000267344 (5;3e-08) | NMT1 (5;3e-06) | SPPL2C (4;5e-24) | ENSG00000267198 (4;6e-10) | RPS26P8 (3;2e-44) | ENSG00000262372 (3;3e-07) | ENSG00000262881 (2;2e-30) | FMNL1 (2;2e-22) | FMNL1-DT (2;5e-10) | NSFP1 (2;3e-06) | FMNL1-AS1 (2;7e-05) | ACBD4 (2;9e-05) | ENSG00000131484 (2;2e-04) | ENSG00000274883 (1;2e-17) | ENSG00000265964 (1;2e-05) | MAP3K14 (1;2e-04) | GOSR2 (1;4e-04)	ENSG00000262539 (49/49;0e+00) | KANSL1-AS1 (49/49;0e+00) | LRRC37A4P (49/49;0e+00) | MAPK8IP1P2 (49/49;0e+00) | MAPK8IP1P1 (37/37;0e+00) | ARL17A (48/49;0e+00) | LRRC37A2 (48/49;0e+00) | DND1P1 (47/49;0e+00) | LINC02210 (46/49;0e+00) | LRRC37A (45/49;0e+00) | ENSG00000266918 (44/48;9e-191) | ENSG00000261575 (43/48;0e+00) | FAM215B (19/22;3e-150) | DCAKD (40/49;6e-35) | KANSL1 (39/49;2e-176) | WNT3 (38/49;6e-267) | NMT1 (36/49;1e-37) | ENSG00000280022 (35/49;0e+00) | ACBD4 (29/49;5e-18) | ENSG00000262372 (27/49;2e-27) | MAPT-IT1 (11/20;6e-45) | PLEKHM1 (25/49;5e-276) | NSFP1 (25/49;4e-11) | ENSG00000267198 (23/46;9e-32)	STH (0.09) | KANSL1 (0.04) | LRRC37A (0.04)	Accelerometer-based physical activity measurement (average acceleration) | Age at first birth | Albumin levels | Alcohol consumption | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | Alcohol consumption (drinks per week) | Alcohol consumption (drinks per week) (MTAG) | Alcohol consumption (heavy vs. light/non-drinkers) | Alcohol frequency weekly (standard GWA) | Alcohol liking | Alcohol use disorder (consumption score) | Alcohol use disorder (total score) | Alzheimer's disease | Alzheimer's disease in APOE e4- carriers | Alzheimer's disease or educational attainment (pleiotropy) | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Anteromedial temporal area (unadjusted for global measures) | aparc-a2009s lh area S-collat-transv-ant | aparc-a2009s lh area S-orbital-H-Shaped | aparc-a2009s lh thickness S-orbital-H-Shaped | aparc-a2009s rh area G-oc-temp-lat-fusifor | aparc-a2009s rh area G+S-occipital-inf | aparc-Desikan lh area fusiform | aparc-Desikan lh area TotalSurface | aparc-Desikan lh thickness inferiortemporal | aparc-Desikan rh area lateraloccipital | aparc-Desikan rh area TotalSurface | aparc-Desikan rh volume fusiform | aparc-DKTatlas lh area fusiform | aparc-DKTatlas rh area lateraloccipital | aparc-DKTatlas rh area lingual | aparc-DKTatlas rh volume fusiform | aparc-pial lh area TotalSurface | aparc-pial rh area TotalSurface | aseg global volume BrainSeg | aseg global volume BrainSegNotVent | aseg global volume BrainSegNotVentSurf | aseg global volume SupraTentorial | aseg global volume SupraTentorialNotVent | aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy) | Automobile speeding propensity | Average diameter for HDL particles | Avocado liking | BA-exvivo rh area V2 | Baked/steamed fish liking | Beans liking | Bioavailable testosterone levels | Bitter alcoholic beverage consumption | Brain age (difference between predicted and chronological age) | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Breast cancer | Breast cancer or critical COVID-19 (pleiotropy) | Breast cancer or hospitalized COVID-19 (pleiotropy) | Breast cancer or ovarian cancer (pleiotropy) | Broad bean liking | Brussel sprout liking | CALCOCO1/IKBKG protein level ratio | CALCOCO1/TJAP1 protein level ratio | Cancer (pleiotropy) | Capers liking | Cardiorespiratory fitness (vo2 max) | CASP2/NUB1 protein level ratio | CDKN2D/CNPY4 protein level ratio | Chronic obstructive pulmonary disease | Circulating docosahexaenoic acid levels | Cognitive ability | Cognitive ability (MTAG) | Cognitive aspects of educational attainment | Common executive function | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Cortical surface area | Cortical surface area (global PC1) | Cortical surface area (MOSTest) | Cortical thickness | Cortical volume | Corticobasal degeneration | COVID-19 (critical illness vs population or mild symptoms) | COVID-19 (critical illness vs population) | COVID-19 (hospitalized covid vs population) | COVID-19 (hospitalized vs population) | COVID-19 hospitalization or systemic lupus erythematosus (MTAG) | COVID-19 severity | CTF1/ITGB1BP2 protein level ratio | Daytime nap | Depressed affect | Dietary macronutrient intake (multi-trait analysis) | Disruptive behavior (multivariate analysis) | Docosahexaenoic acid levels | Docosahexaenoic acid levels (UKB data field 23450) | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsolateral prefrontal thickness (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Drinks per week | Ease of getting up in the morning | ECG cardiac MRI latent space | ECG latent space | Edge-level brain connectivity (multivariate analysis) | Educational attainment | Educational attainment (MTAG) | Educational attainment (years of education) | Eosinophil counts | Eosinophil percentage of white cells | Experiencing mood swings | Externalizing behaviour (multivariate analysis) | Eye color | F-acquired taste liking (derived food-liking factor) | F-bitter food liking (derived food-liking factor) | F-cheese liking (derived food-liking factor) | F-cooking vegetables liking (derived food-liking factor) | F-fatty/salty food liking (derived food-liking factor) | F-fish liking (derived food-liking factor) | F-oily fish liking (derived food-liking factor) | F-savoury food liking (derived food-liking factor) | F-seafood liking (derived food-liking factor) | F-sharp flavour liking (derived food-liking factor) | F-small fish liking (derived food-liking factor) | F-strong flavour liking (derived food-liking factor) | F-strong vegetable liking (derived food-liking factor) | Feeling fed-up | Feeling guilty | Feeling hurt | Feeling miserable | Feeling nervous | Feeling worry | FEV1 | Fornix volume | FOXO1/NUB1 protein level ratio | Free testosterone levels | Frontal QRS-T angle | FVC | General cognitive ability | General factor of neuroticism | Generalized anxiety disorder (mental health questionnaire or predicted) | Generalized anxiety disorder (phenotype risk score) | Globe artichoke liking | Goat cheese liking | Granulocyte count | Hand grip strength | Handedness (left-handed vs. right-handed) | Headache | Headache or migraine | Heel bone mineral density | Height | Height (standard GWA) | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Herring liking | High light scatter reticulocyte count | High light scatter reticulocyte percentage of red cells | Highest math class taken | Highest math class taken (MTAG) | Hip circumference adjusted for BMI | Horseradish liking | Household income | Household income (MTAG) | Hypertrophic cardiomyopathy | Hypertrophic cardiomyopathy (MTAG) | Hypertrophic cardiomyopathy (sarcomere negative) | Idiopathic pulmonary fibrosis | IDP dMRI ProbtrackX ICVF atr l | IDP dMRI ProbtrackX ICVF atr r | IDP dMRI ProbtrackX ICVF slf l | IDP dMRI ProbtrackX ICVF slf r | IDP dMRI ProbtrackX ICVF str l | IDP dMRI ProbtrackX ICVF str r | IDP dMRI ProbtrackX L1 atr l | IDP dMRI ProbtrackX L1 ptr l | IDP dMRI ProbtrackX L1 slf l | IDP dMRI ProbtrackX L1 slf r | IDP dMRI ProbtrackX L1 str r | IDP dMRI ProbtrackX L2 atr l | IDP dMRI ProbtrackX MD atr l | IDP dMRI ProbtrackX MD str l | IDP dMRI ProbtrackX MD str r | IDP dMRI TBSS ICVF Anterior corona radiata L | IDP dMRI TBSS ICVF Anterior corona radiata R | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | IDP dMRI TBSS ICVF External capsule L | IDP dMRI TBSS ICVF External capsule R | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | IDP dMRI TBSS ICVF Superior corona radiata R | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Anterior corona radiata L | IDP dMRI TBSS L1 External capsule L | IDP dMRI TBSS L1 External capsule R | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | IDP dMRI TBSS L1 Uncinate fasciculus L | IDP dMRI TBSS L2 Genu of corpus callosum | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | IDP dMRI TBSS L3 Anterior limb of internal capsule L | IDP dMRI TBSS L3 Anterior limb of internal capsule R | IDP dMRI TBSS L3 Genu of corpus callosum | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Anterior corona radiata L | IDP dMRI TBSS MD Anterior corona radiata R | IDP dMRI TBSS MD Anterior limb of internal capsule L | IDP dMRI TBSS MD Anterior limb of internal capsule R | IDP dMRI TBSS MD Cingulum cingulate gyrus L | IDP dMRI TBSS MD Cingulum cingulate gyrus R | IDP dMRI TBSS MD Genu of corpus callosum | IDP dMRI TBSS MD Posterior limb of internal capsule R | IDP dMRI TBSS MD Superior corona radiata L | IDP dMRI TBSS MD Superior corona radiata R | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | IDP SWI T2star left putamen | IDP T1 SIENAX brain-normalised volume | IDP T1 SIENAX brain-unnormalised volume | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Immature fraction of reticulocytes | Inferior parietal area (unadjusted for global measures) | Inferior parietal thickness (unadjusted for global measures) | Intelligence (MTAG) | Interstitial lung disease | Interventricular septum cross-sectional area | Intracranial volume | Irritable mood | ITGB1BP2/MITD1 protein level ratio | Joint mobility (Beighton score) | Lager liking | Left hippocampal volume (body) | Left molecular layer hippocampal volume (head) | Left ventricle wall thickness | Left ventricular end diastole anterior wall thickness | Left ventricular end diastole anterospetal wall thickness | Left ventricular end diastole inferolateral wall thickness | Left ventricular end diastole inferoseptal wall thickness | Left ventricular end diastolic mass | Left-handedness | Left-hemisphere limbic network to caudate white-matter structural connectivity | Left–right brain asymmetry | Lifetime smoking (without educational attainment) | Liver enzyme levels (alkaline phosphatase) | Liver liking | Loneliness | Low testosterone levels | Lower thalamus volume | Lumbar spine bone mineral density | Lung function (FEV1) | Lung function (FVC) | Lung function in never smokers (low FEV1 vs high FEV1) | Lymphocyte percentage of white cells | Lymphocyte-to-monocyte ratio | Mackerel liking | Macular thickness | Major depressive disorder or hospitalized COVID-19 (pleiotropy) | Major depressive disorder or severe COVID-19 (pleiotropy) | Male puberty timing (age at voice breaking MTAG) | Male puberty timing (late vs. average onset facial hair) | Male puberty timing (late vs. average onset voice breaking) | Male-pattern baldness | Maximum habitual alcohol consumption | Maximum habitual alcohol consumption (MTAG) | Mean corpuscular volume | Mean reticulocyte volume | Mean spheric corpuscular volume | Medial temporal thickness (unadjusted for global measures) | Medication use (anilides) | Medication use (antithrombotic agents) | Menarche (age at onset) | Middle temporal thickness (unadjusted for global measures) | Moderate to vigorous physical activity duration | Mood instability | Motor premotor area (unadjusted for global measures) | Mouth ulcers | Myeloid white cell count | Neurociticism | Neuroticism | Neutrophil count | Neutrophil percentage of white cells | Neutrophil-to-lymphocyte ratio | Node-level brain connectivity (multivariate analysis) | Number of sexual partners | Number of sexual partners in opposite-sex sexual behavior | Obstructive sleep apnea | Occipital area (unadjusted for global measures) | Occipital thickness (unadjusted for global measures) | Occupational attainment | Omega-3 fatty acid levels | Omega-3 fatty acids levels (UKB data field 23444) | Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451) | Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459) | Orbitofrontal area (unadjusted for global measures) | Osteoarthritis (hip) | Osteoarthrosis (time to event) | Ovarian cancer or critical COVID-19 (pleiotropy) | Ovarian cancer or hospitalized COVID-19 (pleiotropy) | Pain (pleiotropy) | Parkinson's disease | Parsopercularis area (unadjusted for global measures) | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | Phospholipid levels in large HDL | Phospholipids to total lipids ratio in small HDL | Phospholipids to total lipids ratio in very large HDL | Photoreceptor cell layer thickness phenotypes (MTAG) | Physical activity | Physical activity (overall physical activity time) | Physical activity (Total log acceleration) | Post-traumatic stress disorder (mental health questionnaire or predicted) | Post-traumatic stress disorder (phenotype risk score) | Post-traumatic stress disorder symptom severity (avoidance) | Post-traumatic stress disorder symptom severity (hyperarousal) | Post-traumatic stress disorder symptom severity (total) | Posterolateral temporal area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Primary biliary cirrhosis | Primary open angle glaucoma (MTAG) | Primary open angle glaucoma (multi-trait analysis) | Problematic alcohol use (MTAG) | Progressive supranuclear palsy | Ratio of docosahexaenoic acid to total fatty acid levels | Ratio of omega-3 fatty acids to total fatty acids | Ratio of omega-6 fatty acids to omega-3 fatty acids | Red blood cell count | Red cell distribution width | Refractive error | Regional cortical thickness (inferiorparietal) | Regional cortical thickness (inferiortemporal) | Regional cortical thickness (lateraloccipital) | Regional cortical thickness (middletemporal) | Reticulocyte count | Reticulocyte fraction of red cells | Right molecular layer hippocampal volume (head) | Risk-taking behavior (multivariate analysis) | Risk-taking tendency (4-domain principal component model) | Salad dressing liking | Salami liking | Sardines liking | Schizophrenia | Schizophrenia or breast cancer (pleiotropy) | Schizophrenia or ER positive breast cancer (pleiotropy) | Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)) | Self-reported math ability | Sensitivity to environmental stress and adversity | Seropositivity for lactobacillus rhamnosus GG peptide (agilent_192425) | Severe COVID-19 or systemic lupus erythematosus (MTAG) | Sleep duration | Sleep duration (long sleep) | Smoking initiation | Snoring | Stool frequency | Subcortical brain region volumes | Sum basophil neutrophil counts | Sum neutrophil eosinophil counts | Superior parietal area (unadjusted for global measures) | Superior temporal area (unadjusted for global measures) | Systemic lupus erythematosus (MTAG) | Systolic blood pressure | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | ThalamNuclei lh volume VAmc | Thalamus volume | Thyroid stimulating hormone levels | Total omega-3 fatty acid levels | Total testosterone levels | Turnip liking | Type 1 diabetes | Ventral frontal thickness (unadjusted for global measures) | Ventromedial occipital thickness (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Waist-hip index | Waist-hip ratio | Waist-to-hip ratio adjusted for BMI | White matter integrity (mean diffusivity) | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis) | Worry | Worry too long after an embarrassing experience	KANSL1	Ning_2021 (rs2696671), Wen_2024 (rs62064415), Leonardsen_2023 (rs2106786), Kim_2023 (rs147431626), Smith_2020 (rs62064364), Jonsson_2019 (rs2435204)	N,W,L,K,S,J
49	3	gap_gm	17	44013966	rs56072903	T	C	0.7983	-0.37387221	0.02692701	7.848e-44	54890	0.0045	0.7972	0.8247	---	0	0.491	2	0.7824	intronic	MAPT	0	MAPT	17q21.31	protein_coding	microtubule associated protein tau	-0.373872	0.0269769	1.12302e-43	0	rs2260227	-291	0.94	CC/TT	17	44305199	1	1	0.66	5	KANSL1 (1.052)	1	0.86	1805	MAPT (0.547) | KANSL1 (0.262) | MAPT-AS1 (0.101) | CRHR1 (0.013) | LINC02210-CRHR1 (0.011) | MAPT-IT1 (0.008) | MAPK8IP1P2 (0.002) | KANSL1-AS1 (0.002) | LINC02210 (0.002) | SPPL2C (0.001) | ARL17B (0.001) | STH (0.000) | PLEKHM1 (0.000)	1.22	1	1794	MAPT (0.552) | KANSL1 (0.259) | MAPT-AS1 (0.100) | CRHR1 (0.013) | LINC02210-CRHR1 (0.011) | MAPT-IT1 (0.008) | MAPK8IP1P2 (0.002) | KANSL1-AS1 (0.002) | LINC02210 (0.001) | SPPL2C (0.001) | ARL17B (0.001) | STH (0.000) | PLEKHM1 (0.000)	NA	KANSL1-AS1 (rs199456;3e-32) | MAPK8IP1P2 (rs199456;4e-32) | MAPK8IP1P1 (rs199451;7e-31) | MAPT (rs2222746;3e-14)	KANSL1 (rs2696532;1e-32) | KANSL1-AS1 (rs199456;5e-29) | MAPT (rs2732599;2e-19) | LRRC37A4P (rs62061817;2e-18) | PLEKHM1 (rs1052594;6e-17) | ARL17A (rs199528;1e-16) | CRHR1-IT1 (rs2668690;3e-14) | MAPT-AS1 (rs62063670;2e-08) | AC005829.1 (rs199441;2e-07)	LINC02210 (49;2e-219) | LRRC37A4P (49;2e-193) | KANSL1-AS1 (49;6e-158) | ENSG00000262539 (49;5e-154) | MAPK8IP1P2 (49;2e-153) | DND1P1 (49;1e-136) | LRRC37A2 (49;2e-118) | ARL17A (46;2e-47) | LRRC37A (45;9e-44) | ENSG00000261575 (44;7e-63) | ENSG00000280022 (39;9e-104) | MAPK8IP1P1 (37;2e-126) | ENSG00000266918 (30;9e-23) | WNT3 (27;2e-41) | PLEKHM1 (27;5e-40) | KANSL1 (24;4e-22) | MAPT (20;4e-117) | NSF (16;1e-09) | ARHGAP27 (15;4e-35) | FAM215B (15;4e-29) | CRHR1 (15;5e-23) | MAPT-AS1 (11;3e-20) | ARL17B (9;5e-34) | DCAKD (7;3e-05) | MAPT-IT1 (6;1e-13) | ENSG00000236234 (6;3e-12) | LRRC37A17P (5;2e-10) | ENSG00000267344 (5;3e-08) | SPPL2C (4;5e-24) | ENSG00000267198 (4;1e-09) | NMT1 (4;3e-06) | RPS26P8 (3;1e-44) | ENSG00000262372 (3;5e-08) | ENSG00000262881 (2;2e-30) | FMNL1 (2;2e-22) | FMNL1-DT (2;5e-10) | FMNL1-AS1 (2;7e-05) | ENSG00000131484 (2;2e-04) | ACBD4 (2;2e-04) | ENSG00000274883 (1;2e-17) | ENSG00000265964 (1;2e-05) | NSFP1 (1;2e-04) | MAP3K14 (1;2e-04) | GOSR2 (1;4e-04)	ENSG00000262539 (49/49;0e+00) | KANSL1-AS1 (49/49;0e+00) | LRRC37A4P (49/49;0e+00) | MAPK8IP1P2 (49/49;0e+00) | MAPK8IP1P1 (37/37;0e+00) | ARL17A (48/49;0e+00) | LRRC37A2 (48/49;0e+00) | DND1P1 (47/49;0e+00) | LINC02210 (46/49;0e+00) | LRRC37A (45/49;0e+00) | ENSG00000261575 (43/48;0e+00) | ENSG00000266918 (43/48;3e-196) | FAM215B (19/22;2e-149) | DCAKD (42/49;1e-35) | KANSL1 (39/49;5e-181) | WNT3 (38/49;2e-270) | ENSG00000280022 (35/49;0e+00) | NMT1 (34/49;4e-37) | ENSG00000262372 (28/49;2e-28) | MAPT-IT1 (11/20;2e-44) | ACBD4 (26/49;2e-17) | PLEKHM1 (25/49;5e-276) | NSFP1 (25/49;4e-11) | ENSG00000267198 (23/46;9e-32)	MAPT (0.75) | KANSL1 (0.19) | CRHR1 (0.09)	Accelerometer-based physical activity measurement (average acceleration) | Age at first birth | Albumin levels | Alcohol consumption | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | Alcohol consumption (drinks per week) | Alcohol consumption (drinks per week) (MTAG) | Alcohol consumption (heavy vs. light/non-drinkers) | Alcohol frequency weekly (standard GWA) | Alcohol liking | Alcohol use disorder (consumption score) | Alcohol use disorder (total score) | Alzheimer's disease in APOE e4- carriers | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Anteromedial temporal area (unadjusted for global measures) | aparc-a2009s lh area S-collat-transv-ant | aparc-a2009s lh area S-orbital-H-Shaped | aparc-a2009s lh thickness S-orbital-H-Shaped | aparc-a2009s rh area G-oc-temp-lat-fusifor | aparc-a2009s rh area G+S-occipital-inf | aparc-Desikan lh area fusiform | aparc-Desikan lh area TotalSurface | aparc-Desikan lh thickness inferiortemporal | aparc-Desikan rh area lateraloccipital | aparc-Desikan rh area TotalSurface | aparc-Desikan rh volume fusiform | aparc-DKTatlas lh area fusiform | aparc-DKTatlas rh area lateraloccipital | aparc-DKTatlas rh area lingual | aparc-DKTatlas rh volume fusiform | aparc-pial lh area TotalSurface | aparc-pial rh area TotalSurface | aseg global volume BrainSeg | aseg global volume BrainSegNotVent | aseg global volume BrainSegNotVentSurf | aseg global volume SupraTentorial | aseg global volume SupraTentorialNotVent | aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy) | Automobile speeding propensity | Average diameter for HDL particles | Avocado liking | BA-exvivo rh area V2 | Beans liking | Bioavailable testosterone levels | Brain age (difference between predicted and chronological age) | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Breast cancer | Breast cancer or critical COVID-19 (pleiotropy) | Breast cancer or hospitalized COVID-19 (pleiotropy) | Breast cancer or ovarian cancer (pleiotropy) | Broad bean liking | Brussel sprout liking | CALCOCO1/IKBKG protein level ratio | CALCOCO1/TJAP1 protein level ratio | Cancer (pleiotropy) | Capers liking | Cardiorespiratory fitness (vo2 max) | CASP2/NUB1 protein level ratio | CDKN2D/CNPY4 protein level ratio | Chronic obstructive pulmonary disease | Circulating docosahexaenoic acid levels | Cognitive ability | Cognitive ability (MTAG) | Cognitive aspects of educational attainment | Common executive function | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Cortical surface area | Cortical surface area (global PC1) | Cortical surface area (MOSTest) | Cortical thickness | Cortical volume | Corticobasal degeneration | COVID-19 (critical illness vs population or mild symptoms) | COVID-19 (critical illness vs population) | COVID-19 (hospitalized covid vs population) | COVID-19 (hospitalized vs population) | COVID-19 hospitalization or systemic lupus erythematosus (MTAG) | COVID-19 severity | CTF1/ITGB1BP2 protein level ratio | Daytime nap | Depressed affect | Dietary macronutrient intake (multi-trait analysis) | Disruptive behavior (multivariate analysis) | Docosahexaenoic acid levels | Docosahexaenoic acid levels (UKB data field 23450) | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsolateral prefrontal thickness (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Drinks per week | Ease of getting up in the morning | ECG cardiac MRI latent space | ECG latent space | Edge-level brain connectivity (multivariate analysis) | Educational attainment | Educational attainment (MTAG) | Educational attainment (years of education) | Eosinophil counts | Eosinophil percentage of white cells | Experiencing mood swings | Eye color | F-acquired taste liking (derived food-liking factor) | F-bitter food liking (derived food-liking factor) | F-cooking vegetables liking (derived food-liking factor) | F-fatty/salty food liking (derived food-liking factor) | F-savoury food liking (derived food-liking factor) | F-sharp flavour liking (derived food-liking factor) | F-small fish liking (derived food-liking factor) | F-strong flavour liking (derived food-liking factor) | F-strong vegetable liking (derived food-liking factor) | Feeling fed-up | Feeling guilty | Feeling hurt | Feeling miserable | Feeling nervous | Feeling worry | FEV1 | Fornix volume | FOXO1/NUB1 protein level ratio | Free testosterone levels | Frontal QRS-T angle | FVC | General cognitive ability | General factor of neuroticism | Generalized anxiety disorder (mental health questionnaire or predicted) | Generalized anxiety disorder (phenotype risk score) | Globe artichoke liking | Goat cheese liking | Granulocyte count | Hand grip strength | Headache | Headache or migraine | Heel bone mineral density | Height | Height (standard GWA) | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Herring liking | High light scatter reticulocyte count | High light scatter reticulocyte percentage of red cells | Highest math class taken | Highest math class taken (MTAG) | Hip circumference adjusted for BMI | Horseradish liking | Household income | Household income (MTAG) | Hypertrophic cardiomyopathy | Hypertrophic cardiomyopathy (MTAG) | Hypertrophic cardiomyopathy (sarcomere negative) | Idiopathic pulmonary fibrosis | IDP dMRI ProbtrackX ICVF atr l | IDP dMRI ProbtrackX ICVF atr r | IDP dMRI ProbtrackX ICVF slf l | IDP dMRI ProbtrackX ICVF slf r | IDP dMRI ProbtrackX ICVF str l | IDP dMRI ProbtrackX ICVF str r | IDP dMRI ProbtrackX L1 atr l | IDP dMRI ProbtrackX L1 ptr l | IDP dMRI ProbtrackX L1 slf l | IDP dMRI ProbtrackX L1 slf r | IDP dMRI ProbtrackX L1 str r | IDP dMRI ProbtrackX L2 atr l | IDP dMRI ProbtrackX MD atr l | IDP dMRI ProbtrackX MD str l | IDP dMRI ProbtrackX MD str r | IDP dMRI TBSS ICVF Anterior corona radiata L | IDP dMRI TBSS ICVF Anterior corona radiata R | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | IDP dMRI TBSS ICVF External capsule L | IDP dMRI TBSS ICVF External capsule R | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | IDP dMRI TBSS ICVF Superior corona radiata R | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Anterior corona radiata L | IDP dMRI TBSS L1 External capsule L | IDP dMRI TBSS L1 External capsule R | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | IDP dMRI TBSS L2 Genu of corpus callosum | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | IDP dMRI TBSS L3 Anterior limb of internal capsule L | IDP dMRI TBSS L3 Anterior limb of internal capsule R | IDP dMRI TBSS L3 Genu of corpus callosum | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Anterior corona radiata L | IDP dMRI TBSS MD Anterior corona radiata R | IDP dMRI TBSS MD Anterior limb of internal capsule L | IDP dMRI TBSS MD Anterior limb of internal capsule R | IDP dMRI TBSS MD Cingulum cingulate gyrus L | IDP dMRI TBSS MD Cingulum cingulate gyrus R | IDP dMRI TBSS MD Genu of corpus callosum | IDP dMRI TBSS MD Posterior limb of internal capsule R | IDP dMRI TBSS MD Superior corona radiata L | IDP dMRI TBSS MD Superior corona radiata R | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | IDP SWI T2star left putamen | IDP T1 SIENAX brain-normalised volume | IDP T1 SIENAX brain-unnormalised volume | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Immature fraction of reticulocytes | Inferior parietal area (unadjusted for global measures) | Inferior parietal thickness (unadjusted for global measures) | Intelligence (MTAG) | Interstitial lung disease | Interventricular septum cross-sectional area | Intracranial volume | Irritable mood | ITGB1BP2/MITD1 protein level ratio | Joint mobility (Beighton score) | Lager liking | Left ventricle wall thickness | Left ventricular end diastole anterior wall thickness | Left ventricular end diastole inferolateral wall thickness | Left ventricular end diastole inferoseptal wall thickness | Left ventricular end diastolic mass | Left-handedness | Left-hemisphere limbic network to caudate white-matter structural connectivity | Left–right brain asymmetry | Lifetime smoking (without educational attainment) | Liver enzyme levels (alkaline phosphatase) | Liver liking | Loneliness | Low testosterone levels | Lower thalamus volume | Lumbar spine bone mineral density | Lung function (FEV1) | Lung function (FVC) | Lung function in never smokers (low FEV1 vs high FEV1) | Lymphocyte percentage of white cells | Lymphocyte-to-monocyte ratio | Mackerel liking | Macular thickness | Major depressive disorder or hospitalized COVID-19 (pleiotropy) | Major depressive disorder or severe COVID-19 (pleiotropy) | Male puberty timing (age at voice breaking MTAG) | Male puberty timing (late vs. average onset facial hair) | Male puberty timing (late vs. average onset voice breaking) | Male-pattern baldness | Maximum habitual alcohol consumption | Maximum habitual alcohol consumption (MTAG) | Mean corpuscular volume | Mean reticulocyte volume | Mean spheric corpuscular volume | Medial temporal thickness (unadjusted for global measures) | Medication use (anilides) | Medication use (antithrombotic agents) | Menarche (age at onset) | Middle temporal thickness (unadjusted for global measures) | Moderate to vigorous physical activity duration | Mood instability | Motor premotor area (unadjusted for global measures) | Mouth ulcers | Myeloid white cell count | Neurociticism | Neuroticism | Neutrophil count | Neutrophil percentage of white cells | Neutrophil-to-lymphocyte ratio | Node-level brain connectivity (multivariate analysis) | Number of sexual partners | Number of sexual partners in opposite-sex sexual behavior | Obstructive sleep apnea | Occipital area (unadjusted for global measures) | Occipital thickness (unadjusted for global measures) | Occupational attainment | Omega-3 fatty acid levels | Omega-3 fatty acids levels (UKB data field 23444) | Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451) | Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459) | Orbitofrontal area (unadjusted for global measures) | Osteoarthritis (hip) | Osteoarthrosis (time to event) | Ovarian cancer or critical COVID-19 (pleiotropy) | Ovarian cancer or hospitalized COVID-19 (pleiotropy) | Pain (pleiotropy) | Parkinson's disease | Parsopercularis area (unadjusted for global measures) | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | Phospholipid levels in large HDL | Phospholipids to total lipids ratio in small HDL | Phospholipids to total lipids ratio in very large HDL | Photoreceptor cell layer thickness phenotypes (MTAG) | Physical activity | Physical activity (overall physical activity time) | Physical activity (Total log acceleration) | Post-traumatic stress disorder (mental health questionnaire or predicted) | Post-traumatic stress disorder (phenotype risk score) | Post-traumatic stress disorder symptom severity (avoidance) | Post-traumatic stress disorder symptom severity (total) | Posterolateral temporal area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Primary biliary cirrhosis | Primary open angle glaucoma (MTAG) | Primary open angle glaucoma (multi-trait analysis) | Problematic alcohol use (MTAG) | Progressive supranuclear palsy | Ratio of docosahexaenoic acid to total fatty acid levels | Ratio of omega-3 fatty acids to total fatty acids | Ratio of omega-6 fatty acids to omega-3 fatty acids | Red blood cell count | Red cell distribution width | Refractive error | Regional cortical thickness (inferiorparietal) | Regional cortical thickness (inferiortemporal) | Regional cortical thickness (lateraloccipital) | Regional cortical thickness (middletemporal) | Reticulocyte count | Reticulocyte fraction of red cells | Risk-taking behavior (multivariate analysis) | Risk-taking tendency (4-domain principal component model) | Salad dressing liking | Salami liking | Sardines liking | Schizophrenia | Schizophrenia or breast cancer (pleiotropy) | Schizophrenia or ER positive breast cancer (pleiotropy) | Self-reported math ability | Sensitivity to environmental stress and adversity | Seropositivity for lactobacillus rhamnosus GG peptide (agilent_192425) | Severe COVID-19 or systemic lupus erythematosus (MTAG) | Sleep duration | Sleep duration (long sleep) | Smoking initiation | Snoring | Stool frequency | Subcortical brain region volumes | Sum basophil neutrophil counts | Sum neutrophil eosinophil counts | Superior parietal area (unadjusted for global measures) | Superior temporal area (unadjusted for global measures) | Systemic lupus erythematosus (MTAG) | Systolic blood pressure | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | ThalamNuclei lh volume VAmc | Thalamus volume | Thyroid stimulating hormone levels | Total omega-3 fatty acid levels | Total testosterone levels | Type 1 diabetes | Ventral frontal thickness (unadjusted for global measures) | Ventromedial occipital thickness (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Waist-hip index | Waist-hip ratio | Waist-to-hip ratio adjusted for BMI | White matter integrity (mean diffusivity) | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis) | Worry | Worry too long after an embarrassing experience	KANSL1	Ning_2021 (rs2696671), Wen_2024 (rs62064415), Leonardsen_2023 (rs2106786), Kim_2023 (rs147431626), Smith_2020 (rs62064364), Jonsson_2019 (rs2435204)	N,W,L,K,S,J
50	1	gap_gm	17	73873656	rs1105917	T	C	0.1521	0.22596493	0.02909583	8.086e-15	54890	0.0024	0.1382	0.1527	+++	0	0.829	2	0.6607	intronic	TRIM47	0	TRIM47	17q25.1	protein_coding	tripartite motif containing 47	0.225965	0.0291114	8.35506e-15	0	rs1105917	0	1	T/C	17	73873656	1	1	0.85	4	TRIM47 (1.054)	1	0.84	10	TRIM47 (0.952) | WBP2 (0.007)	1.34	1	14	TRIM47 (0.937) | WBP2 (0.011) | TRIM65 (0.004)	TRIM47 (1;rs4600514;34.000)	TRIM47 (rs116044941;5e-13)	TRIM47 (rs116044941;1e-09)	TRIM65 (26;1e-24) | FBF1 (24;2e-14) | TEN1 (20;9e-07) | TRIM47 (18;6e-28) | ENSG00000267801 (11;1e-13) | MRPL38 (10;4e-07) | UNC13D (4;2e-11) | WBP2 (4;1e-05) | GALK1 (3;3e-05) | CDK3 (3;3e-05) | ENSG00000267342 (2;2e-05) | UBALD2 (1;1e-05) | ACOX1 (1;9e-05)	TEN1 (48/49;6e-82) | TRIM65 (38/49;1e-184) | FBF1 (36/49;2e-134) | MRPL38 (33/49;4e-52) | ENSG00000267342 (30/49;3e-19) | CDK3 (27/49;3e-17) | TRIM47 (25/49;4e-189) | UNC13D (25/49;5e-36)	TRIM47 (0.68) | TSEN54 (0.39) | GALK1 (0.32)	Mean arterial pressure (BMI adjusted) | Platelet count | Psoriasis | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df)	TRIM47	Novel	-
50	2	gap_gwm	17	73872969	rs3833085	A	AG	0.8487	-0.19490763	0.02780945	2.406e-12	54890	0.0032	0.8479	0.8686	---	0	0.692	2	0.7077	intronic	TRIM47	0	TRIM47	17q25.1	protein_coding	tripartite motif containing 47	-0.194908	0.0278215	2.45848e-12	0	rs1105917	-0.687	0.969	TAG/CA	17	73873656	1	1	0.8	4	TRIM47 (1.030)	1	0.80	24	TRIM47 (0.922) | WBP2 (0.020) | TRIM65 (0.008)	1.19	1	23	TRIM47 (0.927) | WBP2 (0.017) | TRIM65 (0.008)	TRIM47 (1;rs4600514;34.000)	TRIM47 (rs116044941;7e-11)	TRIM47 (rs116044941;2e-08)	TRIM65 (26;4e-25) | FBF1 (24;6e-15) | TEN1 (20;4e-06) | TRIM47 (18;2e-27) | ENSG00000267801 (11;9e-13) | MRPL38 (10;4e-07) | UNC13D (4;2e-10) | WBP2 (4;1e-05) | GALK1 (3;8e-06) | CDK3 (3;2e-05) | ENSG00000267342 (2;4e-05) | UBALD2 (1;1e-05) | ACOX1 (1;9e-05)	TEN1 (48/49;1e-77) | TRIM65 (43/49;4e-191) | FBF1 (38/49;4e-133) | ENSG00000267342 (36/49;6e-19) | MRPL38 (30/49;8e-52) | CDK3 (29/49;1e-15) | TRIM47 (25/49;4e-189) | UNC13D (25/49;5e-36)	TRIM47 (0.66) | TSEN54 (0.41) | RECQL5 (0.39)	Mean arterial pressure (BMI adjusted) | Platelet count | Psoriasis | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df)	TRIM47	Novel	-
51	1	gap_wm	18	53277143	rs763283047	CCT	C	0.6618	0.12132201	0.0220811	3.921e-08	54890	0.0027	0.6476	0.6631	+++	0	0.198	2	0.9059	intronic	TCF4	0	TCF4	18q21.2	protein_coding	transcription factor 4	0.120809	0.0220872	4.50936e-08	0	rs763283047	0	1	CCT/C	18	53277143	1	1	0.77	18	TCF4 (0.782) | LINC01415 (0.169)	1	0.56	21	TCF4 (0.888) | LINC01415 (0.063)	1.13	1	20	TCF4 (0.898) | LINC01415 (0.055)	NA	NA	NA	LINC01415 (2;5e-05)	LINC01415 (27/43;2e-24)	TCF4 (0.92)	NA	LINC01415	Novel	-
52	1	gap_gwm	19	31036276	19:31036276_AC_A	A	AC	0.1642	0.15076744	0.02712627	2.729e-08	54890	0.003	0.151	0.1661	+++	0	0.129	2	0.9374	intronic	ZNF536	0	ZNF536	19q12	protein_coding	zinc finger protein 536	0.150767	0.0271337	2.75293e-08	0	19:31036276_AC_A	0	1	A/AC	19	31036276	1	1	0.71	7	ZNF536 (1.004)	1	0.67	71	ZNF536 (1.230)	1.78	2	69 | 263	ZNF536 (1.902)	NA	NA	NA	ENSG00000280061 (4;9e-10)	ENSG00000280061 (28/42;6e-40)	ZNF536 (1.01)	Body mass index | Height	ZNF536	Novel	-
53	1	gap_gwm	19	45416178	rs483082	T	G	0.2318	0.15453009	0.02391606	1.038e-10	54890	0.0025	0.2191	0.2333	++-	52.8	4.239	2	0.1201	intergenic	APOC1	1404	APOE(dist=3526),APOC1(dist=1404)	19q13.32	protein_coding	apolipoprotein C1	0.15453	0.0239251	1.05452e-10	0	rs483082	0	1	T/G	19	45416178	1	1	0.8	4	APOE (0.618) | APOC1 (0.363)	1	1.00	4	APOC1 (0.991)	1.43	1	4	APOC1 (0.981)	APOE (1;rs429358;0.007)	NA	NA	APOC1 (4;2e-06) | APOE (2;1e-10)	NA	APOE (2.63) | APOC1 (1.54) | TOMM40 (0.53)	1-oleoyl-2-linoleoyl-glycerol (18:1/18:2) levels | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels | 1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2) levels | 1-palmitoyl-GPE (16:0) levels | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels | 1-stearoyl-GPE (18:0) levels | 2-palmitoyl-GPE (16:0) levels | ADP-ribosylation factor-like protein 2 levels | Alanine aminotransferase levels | Alzheimer's disease | Apolipoprotein A1 levels | Apolipoprotein B levels | Apolipoprotein C-I levels | Apolipoprotein E levels | Aspartate aminotransferase to alanine aminotransferase ratio | Average diameter for VLDL particles | Average diameter for VLDL particles (UKB data field 23431) | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels (RFNG.7203.125.3) | Bioavailable testosterone levels | C-reactive protein levels | Calcium-activated chloride channel regulator 2 levels | Cerebral amyloid angiopathy in Alzheimer’s disease | Cerebral amyloid deposition (PET imaging) | Cerebrospinal fluid amyloid beta 42 levels in abnormal amyloid levels | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl ester_18:2_[M+NH4]1+ levels | Cholesteryl esters in large HDL (UKB data field 23562) | Chronic elevation of alanine aminotransferase (cALT) levels | Cirrhosis | Coactosin-like protein levels | Concentration of large HDL particles | Concentration of very large VLDL particles | Concentration of very large VLDL particles (UKB data field 23488) | CUB and zona pellucida-like domain-containing protein 1 levels (CUZD1.7943.16.3) | Dermokine levels | Diacylglycerol_36:3_[M+H-H2O]1+ levels | Diacylglycerol_36:4_[M+H-H2O]1+ levels | Diacylglycerol_38:5_[M+H-H2O]1+ levels | Diacylglycerol_38:6_[M+H-H2O]1+ levels | Disintegrin and metalloproteinase domain-containing protein 11 levels | Dual specificity protein phosphatase 26 levels | Endothelial monocyte-activating polypeptide 2 levels | Ephrin-B1 levels | Erythrocyte band 7 integral membrane protein levels | Estradiol 17-beta-dehydrogenase 8 levels | Family history of Alzheimer's disease | Fasting apolipoprotein B | Fasting cholesterol esters in large VLDL | Fasting cholesterol esters in very large VLDL | Fasting cholesterol esters in very small VLDL | Fasting free cholesterol in large VLDL | Fasting large VLDL particle concentration | Fasting linoleic acid (18:2) | Fasting phospholipid levels in large VLDL | Fasting phospholipid levels in very large VLDL | Fasting polyunsaturated fatty acids | Fasting remnant cholesterol | Fasting serum total triglycerides | Fasting total cholesterol in large VLDL | Fasting total lipids in large VLDL | Fasting total lipids in very large VLDL | Fasting total lipids in very small VLDL | Fasting triglyceride levels | Fasting triglycerides in VLDL | Fasting triglycerides levels in large VLDL | Fasting triglycerides levels in medium VLDL | Fasting triglycerides levels in small HDL | Fasting triglycerides levels in small VLDL | Fasting triglycerides levels in very large VLDL | Fasting triglycerides levels in very small VLDL | Fasting very large VLDL particle concentration | Free cholesterol in very large VLDL (UKB data field 23493) | Free cholesterol to total lipids ratio in large VLDL | Free cholesterol to total lipids ratio in medium HDL | Glutathione S-transferase Mu 1 levels (GSTM1.7239.9.3) | Glycoprotein acetylation | Glycoprotein acetyls levels | HDL cholesterol levels (UKB data field 23406) | High density lipoprotein cholesterol levels | Hip index | HLA class II histocompatibility antigen, DR beta 3 chain levels | Intelligence | Interferon-induced protein with tetratricopeptide repeats 2 levels | Keratin, type I cytoskeletal 19 levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels | Linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] levels | Lipoprotein (a) levels | Lobar intracerebral hemorrhage | Low density lipoprotein cholesterol levels | Low-density lipoprotein levels (MTAG) | Mental health study participation (completed survey) | Metabolic syndrome | MOB-like protein phocein levels | Multi-trait sex score | Multi-trait sum score | N-acetylated-alpha-linked acidic dipeptidase-like protein levels | Neuralized-like protein 4 levels | Neuronal pentraxin-2 levels | Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels | Oleoyl-oleoyl-glycerol (18:1/18:1) [2] levels | Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels | Phosphatidylglycerol-O_42:0_[M-H]1- levels | Phospholipid levels in very large VLDL | Phospholipids in very large HDL | Phospholipids in very large VLDL (UKB data field 23490) | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1]* levels in chronic kidney disease | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [1]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [2]* levels in chronic kidney disease | Platelet distribution width | Postprandial apolipoprotein B | Postprandial cholesterol esters in large VLDL | Postprandial cholesterol esters in very large VLDL | Postprandial free cholesterol in large VLDL | Postprandial free cholesterol in medium VLDL | Postprandial large VLDL particle concentration | Postprandial linoleic acid (18:2) | Postprandial medium VLDL particle concentration | Postprandial omega-6 fatty acids | Postprandial phospholipid levels in large VLDL | Postprandial polyunsaturated fatty acids | Postprandial remnant cholesterol | Postprandial serum total triglycerides | Postprandial total cholesterol in large VLDL | Postprandial total cholesterol in very large VLDL | Postprandial total lipids in large VLDL | Postprandial total lipids in medium VLDL | Postprandial total lipids in very small VLDL | Postprandial triglyceride levels | Postprandial triglycerides in VLDL | Postprandial triglycerides levels in large VLDL | Postprandial triglycerides levels in medium VLDL | Postprandial triglycerides levels in small HDL | Postprandial triglycerides levels in small VLDL | Postprandial triglycerides levels in very small VLDL | Prenylcysteine oxidase 1 levels | Protein FAM69C levels | Protein MENT levels (MENT.5744.12.3) | Protein S100-A13 levels | Protocadherin beta-10 levels | Quinone oxidoreductase-like protein 1 levels | RAC-beta serine/threonine-protein kinase levels | Ras-related protein Rab-14 levels | Ras-related protein Rab-14 levels (RAB14.14283.12.3) | Ratio of triglycerides to phosphoglycerides | Repulsive guidance molecule A levels | Selenoprotein S levels | Serum albumin levels | Serum levels of protein ADAM11 | Serum levels of protein AKT2 | Serum levels of protein ARFGAP1 | Serum levels of protein C1orf56 | Serum levels of protein CRYZL1 | Serum levels of protein CUZD1 | Serum levels of protein FAM159B | Serum levels of protein GAL3ST2 | Serum levels of protein GGT2 | Serum levels of protein GSTM1 | Serum levels of protein HBQ1 | Serum levels of protein HDAC8 | Serum levels of protein HLA-DRB3 | Serum levels of protein IFIT2 | Serum levels of protein NEFL | Serum levels of protein NPTX2 | Serum levels of protein PSG5 | Serum levels of protein RAB14 | Serum levels of protein TMCC3 | Serum levels of protein TOM1L1 | Serum levels of protein TP53I11 | Serum levels of protein YWHAQ | Sex hormone-binding globulin levels | Sex hormone-binding globulin levels adjusted for BMI | SH2 domain-containing protein 3C levels | Sphingomyelin_38:1_[M+H]1+ levels | Sphingomyelin(34:0)_[M+H]1+ levels | Sphingomyelin(42:0)_[M+OAc]1- levels | Synaptotagmin-like protein 4 levels | TOM1-like protein 1 levels | TOM1-like protein 1 levels (TOM1L1.13652.2.3) | Total cholesterol levels | Total lipid levels in large HDL | Total lipid levels in very large VLDL | Total lipids in large HDL (UKB data field 23559) | Total lipids in very large VLDL (UKB data field 23489) | Total triglycerides levels | Total triglycerides levels (UKB data field 23407) | Triacylglycerol_56:5_[M+NH4]1+ levels | Triacylglycerol_56:6_[M+NH4]1+ levels | Triacylglycerol_56:7_[M+NH4]1+ levels | Triglyceride levels | Triglyceride levels (MTAG) | Triglyceride levels in IDL | Triglyceride levels in non-type 2 diabetes | Triglyceride levels in small LDL | Triglyceride levels in small VLDL | Triglyceride levels in very large HDL | Triglyceride levels in very large VLDL | Triglyceride levels in very small VLDL | Triglyceride levels in VLDL | Triglyceride levels x short total sleep time interaction (2df test) | Triglyceride to HDL cholesterol ratio | Triglycerides | Triglycerides in small HDL | Triglycerides in small VLDL (UKB data field 23515) | Triglycerides in very large HDL (UKB data field 23557) | Triglycerides in very large VLDL (UKB data field 23494) | Triglycerides in VLDL (UKB data field 23408) | Triglycerides to total lipids ratio in medium HDL | Triglycerides to total lipids ratio in small HDL | Triglycerides to total lipids ratio in very large HDL | Tubulin-specific chaperone A levels (TBCA.12501.10.3) | Ubiquitin-conjugating enzyme E2 G2 levels | Uncharacterized protein C14orf93 levels | Waist-hip index | Waist-to-hip ratio adjusted for BMI	APOE	Smith_2020 (rs429358)	S
53	2	gap_wm	19	45416178	rs483082	T	G	0.2318	0.15447274	0.02497797	6.235e-10	54890	0.0025	0.2191	0.2333	++-	56.4	4.589	2	0.1008	intergenic	APOC1	1404	APOE(dist=3526),APOC1(dist=1404)	19q13.32	protein_coding	apolipoprotein C1	0.154473	0.0249866	6.32019e-10	0	rs483082	0	1	T/G	19	45416178	1	1	0.79	4	APOE (0.425) | APOC1 (0.358) | TOMM40 (0.186)	1	1	4	APOC1 (0.961)	1.54	1	6	APOC1 (0.920) | APOE (0.039)	APOE (1;rs429358;0.007)	NA	NA	APOC1 (4;2e-06) | APOE (2;1e-10)	NA	APOE (3.18) | APOC1 (1.68) | CLPTM1 (0.40)	1-oleoyl-2-linoleoyl-glycerol (18:1/18:2) levels | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels | 1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2) levels | 1-palmitoyl-GPE (16:0) levels | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels | 1-stearoyl-GPE (18:0) levels | 2-palmitoyl-GPE (16:0) levels | ADP-ribosylation factor-like protein 2 levels | Alanine aminotransferase levels | Alzheimer's disease | Apolipoprotein A1 levels | Apolipoprotein B levels | Apolipoprotein C-I levels | Apolipoprotein E levels | Aspartate aminotransferase to alanine aminotransferase ratio | Average diameter for VLDL particles | Average diameter for VLDL particles (UKB data field 23431) | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels (RFNG.7203.125.3) | Bioavailable testosterone levels | C-reactive protein levels | Calcium-activated chloride channel regulator 2 levels | Cerebral amyloid angiopathy in Alzheimer’s disease | Cerebral amyloid deposition (PET imaging) | Cerebrospinal fluid amyloid beta 42 levels in abnormal amyloid levels | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl ester_18:2_[M+NH4]1+ levels | Cholesteryl esters in large HDL (UKB data field 23562) | Chronic elevation of alanine aminotransferase (cALT) levels | Cirrhosis | Coactosin-like protein levels | Concentration of large HDL particles | Concentration of very large VLDL particles | Concentration of very large VLDL particles (UKB data field 23488) | CUB and zona pellucida-like domain-containing protein 1 levels (CUZD1.7943.16.3) | Dermokine levels | Diacylglycerol_36:3_[M+H-H2O]1+ levels | Diacylglycerol_36:4_[M+H-H2O]1+ levels | Diacylglycerol_38:5_[M+H-H2O]1+ levels | Diacylglycerol_38:6_[M+H-H2O]1+ levels | Disintegrin and metalloproteinase domain-containing protein 11 levels | Dual specificity protein phosphatase 26 levels | Endothelial monocyte-activating polypeptide 2 levels | Ephrin-B1 levels | Erythrocyte band 7 integral membrane protein levels | Estradiol 17-beta-dehydrogenase 8 levels | Family history of Alzheimer's disease | Fasting apolipoprotein B | Fasting cholesterol esters in large VLDL | Fasting cholesterol esters in very large VLDL | Fasting cholesterol esters in very small VLDL | Fasting free cholesterol in large VLDL | Fasting large VLDL particle concentration | Fasting linoleic acid (18:2) | Fasting phospholipid levels in large VLDL | Fasting phospholipid levels in very large VLDL | Fasting polyunsaturated fatty acids | Fasting remnant cholesterol | Fasting serum total triglycerides | Fasting total cholesterol in large VLDL | Fasting total lipids in large VLDL | Fasting total lipids in very large VLDL | Fasting total lipids in very small VLDL | Fasting triglyceride levels | Fasting triglycerides in VLDL | Fasting triglycerides levels in large VLDL | Fasting triglycerides levels in medium VLDL | Fasting triglycerides levels in small HDL | Fasting triglycerides levels in small VLDL | Fasting triglycerides levels in very large VLDL | Fasting triglycerides levels in very small VLDL | Fasting very large VLDL particle concentration | Free cholesterol in very large VLDL (UKB data field 23493) | Free cholesterol to total lipids ratio in large VLDL | Free cholesterol to total lipids ratio in medium HDL | Glutathione S-transferase Mu 1 levels (GSTM1.7239.9.3) | Glycoprotein acetylation | Glycoprotein acetyls levels | HDL cholesterol levels (UKB data field 23406) | High density lipoprotein cholesterol levels | Hip index | HLA class II histocompatibility antigen, DR beta 3 chain levels | Intelligence | Interferon-induced protein with tetratricopeptide repeats 2 levels | Keratin, type I cytoskeletal 19 levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels | Linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] levels | Lipoprotein (a) levels | Lobar intracerebral hemorrhage | Low density lipoprotein cholesterol levels | Low-density lipoprotein levels (MTAG) | Mental health study participation (completed survey) | Metabolic syndrome | MOB-like protein phocein levels | Multi-trait sex score | Multi-trait sum score | N-acetylated-alpha-linked acidic dipeptidase-like protein levels | Neuralized-like protein 4 levels | Neuronal pentraxin-2 levels | Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels | Oleoyl-oleoyl-glycerol (18:1/18:1) [2] levels | Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels | Phosphatidylglycerol-O_42:0_[M-H]1- levels | Phospholipid levels in very large VLDL | Phospholipids in very large HDL | Phospholipids in very large VLDL (UKB data field 23490) | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1]* levels in chronic kidney disease | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [1]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [2]* levels in chronic kidney disease | Platelet distribution width | Postprandial apolipoprotein B | Postprandial cholesterol esters in large VLDL | Postprandial cholesterol esters in very large VLDL | Postprandial free cholesterol in large VLDL | Postprandial free cholesterol in medium VLDL | Postprandial large VLDL particle concentration | Postprandial linoleic acid (18:2) | Postprandial medium VLDL particle concentration | Postprandial omega-6 fatty acids | Postprandial phospholipid levels in large VLDL | Postprandial polyunsaturated fatty acids | Postprandial remnant cholesterol | Postprandial serum total triglycerides | Postprandial total cholesterol in large VLDL | Postprandial total cholesterol in very large VLDL | Postprandial total lipids in large VLDL | Postprandial total lipids in medium VLDL | Postprandial total lipids in very small VLDL | Postprandial triglyceride levels | Postprandial triglycerides in VLDL | Postprandial triglycerides levels in large VLDL | Postprandial triglycerides levels in medium VLDL | Postprandial triglycerides levels in small HDL | Postprandial triglycerides levels in small VLDL | Postprandial triglycerides levels in very small VLDL | Prenylcysteine oxidase 1 levels | Protein FAM69C levels | Protein MENT levels (MENT.5744.12.3) | Protein S100-A13 levels | Protocadherin beta-10 levels | Quinone oxidoreductase-like protein 1 levels | RAC-beta serine/threonine-protein kinase levels | Ras-related protein Rab-14 levels | Ras-related protein Rab-14 levels (RAB14.14283.12.3) | Ratio of triglycerides to phosphoglycerides | Repulsive guidance molecule A levels | Selenoprotein S levels | Serum albumin levels | Serum levels of protein ADAM11 | Serum levels of protein AKT2 | Serum levels of protein ARFGAP1 | Serum levels of protein C1orf56 | Serum levels of protein CRYZL1 | Serum levels of protein CUZD1 | Serum levels of protein FAM159B | Serum levels of protein GAL3ST2 | Serum levels of protein GGT2 | Serum levels of protein GSTM1 | Serum levels of protein HBQ1 | Serum levels of protein HDAC8 | Serum levels of protein HLA-DRB3 | Serum levels of protein IFIT2 | Serum levels of protein NEFL | Serum levels of protein NPTX2 | Serum levels of protein PSG5 | Serum levels of protein RAB14 | Serum levels of protein TMCC3 | Serum levels of protein TOM1L1 | Serum levels of protein TP53I11 | Serum levels of protein YWHAQ | Sex hormone-binding globulin levels | Sex hormone-binding globulin levels adjusted for BMI | SH2 domain-containing protein 3C levels | Sphingomyelin_38:1_[M+H]1+ levels | Sphingomyelin(34:0)_[M+H]1+ levels | Sphingomyelin(42:0)_[M+OAc]1- levels | Synaptotagmin-like protein 4 levels | TOM1-like protein 1 levels | TOM1-like protein 1 levels (TOM1L1.13652.2.3) | Total cholesterol levels | Total lipid levels in large HDL | Total lipid levels in very large VLDL | Total lipids in large HDL (UKB data field 23559) | Total lipids in very large VLDL (UKB data field 23489) | Total triglycerides levels | Total triglycerides levels (UKB data field 23407) | Triacylglycerol_56:5_[M+NH4]1+ levels | Triacylglycerol_56:6_[M+NH4]1+ levels | Triacylglycerol_56:7_[M+NH4]1+ levels | Triglyceride levels | Triglyceride levels (MTAG) | Triglyceride levels in IDL | Triglyceride levels in non-type 2 diabetes | Triglyceride levels in small LDL | Triglyceride levels in small VLDL | Triglyceride levels in very large HDL | Triglyceride levels in very large VLDL | Triglyceride levels in very small VLDL | Triglyceride levels in VLDL | Triglyceride levels x short total sleep time interaction (2df test) | Triglyceride to HDL cholesterol ratio | Triglycerides | Triglycerides in small HDL | Triglycerides in small VLDL (UKB data field 23515) | Triglycerides in very large HDL (UKB data field 23557) | Triglycerides in very large VLDL (UKB data field 23494) | Triglycerides in VLDL (UKB data field 23408) | Triglycerides to total lipids ratio in medium HDL | Triglycerides to total lipids ratio in small HDL | Triglycerides to total lipids ratio in very large HDL | Tubulin-specific chaperone A levels (TBCA.12501.10.3) | Ubiquitin-conjugating enzyme E2 G2 levels | Uncharacterized protein C14orf93 levels | Waist-hip index | Waist-to-hip ratio adjusted for BMI	APOE	Smith_2020 (rs429358)	S
54	1	gap_gm	20	30336992	rs6060924	A	G	0.7093	0.14403343	0.02298341	3.684e-10	54890	0.0039	0.7019	0.7143	+++	0	1.088	2	0.5805	intronic	TPX2	0	TPX2	20q11.21	protein_coding	TPX2 microtubule nucleation factor	0.144033	0.0229913	3.73579e-10	0	rs6060924	0	1	A/G	20	30336992	1	1	0.55	9	BCL2L1 (0.548) | TPX2 (0.442)	1	0.59	133	TPX2 (0.491) | BCL2L1 (0.388) | MYLK2 (0.204) | FOXS1 (0.021)	1.57	2	86 | 2059	TPX2 (0.464) | BCL2L1 (0.310) | MYLK2 (0.234) | LOC101926935 (0.085) | ID1 (0.085) | HM13 (0.084) | NINL (0.071) | LINC01733 (0.069) | MIR663AHG (0.069) | LINC01597 (0.062) | DEFB123 (0.062) | DEFB115 (0.061) | FRG1BP (0.052) | REM1 (0.042) | NCOR1P1 (0.028) | LOC100134868 (0.023) | FAM242B (0.022) | GINS1 (0.022) | DEFB116 (0.007) | FAM182A (0.007) | ZNF337-AS1 (0.007) | TTLL9 (0.005) | XKR7 (0.005) | LOC105372582 (0.005) | NANP (0.005) | ZNF337 (0.003) | FAM182B (0.003) | COX4I2 (0.002) | DEFB122 (0.002) | DEFB118 (0.001) | MLLT10P1 (0.001) | DEFB119 (0.001) | LINC00028 (0.001) | DUSP15 (0.001) | DEFB121 (0.001) | DEFB124 (0.001) | MIR3193 (0.000) | HM13-AS1 (0.000)	NA	NA	NA	COX4I2 (21;6e-16) | MYLK2 (13;4e-16) | DEFB124 (9;9e-22) | ANKRD20A21P (9;9e-09) | DUSP15 (5;2e-05) | FOXS1 (3;1e-09) | TPX2 (3;2e-08) | TTLL9 (3;2e-08) | ABALON (3;2e-07) | HM13 (2;6e-18) | BCL2L1 (2;2e-13) | REM1 (1;8e-11) | HM13-AS1 (1;2e-08) | ENSG00000226239 (1;6e-05) | POFUT1 (1;1e-04)	ANKRD20A21P (24/25;5e-53) | COX4I2 (45/47;3e-177) | ABALON (25/49;4e-28)	ID1 (0.83) | FOXS1 (0.83) | BCL2L1 (0.69)	aseg lh volume Putamen | aseg rh volume Pallidum | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Caudate nucleus volume | Height | Lung function (forced vital capacity) | Lung function (FVC) | Pallidum volume | Parkinson's disease | Platelet count | Platelet-to-lymphocyte ratio | Plateletcrit | Prostate cancer | Putamen volume | Subcortical brain region volumes | Subcortical volume (min-P) | Subcortical volume (MOSTest) | Vertex-wise cortical thickness | Vertex-wise sulcal depth	BCL2L1	Smith_2020 (rs1888995)	S
55	1	gap_wm	22	38457329	rs738442	T	C	0.3753	-0.21345619	0.02148412	2.916e-23	54890	0.0037	0.3729	0.3916	--+	64.1	5.576	2	0.06154	intronic	PICK1	0	PICK1	22q13.1	protein_coding	protein interacting with PRKCA 1	-0.2125	0.0215035	4.97589e-23	-0.00473635	rs738442	0	1	T/C	22	38457329	1	1	0.72	23	PICK1 (0.704) | SLC16A8 (0.120) | POLR2F (0.070) | BAIAP2L2 (0.064)	1	0.99	8	PICK1 (0.959)	1.32	1	8	PICK1 (0.956)	SLC16A8 (2;rs2076371;1.374) | BAIAP2L2 (1;rs142739979;NA)	PICK1 (rs6000991;2e-16) | POLR2F (rs742396;2e-12) | SLC16A8 (rs6000991;4e-11) | SOX10 (rs2076370;2e-10) | AL031587.1 (rs6000991;2e-09) | AL031587.4 (rs2076370;4e-07)	PICK1 (rs5756894;4e-10)	PICK1 (21;4e-26) | SLC16A8 (13;1e-31) | TRIOBP (13;2e-09) | ENSG00000272720 (9;5e-19) | BAIAP2L2 (5;9e-48) | MICALL1 (4;1e-06) | TMEM184B (3;7e-07) | GCAT (3;9e-07) | GALR3 (1;5e-12) | ENSG00000279010 (1;2e-07) | NOL12 (1;3e-06) | CSNK1E (1;1e-05) | PDXP-DT (1;2e-05) | C22orf23 (1;3e-05) | ENSG00000273866 (1;3e-05) | ENSG00000279738 (1;4e-05) | TPTEP2 (1;4e-05) | H1-0 (1;6e-05) | POLR2F (1;6e-05)	TRIOBP (43/49;1e-78) | PICK1 (26/49;4e-223)	LGALS1 (1.24) | SOX10 (1.09) | PICK1 (0.84)	aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | IDP dMRI ProbtrackX FA fmi | IDP dMRI ProbtrackX FA ifo r | IDP dMRI ProbtrackX ICVF cgc r | IDP dMRI ProbtrackX ICVF fmi | IDP dMRI ProbtrackX ICVF ilf r | IDP dMRI ProbtrackX L3 cgc l | IDP dMRI ProbtrackX L3 fmi | IDP dMRI ProbtrackX MD cgc l | IDP dMRI TBSS FA Genu of corpus callosum | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Sagittal stratum R | IDP dMRI TBSS L3 Sagittal stratum L | IDP dMRI TBSS L3 Sagittal stratum R | IDP dMRI TBSS MD Sagittal stratum R | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Regional cortical thickness (cuneus) | Ventral frontal thickness (unadjusted for global measures) | White matter microstructure (fractional anisotropy)	PICK1	Smith_2020 (rs742396), Wen_2024 (rs1894525)	S,W
55	2	gap_gwm	22	38450620	rs2018980	A	G	0.3717	-0.15923167	0.02064007	1.213e-14	54890	0.0038	0.3694	0.3899	--+	42.6	3.485	2	0.1751	intergenic	PICK1	2642	POLR2F(dist=12698),PICK1(dist=2642)	22q13.1	protein_coding	protein interacting with PRKCA 1	-0.158187	0.0206514	1.86157e-14	-0.00491981	rs738442	-6.71	0.979	TA/CG	22	38457329	1	1	0.77	7	PICK1 (0.929) | SLC16A8 (0.059)	1	0.88	11	PICK1 (0.920) | SLC16A8 (0.047)	1.19	1	11	PICK1 (0.922) | SLC16A8 (0.047)	SLC16A8 (1;rs4289289;24.100)	PICK1 (rs6000991;1e-11) | POLR2F (rs742396;1e-09) | AL022322.1 (rs5756894;2e-09) | SLC16A8 (rs6000991;7e-09) | SOX10 (rs2076370;2e-08) | AL031587.1 (rs6000991;7e-08) | AL031587.4 (rs2076370;3e-06)	PICK1 (rs5756894;2e-08)	PICK1 (21;1e-25) | SLC16A8 (13;9e-31) | TRIOBP (13;5e-09) | ENSG00000272720 (9;6e-19) | BAIAP2L2 (5;7e-48) | MICALL1 (4;1e-06) | GCAT (3;2e-07) | TMEM184B (3;2e-07) | GALR3 (1;8e-13) | ENSG00000279010 (1;2e-07) | NOL12 (1;1e-06) | CSNK1E (1;1e-05) | PDXP-DT (1;2e-05) | C22orf23 (1;3e-05) | ENSG00000273866 (1;3e-05) | ENSG00000279738 (1;4e-05) | TPTEP2 (1;4e-05) | H1-0 (1;5e-05) | POLR2F (1;6e-05)	TRIOBP (41/49;1e-73) | PICK1 (26/49;4e-223)	PICK1 (1.05) | LGALS1 (0.86) | SOX10 (0.65)	aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | IDP dMRI ProbtrackX FA fmi | IDP dMRI ProbtrackX FA ifo r | IDP dMRI ProbtrackX ICVF cgc r | IDP dMRI ProbtrackX ICVF fmi | IDP dMRI ProbtrackX ICVF ilf r | IDP dMRI ProbtrackX L3 cgc l | IDP dMRI ProbtrackX L3 fmi | IDP dMRI ProbtrackX MD cgc l | IDP dMRI TBSS FA Genu of corpus callosum | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Sagittal stratum R | IDP dMRI TBSS L3 Sagittal stratum L | IDP dMRI TBSS L3 Sagittal stratum R | IDP dMRI TBSS MD Sagittal stratum R | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Regional cortical thickness (cuneus) | Ventral frontal thickness (unadjusted for global measures) | White matter microstructure (fractional anisotropy)	PICK1	Smith_2020 (rs742396), Wen_2024 (rs1894525)	S,W
56	1	gap_gm	X	13891499	rs2188767	A	G	0.4154	0.10708689	0.01745761	8.564e-10	54890	0.0046	0.4107	0.4333	++-	0	1.89	2	0.3888	intronic	GPM6B	0	GPM6B	Xp22.2	protein_coding	glycoprotein M6B	0.107087	0.0174615	8.63805e-10	0	rs2188767	0	1	A/G	23	13891499	1	NA	NA	NA	NA	2	1.00 | 0.87	1 | 10	GPM6B (1.959)	3.39	3	1 | 1 | 7	GPM6B (2.983)	NA	NA	NA	GEMIN8 (3;2e-05) | GPM6B (1;6e-21) | OFD1 (1;9e-15) | RAB9A (1;3e-10)	GEMIN8 (45/49;5e-34)	NA	Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity	GEMIN8	Novel	-
56	2	gap_gwm	X	13891499	rs2188767	A	G	0.4154	0.09657698	0.01666613	6.84e-09	54890	0.0045	0.4107	0.4333	++-	0	1.711	2	0.4252	intronic	GPM6B	0	GPM6B	Xp22.2	protein_coding	glycoprotein M6B	0.096577	0.0166695	6.88726e-09	0	rs2188767	0	1	A/G	23	13891499	1	NA	NA	NA	NA	1	0.95	8	GPM6B (1.034)	1.74	1	10	GPM6B (0.971)	NA	NA	NA	GEMIN8 (3;2e-05) | GPM6B (1;6e-21) | OFD1 (1;9e-15) | RAB9A (1;3e-10)	GEMIN8 (45/49;5e-34)	NA	Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity	GEMIN8	Novel	-
57	1	gap_gm	X	107888149	X:107888149_CAA_C	CAA	C	0.7409	-0.11428578	0.02045899	2.322e-08	54890	0.006	0.7397	0.7744	---	0	0.103	2	0.95	intronic	COL4A5	0	COL4A5	Xq22.3	protein_coding	collagen type IV alpha 5 chain	-0.114286	0.0204631	2.33739e-08	0	X:107888149_CAA_C	0	1	CAA/C	23	107888149	1	NA	NA	NA	NA	NA	NA	NA	NA	1.5	1	176	COL4A6 (0.795) | COL4A5 (0.146) | IRS4 (0.009)	NA	NA	NA	NA	NA	NA	NA	NA	Novel	-
58	1	gap_gm	X	133781440	X:133781440_CTG_C	CTG	C	0.2876	-0.1127918	0.02001977	1.761e-08	54890	0.003	0.282	0.29	---	0	0.118	2	0.9429	intronic	PLAC1	0	PLAC1	Xq26.3	protein_coding	placenta enriched 1	-0.112792	0.0200239	1.7726e-08	0	X:133781440_CTG_C	0	1	CTG/C	23	133781440	1	NA	NA	NA	NA	2	0.70 | 0.60	41 | 60	PLAC1 (1.193) | PHF6 (0.631) | HPRT1 (0.410) | CCDC160 (0.223) | MIR106A (0.090)	2.38	2	41 | 60	PLAC1 (0.951) | PHF6 (0.451) | HPRT1 (0.267) | MIR106A (0.116) | CCDC160 (0.116)	NA	NA	NA	NA	NA	NA	NA	NA	Novel	-
59	1	gap_wm	XY	2149565	rs34250447	T	C	0.7428	-0.25149953	0.02494865	6.725e-24	53037	4e-04	0.7423	0.7431	--?	68.4	3.167	1	0.07512	intronic	DHRSX	0	DHRSX	Xp22.33	protein_coding	dehydrogenase/reductase X-linked	-0.2515	0.0249735	7.44822e-24	0	rs34250447	0	1	T/C	25	2149565	1	NA	NA	NA	NA	1	0.92	54	DHRSX (0.951)	1.14	1	54	DHRSX (0.951)	NA	NA	NA	DHRSX (11;7e-12) | DHRSX-IT1 (1;4e-05)	DHRSX (47/49;2e-109) | DHRSX-IT1 (25/34;6e-18)	NA	NA	DHRSX	Novel	-
59	2	gap_gwm	XY	2137156	rs35679611	A	G	0.758	-0.22475779	0.02376448	3.147e-21	53037	3e-04	0.7576	0.7583	--?	60.2	2.516	1	0.1127	downstream	DHRSX	0	DHRSX(dist=399)	Xp22.33	protein_coding	dehydrogenase/reductase X-linked	-0.224758	0.0237842	3.39284e-21	0	rs34250447	-12.4	0.95	CG/TA	25	2149565	1	NA	NA	NA	NA	1	0.92	38	DHRSX (0.951)	1.15	1	38	DHRSX (0.952)	NA	NA	NA	DHRSX (11;7e-12) | CD99 (1;7e-06) | DHRSX-IT1 (1;4e-05)	DHRSX (47/49;2e-109) | DHRSX-IT1 (25/34;6e-18)	NA	NA	DHRSX	Novel	-
59	3	gap_gm	XY	2124487	rs189737749	T	C	0.2435	0.16869295	0.02539927	3.102e-11	53037	3e-04	0.2432	0.2439	++?	0	0.795	1	0.3725	intergenic	DHRSX	13068	ASMT(dist=362513),DHRSX(dist=13068)	Xp22.33	protein_coding	dehydrogenase/reductase X-linked	0.168693	0.02541	3.16173e-11	0	rs34250447	-25.1	0.935	CT/TC	25	2149565	1	NA	NA	NA	NA	1	0.91	48	DHRSX (0.950)	1.15	1	47	DHRSX (0.950)	NA	NA	NA	DHRSX (11;2e-10) | CD99 (1;7e-06) | DHRSX-IT1 (1;4e-05)	DHRSX (47/49;4e-105) | DHRSX-IT1 (25/34;6e-18)	NA	NA	DHRSX	Novel	-
